<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">89317</article-id><article-id pub-id-type="doi">10.7554/eLife.89317</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.89317.4</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Suggestion of creatine as a new neurotransmitter by approaches ranging from chemical analysis and biochemistry to electrophysiology</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-307104"><name><surname>Bian</surname><given-names>Xiling</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-307103"><name><surname>Zhu</surname><given-names>Jiemin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-307057"><name><surname>Jia</surname><given-names>Xiaobo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4214-8906</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-319078"><name><surname>Liang</surname><given-names>Wenjun</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307106"><name><surname>Yu</surname><given-names>Sihan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-331522"><name><surname>Li</surname><given-names>Zhiqiang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-246279"><name><surname>Zhang</surname><given-names>Wenxia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-2641"><name><surname>Rao</surname><given-names>Yi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0405-5426</contrib-id><email>yrao@pku.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02v51f717</institution-id><institution>Laboratory of Neurochemical Biology, PKU-IDG/McGovern Institute for Brain Research, Peking-Tsinghua Center for Life Sciences, School of Life Sciences, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/029819q61</institution-id><institution>Chinese Institute for Brain Research (CIBR)</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013xs5b60</institution-id><institution>Chinese Institutes of Medical Research, Capital Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution>Changping Laboratory, Yard 28, Science Park Road, Changping District</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00sdcjz77</institution-id><institution>Institute of Molecular Physiology, Shenzhen Bay Laboratory</institution></institution-wrap><addr-line><named-content content-type="city">Shenzhen</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/042pgcv68</institution-id><institution>Research Unit of Medical Neurobiology, Chinese Academy of Medical Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Doe</surname><given-names>Chris Q</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006w34k90</institution-id><institution>Howard Hughes Medical Institute, University of Oregon</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Huguenard</surname><given-names>John R</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>21</day><month>12</month><year>2023</year></pub-date><volume>12</volume><elocation-id>RP89317</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-05-31"><day>31</day><month>05</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2022-12-23"><day>23</day><month>12</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.12.22.521565"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-08-14"><day>14</day><month>08</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89317.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-10-06"><day>06</day><month>10</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89317.2"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-11-17"><day>17</day><month>11</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89317.3"/></event></pub-history><permissions><copyright-statement>© 2023, Bian, Zhu, Jia et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Bian, Zhu, Jia et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-89317-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-89317-figures-v1.pdf"/><abstract><p>The discovery of a new neurotransmitter, especially one in the central nervous system, is both important and difficult. We have been searching for new neurotransmitters for 12 y. We detected creatine (Cr) in synaptic vesicles (SVs) at a level lower than glutamate and gamma-aminobutyric acid but higher than acetylcholine and 5-hydroxytryptamine. SV Cr was reduced in mice lacking either arginine:glycine amidinotransferase (a Cr synthetase) or SLC6A8, a Cr transporter with mutations among the most common causes of intellectual disability in men. Calcium-dependent release of Cr was detected after stimulation in brain slices. Cr release was reduced in <italic>Slc6a8</italic> and <italic>Agat</italic> mutants. Cr inhibited neocortical pyramidal neurons. SLC6A8 was necessary for Cr uptake into synaptosomes. Cr was found by us to be taken up into SVs in an ATP-dependent manner. Our biochemical, chemical, genetic, and electrophysiological results are consistent with the possibility of Cr as a neurotransmitter, though not yet reaching the level of proof for the now classic transmitters. Our novel approach to discover neurotransmitters is to begin with analysis of contents in SVs before defining their function and physiology.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>neurotransmitters</kwd><kwd>synaptic vesicles</kwd><kwd>neurotransmission</kwd><kwd>synaptic transmission</kwd><kwd>biochemical purification</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005150</institution-id><institution>Chinese Academy of Medical Sciences</institution></institution-wrap></funding-source><award-id>2019RU003</award-id><principal-award-recipient><name><surname>Rao</surname><given-names>Yi</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>Chinese Institute for Brain Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Rao</surname><given-names>Yi</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Peking-Tsinghua Center for Life Sciences</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Rao</surname><given-names>Yi</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Changping Laboratory</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Rao</surname><given-names>Yi</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>32061143017</award-id><principal-award-recipient><name><surname>Rao</surname><given-names>Yi</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81473189</award-id><principal-award-recipient><name><surname>Bian</surname><given-names>Xiling</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>While neurotransmitters were discovered decades ago, evidence suggests that more transmitters are to be discovered using the presented approaches.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Neural signaling depends on chemical transmission between neurons and their target cells (<xref ref-type="bibr" rid="bib83">Du Bois-Reymond, 1877</xref>; <xref ref-type="bibr" rid="bib142">Langley, 1901b</xref>; <xref ref-type="bibr" rid="bib89">Elliot, 1904</xref>; <xref ref-type="bibr" rid="bib90">Elliott, 1905</xref>; <xref ref-type="bibr" rid="bib69">Dale, 1914</xref>; <xref ref-type="bibr" rid="bib152">Loewi, 1921</xref>). Neurotransmission depends on chemicals such as neurotransmitters, neuromodulators, and neuropeptides. Decades of work, sometimes with convoluted paths, were involved before a molecule was established as a classic neurotransmitter (<xref ref-type="bibr" rid="bib203">Rao, 2019</xref>). Initial hints about cholinergic signaling were obtained in the 1800s (<xref ref-type="bibr" rid="bib29">Bernard, 1857</xref>; <xref ref-type="bibr" rid="bib140">Langley and Dickinson, 1890</xref>; <xref ref-type="bibr" rid="bib143">Langley, 1905</xref>; <xref ref-type="bibr" rid="bib144">Langley, 1906</xref>). Choline (<xref ref-type="bibr" rid="bib240">Strecker, 1862</xref>; <xref ref-type="bibr" rid="bib148">Liebreich, 1865</xref>) and acetylcholine (ACh) (<xref ref-type="bibr" rid="bib18">Baeyer, 1867</xref>) were discovered decades before their pharmacological effects were found around the turn of 20th century (<xref ref-type="bibr" rid="bib122">Hunt and Taveau, 1906</xref>; <xref ref-type="bibr" rid="bib174">Mott and Halliburton, 1899</xref>; <xref ref-type="bibr" rid="bib121">Hunt, 1900</xref>). Henry Dale and colleagues realized similarities of ACh and parasympathetic stimulation (<xref ref-type="bibr" rid="bib69">Dale, 1914</xref>; <xref ref-type="bibr" rid="bib91">Ewins, 1914</xref>), but it was not until 1929 when ACh was detected in the body (<xref ref-type="bibr" rid="bib70">Dale and Dudley, 1929</xref>) and 1934 when ACh was proven a neurotransmitter in the peripheral nervous system (PNS) (<xref ref-type="bibr" rid="bib95">Feldberg and Gaddum, 1934</xref>; <xref ref-type="bibr" rid="bib46">Brown and Feldberg, 1936</xref>; <xref ref-type="bibr" rid="bib71">Dale et al., 1936</xref>). It took nearly 100 y from the finding of the effects of supradrenal gland damage (<xref ref-type="bibr" rid="bib7">Addison, 1855</xref>) or removal (<xref ref-type="bibr" rid="bib221">Schäfer, 1908</xref>), the observation of an activity in the supradrenal gland (<xref ref-type="bibr" rid="bib186">Oliver and Schäfer, 1895</xref>), the isolation of an inactive derivative (<xref ref-type="bibr" rid="bib4">Abel, 1898</xref>; <xref ref-type="bibr" rid="bib3">Abel and Crawford, 1897</xref>; <xref ref-type="bibr" rid="bib5">Abel, 1899</xref>; <xref ref-type="bibr" rid="bib6">Abel, 1901</xref>), and the successful isolation of adrenaline (<xref ref-type="bibr" rid="bib245">Takamine, 1901</xref>; <xref ref-type="bibr" rid="bib246">Takamine, 1902</xref>; <xref ref-type="bibr" rid="bib11">Aldrich, 1901</xref>), the notice of similarities between adrenaline and sympathetic stimulation (<xref ref-type="bibr" rid="bib89">Elliot, 1904</xref>; <xref ref-type="bibr" rid="bib90">Elliott, 1905</xref>; <xref ref-type="bibr" rid="bib141">Langley, 1901a</xref>; <xref ref-type="bibr" rid="bib22">Barger and Dale, 1910</xref>; <xref ref-type="bibr" rid="bib51">Cannon et al., 1933</xref>), to the mid-1940s when Ulf von Euler proved that noradrenaline (NA) was the neurotransmitter of the sympathetic nerves (<xref ref-type="bibr" rid="bib256">von Euler, 1946</xref>; <xref ref-type="bibr" rid="bib257">von Euler, 1948</xref>; <xref ref-type="bibr" rid="bib258">von Euler, 1956</xref>). While it is not easy to establish a molecule as a neurotransmitter in the PNS, it is even harder to establish a central nervous system (CNS) neurotransmitter. Three decades elapsed between the time when ACh was proven to be a PNS neurotransmitter and the time when it was established as a CNS neurotransmitter (<xref ref-type="bibr" rid="bib171">Mitchell, 1963</xref>; <xref ref-type="bibr" rid="bib62">Collier and Mitchell, 1966</xref>; <xref ref-type="bibr" rid="bib63">Collier and Mitchell, 1967</xref>) and two decades between NA as a peripheral transmitter and a central transmitter (<xref ref-type="bibr" rid="bib52">Carlsson et al., 1962</xref>; <xref ref-type="bibr" rid="bib31">Björklund et al., 1968</xref>).</p><p>If a neurotransmitter acts only in the CNS, but not in the PNS, it is much more difficult to discover or to prove. Most neurotransmitters were discovered for their effects on peripheral tissues, with muscle contraction or relaxation as a major readout. Glutamate (Glu) (<xref ref-type="bibr" rid="bib207">Robbins, 1958</xref>; <xref ref-type="bibr" rid="bib66">Curtis et al., 1959</xref>; <xref ref-type="bibr" rid="bib67">Curtis and Watkins, 1960</xref>; <xref ref-type="bibr" rid="bib68">Curtis and Watkins, 1963</xref>) and gamma-aminobutyric acid (GABA) (<xref ref-type="bibr" rid="bib67">Curtis and Watkins, 1960</xref>; <xref ref-type="bibr" rid="bib208">Roberts and Frankel, 1950</xref>; <xref ref-type="bibr" rid="bib253">Udenfriend, 1950</xref>; <xref ref-type="bibr" rid="bib97">Florey, 1954</xref>; <xref ref-type="bibr" rid="bib98">Florey and McLennan, 1955</xref>) were discovered partly because of their peripheral effects and partly because of their effects on spinal neurons. There is no reason for central neurotransmitters to also act peripherally, but relatively little efforts have been reported to find small-molecule neurotransmitters acting only on CNS neurons with no peripheral bioassays available. Premature assumptions and technical difficulties are among the major reasons why the hunt for neurotransmitters has not been a highly active area of research over the last three decades.</p><p>Are there more neurotransmitters and how can they be discovered? Classic neurotransmitters are stored in synaptic vesicles (SVs) (<xref ref-type="bibr" rid="bib92">Fatt and Katz, 1950</xref>; <xref ref-type="bibr" rid="bib93">Fatt and Katz, 1952</xref>; <xref ref-type="bibr" rid="bib77">Del Castillo and Katz, 1954</xref>; <xref ref-type="bibr" rid="bib209">Robertson, 1953</xref>; <xref ref-type="bibr" rid="bib189">Palade and Palay, 1954</xref>; <xref ref-type="bibr" rid="bib190">Palay, 1954</xref>; <xref ref-type="bibr" rid="bib79">De Robertis and Bennett, 1954</xref>; <xref ref-type="bibr" rid="bib80">De Robertis and Bennett, 1955</xref>; <xref ref-type="bibr" rid="bib78">del Castillo and Katz, 1956</xref>). They are released upon electric stimulation before being degraded enzymatically or taken up into the presynaptic terminal by cytoplasmic transporters and into SVs by vesicular transporters (<xref ref-type="bibr" rid="bib17">Axelrod et al., 1959</xref>; <xref ref-type="bibr" rid="bib199">Radian and Kanner, 1985</xref>; <xref ref-type="bibr" rid="bib200">Radian et al., 1986</xref>; <xref ref-type="bibr" rid="bib109">Guastella et al., 1990</xref>; <xref ref-type="bibr" rid="bib188">Pacholczyk et al., 1991</xref>; <xref ref-type="bibr" rid="bib32">Blakely et al., 1991</xref>). Most of the major textbooks list either three (<xref ref-type="bibr" rid="bib195">Purves et al., 2001</xref>; <xref ref-type="bibr" rid="bib196">Purves et al., 2016</xref>; <xref ref-type="bibr" rid="bib26">Bear et al., 2016</xref>) or four (<xref ref-type="bibr" rid="bib131">Kandel et al., 2013</xref>; <xref ref-type="bibr" rid="bib132">Kandel et al., 2021</xref>; <xref ref-type="bibr" rid="bib228">Siegel and Sapru, 2011</xref>) criteria of a neurotransmitter: presence in presynaptic neurons, release upon stimulation, action on postsynaptic neurons, mechanism of removal. Some molecules commonly accepted as neurotransmitters still do not meet all the criteria listed in different textbooks, but they nonetheless play important functional roles in the CNS and their defects cause human diseases. Over time, different small molecules have been proposed to function as neurotransmitters (e.g., <xref ref-type="bibr" rid="bib31">Björklund et al., 1968</xref>; <xref ref-type="bibr" rid="bib96">Felix and Künzle, 1974</xref>), but none satisfies all the criteria. Robust and reliable detection of the candidate molecule in SVs is often, though not always, the problem (cf. <xref ref-type="bibr" rid="bib53">Chantranupong et al., 2020</xref>).</p><p>Beginning in 2011, we have been actively searching for new neurotransmitters in the mammalian brain. We have tried different approaches, including searching for neuroactive substances in the cerebral spinal fluid (CSF) and following transporters potentially localized in the SVs. One approach that we have now taken to fruition is the purification of the SVs from mouse brains coupled with chemical analysis of their contents. We have found known transmitters such as Glu, GABA, ACh, and 5-hydroxytryptamine (5-HT). But more importantly, we have reproducibly detected creatine (Cr) in SVs.</p><p>Cr was discovered in 1832 by Michel-Eugène Chevreul (<xref ref-type="bibr" rid="bib56">Chevreul, 1835</xref>; <xref ref-type="bibr" rid="bib147">Liebig, 1847</xref>) and has long been considered as an energy buffer in the muscle and the brain (<xref ref-type="bibr" rid="bib265">Wyss and Kaddurah-Daouk, 2000</xref>; <xref ref-type="bibr" rid="bib44">Brosnan and Brosnan, 2007</xref>; <xref ref-type="bibr" rid="bib259">Wallimann et al., 2011</xref>). Half of Cr in a mammalian animal is thought to come from diet and the rest from endogenous synthesis (<xref ref-type="bibr" rid="bib40">Braissant et al., 2011</xref>). Most of the Cr is present in the muscle, but it is also present in the brain. Although most of the endogenous Cr is synthesized in the kidney, the pancreas, and the liver (<xref ref-type="bibr" rid="bib265">Wyss and Kaddurah-Daouk, 2000</xref>; <xref ref-type="bibr" rid="bib183">Ohtsuki et al., 2002</xref>), Cr is also synthesized in the brain (<xref ref-type="bibr" rid="bib40">Braissant et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Braissant et al., 2001</xref>; <xref ref-type="bibr" rid="bib37">Braissant et al., 2007</xref>).</p><p>Solute carriers (SLC) contribute to both cytoplasmic and vesicular transporters. With 19 members in humans, family 6 (SLC6) are secondary active transporters relying on electrochemical Na<sup>+</sup> or H<sup>+</sup> gradients (<xref ref-type="bibr" rid="bib180">Nelson, 1998</xref>; <xref ref-type="bibr" rid="bib55">Chen et al., 2004</xref>; <xref ref-type="bibr" rid="bib120">Höglund et al., 2005</xref>; <xref ref-type="bibr" rid="bib43">Bröer and Gether, 2012</xref>; <xref ref-type="bibr" rid="bib127">Iversen, 2006</xref>; <xref ref-type="bibr" rid="bib42">Bröer, 2006</xref>). SLC6 is also known as the neurotransmitter transporter (NTT) family because some members transport neurotransmitters such as GABA (by SLC6A1 or GABA transporter 1, GAT1; SLC6A13 or GAT2; SLC6A11 or GAT3) (<xref ref-type="bibr" rid="bib110">Guastella et al., 1992</xref>; <xref ref-type="bibr" rid="bib59">Clark et al., 1992</xref>; <xref ref-type="bibr" rid="bib34">Borden et al., 1992</xref>; <xref ref-type="bibr" rid="bib153">Lopez-Corcuera et al., 1992</xref>), NA (by SLC6A2 or NA transporter [NET]) (<xref ref-type="bibr" rid="bib188">Pacholczyk et al., 1991</xref>), dopamine (by SLC6A3 or DAT) (<xref ref-type="bibr" rid="bib104">Giros et al., 1991</xref>; <xref ref-type="bibr" rid="bib135">Kilty et al., 1991</xref>; <xref ref-type="bibr" rid="bib227">Shimada et al., 1991</xref>), 5-HT (by SLC6A4 or serotonin transporter [SERT]) (<xref ref-type="bibr" rid="bib32">Blakely et al., 1991</xref>; <xref ref-type="bibr" rid="bib119">Hoffman et al., 1991</xref>), and glycine (by SLC6A9, or GlyT1; SLC6A5 or GlyT2) (<xref ref-type="bibr" rid="bib110">Guastella et al., 1992</xref>; <xref ref-type="bibr" rid="bib232">Smith et al., 1992</xref>; <xref ref-type="bibr" rid="bib151">Liu et al., 1992</xref>). Cr is transported by SLC6A8 (also known as CrT, CT1, or CRCT) (<xref ref-type="bibr" rid="bib161">Mayser et al., 1992</xref>; <xref ref-type="bibr" rid="bib111">Guimbal and Kilimann, 1993</xref>; <xref ref-type="bibr" rid="bib105">Gonzalez and Uhl, 1994</xref>; <xref ref-type="bibr" rid="bib179">Nash et al., 1994</xref>; <xref ref-type="bibr" rid="bib224">Schloss et al., 1994</xref>; <xref ref-type="bibr" rid="bib233">Sora et al., 1994</xref>; <xref ref-type="bibr" rid="bib23">Barnwell et al., 1995</xref>). In addition to peripheral organs and tissues, SLC6A8 is also expressed in the nervous system where it is mainly in neurons (<xref ref-type="bibr" rid="bib36">Braissant et al., 2001</xref>; <xref ref-type="bibr" rid="bib224">Schloss et al., 1994</xref>; <xref ref-type="bibr" rid="bib116">Happe and Murrin, 1995</xref>; <xref ref-type="bibr" rid="bib216">Saltarelli et al., 1996</xref>; <xref ref-type="bibr" rid="bib155">Mak et al., 2009</xref>). SLC6A8 protein could be found on the plasma membrane of neurons (<xref ref-type="bibr" rid="bib155">Mak et al., 2009</xref>; <xref ref-type="bibr" rid="bib234">Speer et al., 2004</xref>; <xref ref-type="bibr" rid="bib154">Lowe et al., 2015</xref>).</p><p>The functional significance of SLC6A8 in the brain is supported by symptoms of humans defective in SLC6A8. Mutations in <italic>SLC6A8</italic> were found in human patients with intellectual disability (ID), delayed language development, epileptic seizures, and autistic-like behaviors (<xref ref-type="bibr" rid="bib215">Salomons et al., 2001</xref>; <xref ref-type="bibr" rid="bib157">Margherita Mancardi et al., 2007</xref>). They are collectedly known as Cr transporter deficiency (CTD), with ID as the hallmark. Particular vulnerability of language development has been observed in some <italic>SLC6A8</italic> mutations which had mild ID but severe language delay (<xref ref-type="bibr" rid="bib25">Battini et al., 2011</xref>). CTD contributes to approximately 1–2.1% of X-linked mental retardation (<xref ref-type="bibr" rid="bib211">Rosenberg et al., 2004</xref>; <xref ref-type="bibr" rid="bib182">Newmeyer et al., 2005</xref>; <xref ref-type="bibr" rid="bib60">Clark et al., 2006</xref>; <xref ref-type="bibr" rid="bib150">Lion-François et al., 2006</xref>; <xref ref-type="bibr" rid="bib16">Arias et al., 2007</xref>; <xref ref-type="bibr" rid="bib197">Puusepp et al., 2010</xref>; <xref ref-type="bibr" rid="bib54">Cheillan et al., 2012</xref>; <xref ref-type="bibr" rid="bib255">van de Kamp et al., 2014</xref>; <xref ref-type="bibr" rid="bib130">Joncquel-Chevalier Curt et al., 2015</xref>). While CTD is highly prevalent in ID males, it is also present in females, with an estimated carrier frequency of 0.024% (<xref ref-type="bibr" rid="bib81">DesRoches et al., 2015</xref>).</p><p><italic>Slc6a8</italic> knockout mice (<xref ref-type="bibr" rid="bib231">Skelton et al., 2011</xref>; <xref ref-type="bibr" rid="bib139">Kurosawa et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Baroncelli et al., 2016</xref>) showed typical symptoms of human CTD patients with early and progressive impairment in learning and memory. Mice with brain- and neuronal-specific knockout of <italic>Slc6a8</italic> showed deficits in learning and memory without changes in locomotion caused by peripheral involvement of <italic>Slc6a8</italic> (<xref ref-type="bibr" rid="bib254">Udobi et al., 2018</xref>; <xref ref-type="bibr" rid="bib173">Molinaro et al., 2019</xref>). Deletion of <italic>Slc6a8</italic> from dopaminergic neurons in the brain caused hyperactivity (<xref ref-type="bibr" rid="bib1">Abdulla et al., 2020</xref>). These results demonstrate that SLC6A8 is functionally important in neurons.</p><p>Cr deficiency syndromes (CDS) are inborn errors of Cr metabolism, which can result from defects in one of the three genes: guanidinoacetate methyltransferase (<italic>GAMT</italic>) (<xref ref-type="bibr" rid="bib237">Stöckler et al., 1994</xref>), arginine-glycine amidinotransferase (<italic>AGAT</italic>) (<xref ref-type="bibr" rid="bib30">Bianchi et al., 2000</xref>; <xref ref-type="bibr" rid="bib126">Item et al., 2001</xref>), and <italic>SLC6A8</italic> (<xref ref-type="bibr" rid="bib215">Salomons et al., 2001</xref>). That they all show brain disorders indicates the functional importance of Cr in the brain (<xref ref-type="bibr" rid="bib238">Stockler-Ipsiroglu et al., 2014</xref>; <xref ref-type="bibr" rid="bib239">Stockler-Ipsiroglu et al., 2015</xref>; <xref ref-type="bibr" rid="bib134">Khan et al., 2016</xref>; <xref ref-type="bibr" rid="bib99">Fons and Campistol, 2016</xref>).</p><p>Here we first biochemically purified SVs from the mouse brain and discovered the presence of Cr, as well as classic neurotransmitters Glu and GABA, ACh and 5-HT, in SVs. We then detected calcium (Ca<sup>2+</sup>)-dependent releases of Cr, Glu, and GABA but not ACh and 5-HT when neurons were depolarized by increased extracellular concentrations of potassium (K<sup>+</sup>). Both the level of Cr in SVs and that of Cr released upon stimulation were decreased significantly when either the gene for <italic>Slc6a8</italic> or the gene for <italic>Agat</italic> were eliminated genetically. When Cr was applied to slices from the neocortex, the activities of pyramidal neurons were inhibited. Furthermore, we confirmed that Cr was taken up by synaptosomes and found that Cr uptake was significantly reduced when the <italic>Slc6a8</italic> gene was deleted. Finally, we found that Cr was transported into SVs. Thus, multidisciplinary studies with biochemistry, genetics, and electrophysiology have suggested that Cr is a new neurotransmitter, though the discovery of a receptor for Cr would prove it.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Detection of Cr in SVs from the mouse brain</title><p>To search for new neurotransmitters, we tried several approaches. For example, we used Ca<sup>2+</sup> imaging to detect neuroactive substances in the cerebrospinal fluid (CSF), but it was difficult to rule out existing neurotransmitters and select responses from potentially new neurotransmitters. We also transfected cDNAs for all human SLCs into dissociated cultures of primary neurons from the mouse brain and found that more than 50 out of all SLCs could be localized in SVs. However, when we used CRISPR-Cas9 to tag some of the candidate SLCs in mice, some of them were found to be expressed outside the CNS, indicating that, while ectopic expression of these candidate SLCs could be localized on SVs, the endogenous counterparts were not localized on SVs.</p><p>Here, we report our approach using the purification of SVs as the first step (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib262">Whittaker et al., 1964</xref>; <xref ref-type="bibr" rid="bib177">Nagy et al., 1976</xref>; <xref ref-type="bibr" rid="bib159">Matthew et al., 1981</xref>; <xref ref-type="bibr" rid="bib74">De Camilli et al., 1983</xref>; <xref ref-type="bibr" rid="bib123">Huttner et al., 1983</xref>; <xref ref-type="bibr" rid="bib48">Burger et al., 1989</xref>; <xref ref-type="bibr" rid="bib49">Burger et al., 1991</xref>; <xref ref-type="bibr" rid="bib160">Maycox et al., 1992</xref>). Synaptophysin (Syp) is a specific marker for SVs (<xref ref-type="bibr" rid="bib128">Jahn et al., 1985</xref>; <xref ref-type="bibr" rid="bib263">Wiedenmann and Franke, 1985</xref>; <xref ref-type="bibr" rid="bib145">Leube et al., 1987</xref>; <xref ref-type="bibr" rid="bib242">Südhof et al., 1987</xref>) and an anti-Syp antibody was used to immunoisolate SVs (<xref ref-type="bibr" rid="bib48">Burger et al., 1989</xref>; <xref ref-type="bibr" rid="bib49">Burger et al., 1991</xref>; <xref ref-type="bibr" rid="bib129">Jahn and Sudhof, 1994</xref>; <xref ref-type="bibr" rid="bib158">Martineau et al., 2013</xref>; <xref ref-type="bibr" rid="bib35">Bradberry et al., 2022</xref>). Visualization by electronic microscopy (EM) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>, left panel) showed that the purified vesicles were homogeneous, with an average diameter of 40.44 ± 0.26 nm (n = 596 particles) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>, right panel), consistent with previous descriptions of SVs (<xref ref-type="bibr" rid="bib9">Ahmed et al., 2013</xref>; <xref ref-type="bibr" rid="bib248">Takamori et al., 2006</xref>).</p><p>Immunoblot analysis with 20 markers of subcellular organelles of neurons and 1 marker for glia (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>) indicates that our purifications were highly effective, with SV markers detected after purification with the anti-Syp antibody, but not that with the control immunoglobulin G (IgG). SV proteins included Syp (<xref ref-type="bibr" rid="bib128">Jahn et al., 1985</xref>; <xref ref-type="bibr" rid="bib263">Wiedenmann and Franke, 1985</xref>; <xref ref-type="bibr" rid="bib145">Leube et al., 1987</xref>; <xref ref-type="bibr" rid="bib242">Südhof et al., 1987</xref>), synaptotagmin (Syt1) (<xref ref-type="bibr" rid="bib101">Geppert et al., 1994</xref>), synatobrevin2 (Syb2) (<xref ref-type="bibr" rid="bib149">Link et al., 1992</xref>; <xref ref-type="bibr" rid="bib223">Schiavo et al., 1992</xref>), SV2A (<xref ref-type="bibr" rid="bib19">Bajjalieh et al., 1992</xref>), H<sup>+</sup>-ATPase (<xref ref-type="bibr" rid="bib58">Cidon and Sihra, 1989</xref>), and vesicular neurotransmitter transporters for glutamate (VGLUT1, VGLUT2) (<xref ref-type="bibr" rid="bib247">Takamori et al., 2000</xref>) and GABA (VGAT) (<xref ref-type="bibr" rid="bib163">McIntire et al., 1997</xref>). Immunoisolation by the anti-Syp antibody did not bring down markers for the synaptic membrane (with SNAP23 as a marker) (<xref ref-type="bibr" rid="bib138">Kunii et al., 2021</xref>; <xref ref-type="bibr" rid="bib204">Ravichandran et al., 1996</xref>; <xref ref-type="bibr" rid="bib243">Suh et al., 2010</xref>), postsynaptic components (with PSD95 and GluN1 as markers) (<xref ref-type="bibr" rid="bib264">Woods and Bryant, 1991</xref>; <xref ref-type="bibr" rid="bib57">Cho et al., 1992</xref>), the Golgi apparatus (with GM130 and Golgin 97 as markers) (<xref ref-type="bibr" rid="bib178">Nakamura et al., 1995</xref>; <xref ref-type="bibr" rid="bib107">Griffith et al., 1997</xref>), early endosome (with early endosome-associated 1 [EEA1] as a marker) (<xref ref-type="bibr" rid="bib175">Mu et al., 1995</xref>), the lysosome (with LC3B and cathepsinB as markers), the cytoplasma (with glyceraldehyde-3-phophate dehydrogenase [GAPDH] as a marker), mitochondria (with voltage-dependent anion channel [VDAC] as a marker), cytoplasmic membrane (with calcium voltage-gated channel subunit alpha 1 [CACNA1A] as a marker), axonal membrane (with glucose transporter type 4 [GluT4] as a marker), and glia membrane (with myelin basic protein [MBP] as a marker). These results indicated that the SVs we obtained were of high integrity and purity.</p><p>To detect and quantify small molecules as candidate transmitters present in the purified SVs, capillary electrophoresis-mass spectrometry (CE-MS) was optimized and utilized (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib158">Martineau et al., 2013</xref>; <xref ref-type="bibr" rid="bib250">Tie et al., 2012</xref>). We found that the levels of classical neurotransmitters such as Glu, GABA, ACh, and 5-HT were significantly higher in SVs pulled down by the anti-Syp antibody than those in lysates pulled down by the control IgG (<xref ref-type="fig" rid="fig1">Figure 1A–E</xref>). Consistent with previous reports (<xref ref-type="bibr" rid="bib49">Burger et al., 1991</xref>; <xref ref-type="bibr" rid="bib158">Martineau et al., 2013</xref>), significant enrichment of neurotransmitters was observed only from SVs immunoisolated at near 0°C, but not at the room temperature (RT) (<xref ref-type="fig" rid="fig1">Figure 1A–E</xref>). By contrast, another small molecule, alanine (<xref ref-type="fig" rid="fig1">Figure 1G</xref>), was not elevated in SVs compared to the control.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Presence of creatine (Cr) in synaptic vesicles (SVs) from the mouse brain.</title><p>(<bold>A</bold>) Representative raw traces from capillary electrophoresis-mass spectrometry (CE-MS) of indicated molecules from samples immunoisolated by the control immunoglobulin G (IgG) (blue) at 0–2°C, the monoclonal anti-synaptophysin (anti-Syp) antibody at 0–2°C (red), and the anti-Syp antibody at room temperature (RT, green). Q1/Q3 for identifying targets are indicated. (<bold>B–G</bold>) Quantification of the amounts of indicated molecules. The amount of a molecule was divided by the amount of the anti-Syp antibody bound to magnetic beads. Note glutamate (Glu) (<bold>B</bold>), gamma-aminobutyric acid (GABA)(C), acetylcholine (ACh) (<bold>D</bold>), 5-hydroxytryptamine (5-HT) (<bold>E</bold>), Cr (<bold>F</bold>), but not alanine (<bold>G</bold>) was higher in SVs pulled down by the anti-Syp antibody at 0–2°C than those pulled down by the IgG control or those pulled down at the RT. n = 10 (<bold>B–E, G</bold>) or 14 (<bold>F</bold>) samples per group, *** p&lt;0.001, ns, not significant. One-way ANOVA with Tukey’s correction.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig1">Figure 1B-G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Validation of synaptic vesicle (SV) purification from the mouse brain.</title><p>(<bold>A</bold>) A diagram for SV purification and SV content analysis. Brain homogenates were centrifugated at 35,000 × <italic>g</italic> for 25 min and supernatants containing SVs were collected as the starting material. Following immunopurification by the anti-Syn antibody, SVs were broken by water to release their contents. Metabolites were analyzed by capillary electrophoresis-mass spectrometry (CE-MS). (<bold>B</bold>) Electronic microscopy (EM) of SVs captured by the anti-Syn antibody. Arrows point to SVs, the size each being 40.4 ± 0.26 nm, with size distribution shown on the right. (<bold>C</bold>) Analysis of SV purity by immunoblotting. Markers for SVs (Syp, syt, H<sup>+</sup>-ATPase, syb2, SV2A, VGLU1, VGLU2 and VGAT) were effectively pulled down by beads coated with the anti-Syn antibody but not by those coated with immunoglobulin G (IgG). Non-SV markers present in supernatants, including those for the lysosome (LAMP1, cathepasinB, LC3B), the Golgi apparatus (GM130, Golgi 97), the early endosome (EEA1), the cytoplasma (GAPDH), synaptic membrane (SNAP23) and postsynaptic components (PSD95, GluN1), the mitochondria (VDAC), the cytoplasmic membrane (CACNA1A), axonal membrane (GluT4), and glia membrane (MBP), could not be pulled down by either the anti-Syp antibody or IgG.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Particle diameter of SVs for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Original western blot files for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig1-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title>Labelled western blot files for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig1-figsupp1-data3-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Effects of pharmacological inhibitors on synaptic vesicle (SV) contents.</title><p>(<bold>A</bold>) Creatine (Cr), (<bold>B</bold>) glutamate (Glu) ,(<bold>C</bold>) gamma-aminobutyric acid (GABA), (<bold>D</bold>) acetylcholine (ACh), (<bold>E</bold>) 5-hydroxytryptamine (5-HT), and (<bold>F</bold>) alanine. *p&lt;0.5, **p&lt;0.05, ***p&lt;0.01, one-way ANOVA with Tukey’s correction (n = 4 per group). Data were normalized to average amount of molecules pulled down by the anti-Syp antibody. NIG, nigericin.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig1-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig1-figsupp2-v1.tif"/></fig></fig-group><p>The amount of Glu was 171.1 ± 5.4 pmol/μg anti-Syp antibody (n = 10, <xref ref-type="fig" rid="fig1">Figure 1B</xref>), approximately 10 times that of GABA (n = 10,17.81 ± 1.47 pmol/μg anti-Syp antibody, <xref ref-type="fig" rid="fig1">Figure 1C</xref>). The amount of ACh was 1.29 ± 0.10 pmol/μg anti-Syp antibody (n = 10, <xref ref-type="fig" rid="fig1">Figure 1D</xref>), approximately 0.072 that of GABA. The amount of 5-HT was 0.096 ± 0.017 pmol/μg anti-Syp antibody (n = 10, <xref ref-type="fig" rid="fig1">Figure 1E</xref>). Thus, our purification and detection methods were highly reliable and sensitive enough to detect established neurotransmitters.</p><p>Under the same conditions, we also detected Cr in SVs (n = 14, <xref ref-type="fig" rid="fig1">Figure 1A, F</xref>). Amount of Cr in the SVs was found to be 3.43 ± 0.40 pmol/μg anti-Syp antibody (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), which was approximately 2% of Glu, 19% of GABA, 266% of ACh, and 3573% of 5-HT. It is unlikely that these could be attributable to different levels for different neurotransmitters in each SV, but more likely attributable to the relative abundance of SVs containing different neurotransmitters. Also, 85–90% neurons in the mouse brain were glutamatergic while 10–15% were GABAergic (<xref ref-type="bibr" rid="bib169">Meyer et al., 2011</xref>; <xref ref-type="bibr" rid="bib185">Olbrich and Braak, 1985</xref>; <xref ref-type="bibr" rid="bib252">Tremblay et al., 2016</xref>), which can explain our detection of Glu as approximately 10 times that of GABA (<xref ref-type="fig" rid="fig1">Figure 1B, C</xref>). Similarly, cholinergic neurons (5.67 × 10<sup>5</sup>) (<xref ref-type="bibr" rid="bib146">Li et al., 2018</xref>) represented 0.81% of total number of neurons (approximately 70 million) in the mouse brain (<xref ref-type="bibr" rid="bib118">Herculano-Houzel et al., 2006</xref>), serotonergic neurons (approximately 26,000) for 0.037% of total neurons (<xref ref-type="bibr" rid="bib118">Herculano-Houzel et al., 2006</xref>; <xref ref-type="bibr" rid="bib125">Ishimura et al., 1988</xref>). Assuming that the content of each neurotransmitter in a single SV is similar, extrapolation from the above data would suggest that approximately 1.3–2.15% of neurons in the mouse brain are creatinergic.</p><p>To distinguish whether small molecules co-purified with SVs were in the SVs (<xref ref-type="bibr" rid="bib48">Burger et al., 1989</xref>; <xref ref-type="bibr" rid="bib49">Burger et al., 1991</xref>), or that they were just associated with the outside of SVs (<xref ref-type="bibr" rid="bib248">Takamori et al., 2006</xref>), we tested the dependence of the presence of these molecules in the SVs on temperature and on the electrochemical gradient of H<sup>+</sup>. Cr was significantly reduced in SVs purified at RT compared to that immunoisolated at near 0°C (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), supporting the presence of Cr inside, instead of outside, SVs.</p><p>Classical neurotransmitters are stored in SVs with an acidic environment inside (pH of 5.6–6.4) (<xref ref-type="bibr" rid="bib87">Egashira et al., 2016</xref>; <xref ref-type="bibr" rid="bib156">Mani and Ryan, 2009</xref>; <xref ref-type="bibr" rid="bib86">Egashira et al., 2015</xref>). To further verify the storage of Cr in SVs and examine the role of H<sup>+</sup> electrochemical gradient, we applied pharmacological inhibitors during purification (<xref ref-type="bibr" rid="bib53">Chantranupong et al., 2020</xref>; <xref ref-type="bibr" rid="bib198">Qian et al., 2021</xref>). The proton ionophore FCCP (carbonyl cyanide-4-(tri-fluoromethoxy) phenylhydrazone) was used to dissipate H<sup>+</sup> electrochemical gradient (<xref ref-type="bibr" rid="bib198">Qian et al., 2021</xref>; <xref ref-type="bibr" rid="bib222">Schenck et al., 2009</xref>). FCCP significantly reduced the amount of Cr as well as classical neurotransmitters in SVs (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–E</xref>). The extent of FCCP-induced reduction was correlated with the value of pKa or PI (isoelectric point) for different molecule: 5-HT (with pKa predicted to 10 and 9.31, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E</xref>) &gt; Cr (PI of ~7.94, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>) &gt; GABA (PI of 7.33, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>) &gt; Glu (PI of 3.22, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>). Nigericin, a K<sup>+</sup>/H<sup>+</sup> exchanger which dissipates ΔpH (<xref ref-type="bibr" rid="bib198">Qian et al., 2021</xref>; <xref ref-type="bibr" rid="bib222">Schenck et al., 2009</xref>), also reduced the amount of Cr and classical neurotransmitters in SVs (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–E</xref>). Furthermore, in the presence of FCCP or nigericin, SV Cr was reduced to a level comparable to that pulled down by control IgG (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>), demonstrating the storage of Cr in SVs was dependent on H<sup>+</sup> gradient. As a control, the non-neurotransmitter molecule alanine in SVs was not changed by the inhibitors (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2F</xref>).</p></sec><sec id="s2-2"><title>Reduction of SV Cr in mouse mutants lacking <italic>Slc6a8</italic></title><p><italic>SLC6A8</italic>, located on the X chromosome, encodes a transporter for Cr and its loss-of-function (LOF) mutations caused behavioral deficits in humans (<xref ref-type="bibr" rid="bib215">Salomons et al., 2001</xref>; <xref ref-type="bibr" rid="bib157">Margherita Mancardi et al., 2007</xref>) and mice (<xref ref-type="bibr" rid="bib231">Skelton et al., 2011</xref>; <xref ref-type="bibr" rid="bib139">Kurosawa et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Baroncelli et al., 2016</xref>; <xref ref-type="bibr" rid="bib254">Udobi et al., 2018</xref>; <xref ref-type="bibr" rid="bib173">Molinaro et al., 2019</xref>; <xref ref-type="bibr" rid="bib1">Abdulla et al., 2020</xref>). To investigate whether SLC6A8 affects Cr in SVs, we generated <italic>Slc6a8</italic> knockout (KO) mice. Exon 1 of the <italic>Slc6a8</italic> gene was partially replaced with CreERT2-WPRE-polyA by CRISPR/Cas9 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Examination by reverse polymerase chain reaction (RT-PCR) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A, B</xref>) and quantitative real-time reverse PCR (qPCR, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C, D</xref>) showed that <italic>Slc6a8</italic> mRNA was not detected in either male or female mutants, and significantly reduced in female heterozygous (<italic>Slc6a8<sup>+/-</sup></italic>). Consistent with previous reports, the body weights of <italic>Slc6a8</italic> KO mice were reduced (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B, D</xref>; <xref ref-type="bibr" rid="bib231">Skelton et al., 2011</xref>; <xref ref-type="bibr" rid="bib85">Duran-Trio et al., 2021</xref>; <xref ref-type="bibr" rid="bib236">Stockebrand et al., 2018</xref>). Brain weight was not significantly different between <italic>Slc6a8</italic> KO mice and WT mice (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A, C</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Slc6a8</italic> and creatine (Cr) in synaptic vesicles (SVs).</title><p>(<bold>A</bold>) A schematic illustration of the strategy for generating <italic>Slc6a8</italic> knockouts using CRISPR/Cas9. An iCreERT2-WPRE-pA cassette (~3.5 kb) was inserted immediately downstream of ATG in the <italic>Slc6a8</italic> gene, substituting bp 4 to bp 51 in exon 1 (E1). (<bold>B</bold>) Representative raw traces of Cr immunoisolated by control immunoglobulin G (IgG) from WT mice (blue), the anti-synaptophysin (anti-Syp) antibody from WT mice (red), IgG from <italic>Slc6a8</italic> KO mice (blue), and the anti-Syp antibody from <italic>Slc6a8</italic> KO mice (red). (<bold>C–H</bold>) Quantification of indicated molecules. Note the selective reduction of Cr in SVs from <italic>Slc6a8</italic> KO mice. n = 14 samples per group. ***p&lt;0.001, ns, not significant. One-way ANOVA with Tukey’s correction.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig2">Figure 2C–H</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Validation of SLC6A8 knockout mice.</title><p>(<bold>A</bold>) Reverse polymerase chain reaction (RT-PCR) analysis of full-length coding sequences showing absence of <italic>Slc6a8</italic> mRNA expression in brains from hemizygous (<italic>Slc6a8<sup>-/Y</sup></italic>) male knockout mice. GAPDH serves as the control. (<bold>B</bold>) Detection of <italic>Slc6a8</italic> mRNA expression in female mice, showing reduced expression in heterozygous (<italic>Slc6a8<sup>+/-</sup></italic>) and loss of <italic>Slc6a8</italic> expression in homozygous (<italic>Slc6a8<sup>-/-</sup></italic>) knockout mice. (<bold>C, D</bold>) Quantitative RT-PCR analysis. The average values of <italic>Slc6a8</italic> mRNA/<italic>Gapdh</italic> in WT mice (<italic>Slc6a8<sup>+/Y</sup></italic> males in C<bold> </bold>and <italic>Slc6a8<sup>+/+</sup></italic> females in D) were set to 1. **p&lt;0.01 in (<bold>C</bold>), Student’s <italic>t</italic>-test. *** in (<bold>D</bold>), p&lt;0.001, one-way ANOVA with Tukey’s correction (n = 4 mice per group, with three repeats for each mice).</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Original gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig2-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Labelled gels for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig2-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata3"><label>Figure 2—figure supplement 1—source data 3.</label><caption><title>Data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C and D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig2-figsupp1-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Brain and body weights of <italic>Slc6a8</italic> knockout mice.</title><p>(<bold>A</bold>) Brain weights of male mice. (<bold>B</bold>) Body weights of male mice. (<bold>C</bold>) Brain weight of female mice. (<bold>D</bold>) Body weights of female mice. **p&lt;0.01 in (<bold>B</bold>), Student’s <italic>t</italic>-test. *p&lt;0.05, **p&lt;0.01, *** in (<bold>E</bold>), p&lt;0.001, one-way ANOVA with Tukey’s correction (n = 5 mice per group, 7 weeks old).</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A–D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig2-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Representative capillary electrophoresis-mass spectrometry (CE-MS) data of molecules.</title><p>(<bold>A–E</bold>) Molecules pull-down from WT mice by immunoglobulin G (WT-IgG), anti-synaptophysin antibody (WT-Syp), and those from knockout mice (<italic>Slc6a8</italic> KO-IgG, <italic>Slc6a8</italic> KO-Syp). (<bold>A</bold>) Glutamate (Glu). (<bold>B</bold>) Gamma-aminobutyric acid (GABA). (<bold>C</bold>) Acetylcholine (ACh). (<bold>D</bold>) 5-Hydroxytryptamine (5-HT). (<bold>E</bold>) Alanine. Vertical: signal amplitude; abscissa: retention time.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig2-figsupp3-v1.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Proteins and small molecules detected in synaptic vesicles (SVs) from WT and <italic>Slc6a8</italic> KO mice.</title><p>(<bold>A</bold>) Immunoblotting analysis of SV markers synaptophysin (Syp), syt, H-ATPase, and postsynaptic components (PSD95). (<bold>B–D</bold>) Peak areas of capillary electrophoresis-mass spectrometry (CE-MS) signals for neurotransmitters: glutamate (Glu), gamma-aminobutyric acid (GABA), and acetylcholine (ACh). These neurotransmitters are enriched in SVs and not affected by <italic>Slc6a8</italic> genotypes. (<bold>E</bold>) Alanine was not enriched in SVs of either WT or <italic>Slc6a8</italic> KO mice. (<bold>F</bold>) Representative raw example traces of creatine (Cr). (<bold>G</bold>) Cr in SVs was lower in <italic>Slc6a8</italic> KO mice than that in WT mice. **p&lt;0.01, ***p&lt;0.001, one-way ANOVA with Tukey’s correction (n = 8 samples per group).</p><p><supplementary-material id="fig2s4sdata1"><label>Figure 2—figure supplement 4—source data 1.</label><caption><title>Original western blot files for <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig2-figsupp4-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2s4sdata2"><label>Figure 2—figure supplement 4—source data 2.</label><caption><title>Labelled western blot files for <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig2-figsupp4-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2s4sdata3"><label>Figure 2—figure supplement 4—source data 3.</label><caption><title>Data for <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4B–E, and G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig2-figsupp4-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig2-figsupp4-v1.tif"/></fig></fig-group><p>When we examined the contents of SVs isolated by the anti-Syp antibody vs the control IgG, significant reduction was only observed for Cr, but not classical neurotransmitters (<xref ref-type="fig" rid="fig2">Figure 2B–H</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A–E</xref>). While Cr pulled down by IgG was not significantly different between <italic>Slc6a8<sup>-/Y</sup></italic> and <italic>Slc6a8<sup>+/Y</sup></italic> mice, SV Cr purified by the anti-Syp antibody from <italic>Slc6a8<sup>-/Y</sup></italic> was reduced to approximately 1/3 that of the WT (<italic>Slc6a8<sup>+/Y</sup></italic>) littermates (n = 14, <xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). Compared to the IgG control, Cr in SVs was enriched in WT mice, but not in <italic>Slc6a8<sup>-/Y</sup></italic> mice (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). In both <italic>Slc6a8<sup>-/Y</sup></italic> and <italic>Slc6a8<sup>+/Y</sup></italic> mice, classical neurotransmitters in SVs were all enriched as compared to IgG controls (<xref ref-type="fig" rid="fig2">Figure 2D–G</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A–D</xref>). The amounts of Glu (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>), GABA (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B</xref>), ACh (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3C</xref>), and 5-HT (<xref ref-type="fig" rid="fig2">Figure 2G</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3D</xref>) in SVs were not different between <italic>Slc6a8<sup>-/Y</sup></italic> and <italic>Slc6a8<sup>+/Y</sup></italic> mice. Molecules not enriched in SVs from WT mice, such as alanine, were also unaffected by <italic>Slc6a8</italic> KO (<xref ref-type="fig" rid="fig2">Figure 2H</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3E</xref>).</p><p>It is unlikely that the specific reduction of Cr in SVs from <italic>Slc6a8</italic> KO mice was due to technical artifacts. First, the possibility of less SVs obtained from <italic>Slc6a8</italic> KO mice was precluded by immunoblot analysis, as assessed by SV markers Syp, Syt, and H<sup>+</sup>-ATPase (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4A</xref>). Second, data collected by high-resolution MS (Q Exactive HF-X, Thermo Scientific, Waltham, MA) also revealed selective decrease of SV Cr (m/z = 132.0576) from <italic>Slc6a8</italic> KO mice (n = 8, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4B–G</xref>), as quantified by the peak area. Peak areas for Glu (n = 8, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4B</xref>, m/z = 148.0604), GABA (n = 8, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4C</xref>, m/z = 104.0712), ACh (n = 8, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4D</xref>, m/z = 146.1178), and alanine (n = 8, Ala, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4E</xref>, m/z = 90.055) were not significantly different between SVs immmunoisolated with the anti-Syp antibody and control IgG from WT and <italic>Slc6a8</italic> KO mice. However, peak areas (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4G</xref>) and amplitude of Cr (n = 8, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4F</xref>) signal were significantly increased in SVs from WT mice (anti-Syp antibody vs IgG), but not that from <italic>Slc6a8</italic> KO mice.</p></sec><sec id="s2-3"><title>Reduction of SV Cr in mouse mutants lacking <italic>Agat</italic></title><p>AGAT is the enzyme catalyzing the first step in Cr synthesis (<xref ref-type="bibr" rid="bib36">Braissant et al., 2001</xref>; <xref ref-type="bibr" rid="bib113">Guthmiller et al., 1994</xref>) and its absence also led to Cr deficiency in the human brain and mental retardation (<xref ref-type="bibr" rid="bib30">Bianchi et al., 2000</xref>; <xref ref-type="bibr" rid="bib126">Item et al., 2001</xref>).</p><p>To investigate the requirement of AGAT for SV Cr, we utilized <italic>Agat</italic> ‘knockout-first’ mice (Figure 6A; <xref ref-type="bibr" rid="bib230">Skarnes et al., 2011</xref>). The targeting cassette containing Frt (Flip recombination sites)-flanked EnS2A, an IRES::lacZ trapping cassette, and a floxed <italic>neo</italic> cassette were inserted downstream of exon 2 to interfere with normal splicing of <italic>Agat</italic> pre-mRNA. Examination by RT-PCR (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>) and quantitative RT-PCR (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>) showed reduction of <italic>Agat</italic> mRNA in <italic>Agat<sup>+/-</sup></italic> and absence of <italic>Agat</italic> mRNA in <italic>Agat<sup>-/-</sup></italic> mice. Body weight (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>), but not brain weight (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>), of <italic>Agat<sup>-/-</sup></italic> mice was lower than both <italic>Agat<sup>+/+</sup></italic> and <italic>Agat</italic><sup>+/-</sup> mice, which were similar to <italic>Slc6a8</italic> KO mice.</p><p>Immunoblot analysis showed SVs purified from the brains were not significantly different among <italic>Agat<sup>+/+</sup></italic>, <italic>Agat <sup>+/-</sup>,</italic> and <italic>Agat<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A–D</xref>), as supported by quantitative analysis of Syp, Syt, and H<sup>+</sup>-ATPase (n = 20, with two repeats for 10 samples).</p><p>We analyzed small molecules present in SVs from <italic>Agat<sup>+/+</sup></italic>, <italic>Agat<sup>+/-</sup></italic>, and <italic>Agat<sup>-/-</sup></italic> mice. Cr was significantly enriched in SVs from all three genotypes compared to the IgG control (+/-). However, the level of Cr from <italic>Agat<sup>-/-</sup></italic> mice was significantly lower than those from <italic>Agat<sup>+/+</sup></italic> and <italic>Agat<sup>+/-</sup></italic> (n = 10, <xref ref-type="fig" rid="fig3">Figure 3A and B</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Reduction of synaptic vesicle (SV) creatine (Cr) in <italic>Agat</italic> knockout mice.</title><p>(<bold>A</bold>) Representative raw traces of Cr, pulled down by immunoglobulin G (IgG) or anti-synaptophysin (anti-Syp) from A<italic>gat<sup>+/+</sup></italic>, A<italic>gat <sup>+/-</sup></italic>, and A<italic>gat<sup>-/-</sup></italic> mice. (<bold>B–G</bold>) Quantification of indicated molecules. Cr was significantly decreased in A<italic>gat<sup>-/-</sup></italic> mice compared to Cr in A<italic>gat<sup>+/+</sup></italic> or A<italic>gat <sup>+/-</sup></italic> mice (<bold>B</bold>). Gamma-aminobutyric acid (GABA) was significantly decreased in SVs from A<italic>gat<sup>-/-</sup></italic> mice compared to A<italic>gat<sup>+/+</sup></italic> mice (<bold>D</bold>) but the difference was smaller than that of Cr. Glutamate (Glu) (<bold>C</bold>), acetylcholine (ACh) (<bold>E</bold>), 5-hydroxytryptamine (5-HT) (<bold>F</bold>), and alanine was not different among A<italic>gat<sup>+/+</sup></italic>, A<italic>gat <sup>+/-</sup></italic>, and A<italic>gat<sup>-/-</sup></italic>mice. n = 10 samples per group. ***p&lt;0.001, ns, not significant. One-way ANOVA with Tukey’s correction.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig3">Figure 3B–G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Validation <italic>Agat</italic>-KO first mice.</title><p>(<bold>A</bold>) Reverse polymerase chain reaction (RT-PCR) analysis of the entire coding region showing the absence of <italic>Agat</italic> mRNA in <italic>Agat<sup>-/-</sup></italic> mice and decreased expression in <italic>Agat<sup>+/-</sup></italic>. (<bold>B</bold>) Quantitative RT-PCR analysis. ***p&lt;0.001, one-way ANOVA with Tukey’s correction (n = 4 mice per group, with three repeats for each mice).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Original gels for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig3-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Labelled gels for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig3-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata3"><label>Figure 3—figure supplement 1—source data 3.</label><caption><title>Data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig3-figsupp1-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Brain and body weights of <italic>Agat</italic><sup>+/+</sup>, <italic>Agat</italic><sup>+/-</sup>, and <italic>Agat</italic><sup>-/-</sup> mice.</title><p>(<bold>A</bold>) Brain weights of male mice. (<bold>B</bold>) Body weights of male mice. *p&lt;0.05, ***p&lt;0.001, one-way ANOVA with Tukey’s correction, ns, not significant (n = 5 mice per group, 7 wk).</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A and B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig3-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Similar amounts of synaptic vesicles (SVs) pulled down from <italic>Agat</italic><sup>+/+</sup>, <italic>Agat</italic><sup>+/-</sup>, and <italic>Agat</italic><sup>-/-</sup> mice.</title><p>(<bold>A</bold>) Representative western analysis of SV markers H<sup>+</sup>-ATPase, Syt, and synaptophysin (Syp) from input, samples pulled down by immunoglobulin G (IgG) (IgG-P) and anti-Syp antibody (Syp-P). (<bold>B–D</bold>) Quantification of protein band densities for Syp (<bold>B</bold>), Syt (<bold>C</bold>), and H<sup>+</sup>-ATPase (<bold>D</bold>) (+/- = 20 per group).</p><p><supplementary-material id="fig3s3sdata1"><label>Figure 3—figure supplement 3—source data 1.</label><caption><title>Original western blot files for <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig3-figsupp3-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s3sdata2"><label>Figure 3—figure supplement 3—source data 2.</label><caption><title>Labelled western blot files for <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig3-figsupp3-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s3sdata3"><label>Figure 3—figure supplement 3—source data 3.</label><caption><title>Data for <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B–D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig3-figsupp3-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig3-figsupp3-v1.tif"/></fig></fig-group><p>Glu (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), ACh (<xref ref-type="fig" rid="fig3">Figure 3E</xref>), and 5-HT (<xref ref-type="fig" rid="fig3">Figure 3F</xref>) were all enriched in SVs (compared to IgG controls) and not significantly different among <italic>Agat<sup>+/+</sup></italic>, <italic>Agat<sup>+/-</sup></italic>, and <italic>Agat<sup>-/-</sup></italic> mice. GABA in SVs from <italic>Agat<sup>-/-</sup></italic> mice was also decreased from <italic>Agat<sup>+/+</sup></italic> mice by 30%, to an extent less than that of Cr (78.4%). Alanine was not different among three genotypes of mice (n = 6, <xref ref-type="fig" rid="fig3">Figure 3G</xref>). Thus, Cr and GABA, but not other neurotransmitters, in SVs were reduced in <italic>Agat</italic> KO mice.</p></sec><sec id="s2-4"><title>Pattern of SLC6A8 expression indicated by knockin mice</title><p>We generated <italic>Slc6a8<sup>HA</sup></italic> knockin mice by CRISPR/Cas9. Three repeats of the hemagglutinin (HA) tag (<xref ref-type="bibr" rid="bib137">Kolodziej and Young, 1991</xref>), the T2A sequence (<xref ref-type="bibr" rid="bib214">Ryan et al., 1991</xref>; <xref ref-type="bibr" rid="bib8">Ahier and Jarriault, 2014</xref>; <xref ref-type="bibr" rid="bib73">Daniels et al., 2014</xref>), and CreERT2 (<xref ref-type="bibr" rid="bib219">Sauer and Henderson, 1989</xref>; <xref ref-type="bibr" rid="bib108">Gu et al., 1993</xref>; <xref ref-type="bibr" rid="bib94">Feil et al., 1997</xref>; <xref ref-type="bibr" rid="bib124">Indra et al., 1999</xref>) were inserted in-frame at the C terminus of the SLC6A8 protein (<xref ref-type="fig" rid="fig4">Figure 4A</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Expression pattern of SLC6a8.</title><p>(<bold>A</bold>) A diagram illustrating the generation of <italic>Slc6a8<sup>HA</sup></italic> KI mice. 3*HA, T2A, and CreERT2 were inserted in-frame, before the stop codon, to the C terminus of SLC6A8 protein. (<bold>B–K</bold>) Low-magnification photomicrographs of coronal sections immunohistochemically labeled with the anti-HA antibody in <italic>Slc6a8<sup>HA</sup></italic> mice. (<bold>I, M</bold>) immunostaining with the anti-HA antibody in control WT mice. Pir, piriform cortex; M, motor cortex; LS, lateral septum; Hp, hippocampus; Hb, habenular nucleus; Vp, ventral posterior nucleus of thalamus; Auauditory cortex; Amyg, amygdala; Ip, interpeduncular nucleus; Pn, pontine nucleus; Cb, cerebellum; Pr, prepositus; SC, superior colliculus; MVe, medial vestibular nucleus. Scale bar: 500 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig4-v1.tif"/></fig><p>To examine the expression pattern of SLC6A8, we performed immunocytochemistry with an antibody against the HA epitope in <italic>Slc6a8<sup>HA</sup></italic> and WT mice. <italic>Slc6a8<sup>HA</sup></italic> mice showed positive signals in the olfactory bulb (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), the piriform cortex (<xref ref-type="fig" rid="fig4">Figure 4C–F</xref>), the somatosensory cortex (<xref ref-type="fig" rid="fig4">Figure 4F and G</xref>), the ventral posterior thalamus (<xref ref-type="fig" rid="fig4">Figure 4H</xref>), the interpeduncular nucleus (<xref ref-type="fig" rid="fig4">Figure 4I</xref>), and the pontine nuclei (<xref ref-type="fig" rid="fig4">Figure 4J</xref>). In addition, moderate levels of immunoreactivity were observed in the motor cortex (<xref ref-type="fig" rid="fig4">Figure 4D–H</xref>), the medial habenular nucleus (<xref ref-type="fig" rid="fig4">Figure 4H</xref>), the hippocampus (<xref ref-type="fig" rid="fig4">Figure 4H</xref>), and the cerebellum (<xref ref-type="fig" rid="fig4">Figure 4K</xref>). These results were consistent with previous reports (<xref ref-type="bibr" rid="bib155">Mak et al., 2009</xref>; <xref ref-type="bibr" rid="bib154">Lowe et al., 2015</xref>). WT mice were negative for anti-HA antibody staining (<xref ref-type="fig" rid="fig4">Figure 4L and M</xref>).</p></sec><sec id="s2-5"><title>Ca<sup>2+</sup>-dependent release of Cr upon stimulation</title><p>Classical neurotransmitters are released from the SVs into the synaptic cleft in a Ca<sup>2+</sup>-dependent manner after stimulation. For example, high extracellular potassium (K<sup>+</sup>) stimulated Ca<sup>2+</sup>-dependent release of Glu, GABA, and other neurotransmitters in brain slices (<xref ref-type="bibr" rid="bib115">Hamberger et al., 1979b</xref>; <xref ref-type="bibr" rid="bib114">Hamberger et al., 1979a</xref>; <xref ref-type="bibr" rid="bib162">McBride et al., 1983</xref>; <xref ref-type="bibr" rid="bib176">Nadler et al., 1977</xref>; <xref ref-type="bibr" rid="bib133">Keith et al., 1993</xref>).</p><p>Thus, 300-μm-thick coronal slices of the mouse brain within 1–2 mm posterior to the bregma were used because the cortex, the thalamus, the habenular nucleus, and the hippocampus were positive for SLC6A8 (cf., <xref ref-type="fig" rid="fig4">Figure 4H</xref>). We monitored the effect of K<sup>+</sup> stimulation by recording neurons in the slices. Immediately after K<sup>+</sup> stimulation, pyramidal neurons in the CA1 region of the hippocampus were depolarized, firing a train of action potentials and reaching a large depolarization plateau in less than 1 min (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). K<sup>+</sup>-induced depolarization persisted for several minutes before returning to the baseline and being washed within 10 min. Thus, superfusates in 1 min fraction at the time points of 1.5 min before (control) and after K<sup>+</sup> stimulation, and 10 min after the wash were collected (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), and the metabolites in the superfusates were analyzed by CE-MS.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Creatine (Cr) release in brain slices from WT and <italic>Slc6a8</italic> knockout mice.</title><p>(<bold>A</bold>) Neuronal depolarization induced by 70 mM K<sup>+</sup> and time points for collecting the release sample. ‘Control’ samples were collected 1.5 min to 0.5 min before K<sup>+</sup> stimulation, ‘70 mM K<sup>+’</sup> artificial cerebrospinal fluid (ACSF) samples were collected during 70 mM K<sup>+</sup> stimulation, and ‘wash’ samples were collected 10 min after washout with ACSF. Efflux of glutamate (Glu) (<bold>B</bold>), gamma-aminobutyric acid (GABA) (<bold>C</bold>), or Cr (<bold>D</bold>) from WT or <italic>Slc6a8</italic> KO male mice (n = 7 samples per group). Note that a small amount of Cr released in <italic>Slc6a8</italic> KO mice did not return to the baseline after 10 min of washing. (<bold>E–G</bold>) Ca<sup>2+</sup>-dependent release of Glu, GABA, and Cr in WT and <italic>Slc6a8</italic> KO mice (n = 5 samples per group). ***p&lt;0.001, ns, not significant. One-way ANOVA with Tukey’s correction. #p&lt;0.05, ##p&lt;0.01, paired <italic>t</italic>-test.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig5">Figure 5B–G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig5-v1.tif"/></fig><p>In the presence of Ca<sup>2+</sup>, depolarization with elevated extracellular K<sup>+</sup> led to robust release of Glu and GABA in slices from WT (<italic>Slc6a8<sup>+/Y</sup></italic>) mice (n = 7 per group, <xref ref-type="fig" rid="fig5">Figure 5B and C</xref>). After 10 min wash, levels of Glu and GABA returned to the baseline (<xref ref-type="fig" rid="fig5">Figure 5B and C</xref>). In the presence of Ca<sup>2+</sup>, depolarization with elevated K<sup>+</sup> led to robust release of Cr. Extracellular Cr returned to the baseline after 10 min wash (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). For quantification, the stimulated releases of metabolites were calculated by subtracting the basal levels from the total releases in response to K<sup>+</sup> stimulation. In the presence of Ca<sup>2+</sup>, K<sup>+</sup> stimulation induced the efflux of Glu, GABA, and Cr at 0.46, 0.33, and 0.086 nmol/min, respectively (n = 7 per group) (<xref ref-type="fig" rid="fig5">Figure 5B–D</xref>). From the detection limits of ACh and 5-HT in our system, we inferred that the efflux rate for ACh was lower than 0.001 nmol/min and that for 5-HT lower than 0.003 nmol/min. The efflux rate for Cr in brain slices is lower than those of Glu and GABA, but higher than those for ACh and 5-HT.</p><p>Ca<sup>2+</sup> dependence of transmitter release was examined by comparing responses to ACSF without Ca<sup>2+</sup> or elevated K<sup>+</sup> (supplemented with 1 mM EGTA), elevated extracellular K<sup>+</sup> in the absence of Ca<sup>2+</sup> (supplemented with 1 mM EGTA), or K<sup>+</sup> in the presence of 2.5 mM Ca<sup>2+</sup> (<xref ref-type="fig" rid="fig5">Figure 5E–G</xref>, n = 5 per group). In the absence of Ca<sup>2+</sup>, elevated K<sup>+</sup> stimulated the release of a small but significant amount of Glu and GABA, with efflux rates at 0.056 nmol/min and 0.066, respectively (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>). In the presence of 2.5 mM Ca<sup>2+</sup>, elevated K<sup>+</sup> further augmented the release of Glu and GABA by 5–6 times, confirming previously reported Ca<sup>2+</sup>-dependent release of neurotransmitters in response to depolarization (<xref ref-type="bibr" rid="bib115">Hamberger et al., 1979b</xref>; <xref ref-type="bibr" rid="bib162">McBride et al., 1983</xref>).</p><p>Cr was also released both in a Ca<sup>2+</sup>-dependent and a Ca<sup>2+</sup>-independent manner (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). More Cr was released in response to K<sup>+</sup> stimulation in the presence of 2.5 mM Ca<sup>2+</sup> than that in the absence of Ca<sup>2+</sup>. These results demonstrate Ca<sup>2+</sup>-dependent release of Cr upon stimulation.</p></sec><sec id="s2-6"><title>Reduced Cr release in <italic>Slc6a8</italic> and <italic>Agat</italic> mutant mice</title><p>We examined whether <italic>Slc6a8</italic> KO affected K<sup>+</sup>-induced release of Cr. While Glu and GABA were released in slices from <italic>Slc6a8</italic> KO (<italic>Slc6a8<sup>+/Y</sup></italic>) mice at levels not significantly different from those of WT mice (<xref ref-type="fig" rid="fig5">Figure 5B and C</xref>), release of Cr in response to K<sup>+</sup> stimulation was significantly reduced in <italic>Slc6a8<sup>-/Y</sup></italic> mice compared to <italic>Slc6a8<sup>+/Y</sup></italic> mice (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). The basal level of Cr in <italic>Slc6a8</italic> KO mice was lower than that of WT mice. In addition, K<sup>+</sup> stimulation-induced release of Cr persisted to some extent even after 10 min of washout (<xref ref-type="fig" rid="fig5">Figure 5D</xref>), possibly due to the inability of presynaptic terminals in <italic>Slc6a8</italic> KO mice to reuptake Cr in the synaptic cleft (Figure 8).</p><p>Experiments with slices from brains of <italic>Slc6a8</italic> KO (<italic>Slc6a8<sup>-/Y</sup></italic>) mice showed that Ca<sup>2+</sup>-dependent release of either Glu or GABA was not affected by the genotype of <italic>Slc6a8</italic> (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>). By contrast, Ca<sup>2+</sup>-dependent release of Cr was abolished in <italic>Slc6a8<sup>-/Y</sup></italic> slices. Interestingly, Ca<sup>2+</sup>-independent release of Cr was reduced by a third, but did not reach statistical significance, in <italic>Slc6a8<sup>-/Y</sup></italic> slices. In the absence of Ca<sup>2+</sup>, the basal level of Cr was not changed in <italic>Slc6a8</italic> KO mice. Taken together, these results indicate that there is Ca<sup>2+</sup>-dependent release of Cr upon stimulation and that SLC6A8 is required specifically for Ca<sup>2+</sup>-dependent release of Cr, but not for Ca<sup>2+</sup>-dependent release of other neurotransmitters such as Glu and GABA, or for Ca<sup>2+</sup>-independent release of Cr.</p><p>Knockout of <italic>Agat</italic> (<xref ref-type="fig" rid="fig6">Figure 6A</xref>) selectively reduced K<sup>+</sup> evoked release of Cr, but not those of Glu or GABA (n = 5 per group, <xref ref-type="fig" rid="fig6">Figure 6B–D</xref>). Although K<sup>+</sup> stimulation still elicited Cr release from brain slices of <italic>Agat<sup>+/-</sup></italic>, the efflux rate in <italic>Agat<sup>-/-</sup></italic> mice was reduced to less than 10% that in <italic>Agat<sup>+/+</sup></italic> mice and 20% that in <italic>Agat<sup>+/-</sup></italic>.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Creatine (Cr) release in WT and arginine:glycine amidinotransferase (AGAT) knockout mice.</title><p>(<bold>A</bold>) A schematic diagram illustrating the strategy of <italic>Agat</italic> knockout first. With the <italic>Agat</italic> gene (also known as <italic>Gatm</italic>) shown in the upper part, and the gene targeting strategy in the lower part. The homologous arm is approximately 10 kb. A targeting cassette, containing Frt-flanked lacZ and neomycin, was inserted downstream of exon 2. At the same time, exon 3 of <italic>Agat</italic> was flanked by two loxP sites. K<sup>+</sup>-induced release of glutamate (Glu) (<bold>C</bold>) and gamma-aminobutyric acid (GABA) (<bold>D</bold>) were not significantly different among <italic>Agat<sup>+/+</sup></italic>, <italic>Agat<sup>+/-</sup></italic>, and <italic>Agat<sup>-/-</sup></italic> mice, whereas that of Cr (<bold>B</bold>) was significantly lower in AGAT<sup>-/-</sup> mice than those in <italic>Agat<sup>+/+</sup></italic> and <italic>Agat<sup>+/-</sup></italic>-.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig6">Figure 6B–D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig6-v1.tif"/></fig></sec><sec id="s2-7"><title>Cr inhibition of neocortical neurons</title><p>Our own data (<xref ref-type="fig" rid="fig4">Figure 4H</xref>) and previous reports (<xref ref-type="bibr" rid="bib155">Mak et al., 2009</xref>; <xref ref-type="bibr" rid="bib154">Lowe et al., 2015</xref>) have shown SLC6A8 in the neocortex, with dense SLA6A8-HA immunoreactive fibers in layer 4 (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib88">Eliseeva and Durinian, 1975</xref>; <xref ref-type="bibr" rid="bib267">Yamawaki et al., 2021</xref>). Layer 5 neurons in the somatosensory cortex have been reported to express SLC6A8 previously (<xref ref-type="bibr" rid="bib155">Mak et al., 2009</xref>; <xref ref-type="bibr" rid="bib154">Lowe et al., 2015</xref>). To investigate electrophysiological effects of Cr, we performed whole-cell patch-clamp recordings from the pyramidal neurons in layer 4/5 of the somatosensory cortex (<xref ref-type="fig" rid="fig7">Figure 7A and B</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Inhibitory effects of creatine (Cr) on cortical neurons.</title><p>(<bold>A</bold>) A photograph showing recording at layer 4 in the somatosensory cortex. Scale bar: 10 μm. (<bold>B</bold>) Patch-clamp recording of a pyramidal neuron. Scale bar: 10 μm. (<bold>C</bold>) Ratios of Cr-responsive and -unresponsive neurons in the region. (<bold>D</bold>) Representative raw electrophysiological traces showing inhibition of evoked firing by Cr, with the lower panel showing the stimulus protocol. (<bold>E</bold>) Evoked spike numbers in response to different current injections from (<bold>D</bold>). (<bold>F</bold>) Relationship between evoked spike numbers and different current injections to neurons that were inhibited by Cr (n = 16). (<bold>G</bold>) The same for Cr-unresponsive neurons (n = 35). (<bold>H</bold>) Rheobase for Cr-responsive neurons. (<bold>I</bold>) Evoked spike number when these neurons were injected with current of rheobase + 50 pA. (<bold>J</bold>) input resistance. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001, paired <italic>t</italic>-test.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig7">Figure 7E–J</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig7-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Layer distribution of recording sites in the somatosensory cortex.</title><p>(<bold>A</bold>) High levels of SLC6A8-HA signal observed in the somatosensory cortex, especially in layer 4. (<bold>B</bold>) Recording sites. Red denotes the responsive neurons and blue the unresponsive neurons.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Electrophysiological parameters of creatine (Cr)-responsive (blue) and Cr-nonresponsive neurons (red).</title><p>There was no significant difference between the two groups of neurons in membrane capacitance (Cm) (<bold>A</bold>) and membrane resistance (Rm) (<bold>B</bold>), resting membrane potential (RMP) (<bold>C</bold>), spike threshold (<bold>D</bold>), spike amplitude (<bold>E</bold>), half width of spike (<bold>F</bold>), and amplitude of afterhyperpolarization (AHP) (<bold>G</bold>). While no electrical parameters detected were changed by Cr in non-responsive neurons (n = 35), RMP (<bold>C</bold>) was slightly inhibited by Cr and AHP (<bold>G</bold>) was slightly elevated (n = 16) in Cr-responsive neurons (*p&lt;0.05, paired <italic>t</italic>-test).</p><p><supplementary-material id="fig7s2sdata1"><label>Figure 7—figure supplement 2—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2A–G</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig7-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig7-figsupp2-v1.tif"/></fig><fig id="fig7s3" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 3.</label><caption><title>Electrophysiological data of creatine (Cr)-unresponsive neurons.</title><p>(<bold>A</bold>) Representative raw traces. (<bold>B</bold>) I-V curve of this same neuron. No effect of 100 μM Cr on rheobase current and evoked spike number at a current of 50 pA above rheobase current was observed. (<bold>C, D</bold>) Rheobase and spike number were not changed during Cr application.</p><p><supplementary-material id="fig7s3sdata1"><label>Figure 7—figure supplement 3—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3B–D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89317-fig7-figsupp3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig7-figsupp3-v1.tif"/></fig></fig-group><p>Medium-sized pyramidal neurons (<xref ref-type="fig" rid="fig7">Figure 7B</xref>) with a membrane capacitance (Cm) of 114.96 ± 3.92 pF (n = 51, <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2A</xref>) were recorded. These neurons exhibited regular firing patterns (<xref ref-type="bibr" rid="bib220">Scala et al., 2019</xref>; <xref ref-type="bibr" rid="bib241">Stumpf et al., 2018</xref>) in response to depolarization current injection (<xref ref-type="fig" rid="fig7">Figure 7D</xref>, <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3A</xref>) with moderate maximal evoked spiking frequencies of 10–30 spikes per 500 ms (<xref ref-type="fig" rid="fig7">Figure 7E–G</xref>), increasing of inter-spike intervals during depolarizing steps (<xref ref-type="fig" rid="fig7">Figure 7D</xref>, <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3A</xref>), high action potential amplitude (81.64 ± 1.06 mV, <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2E</xref>), and large spike half-width (1.12 ± 0.031 ms, <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2F</xref>).</p><p>Cr was bath-applied only after the evoked firing pattern reached a steady state. Of the 51 neurons, 16 were inhibited by 100 μM creatine (<xref ref-type="fig" rid="fig7">Figure 7B–F</xref>). Fewer spikes were evoked in Cr-responsive neurons in response to depolarizing current injections during Cr application (25 pA step, 500 ms) (<xref ref-type="fig" rid="fig7">Figure 7D–F</xref>). The inhibitory effect of Cr was reversible (<xref ref-type="fig" rid="fig7">Figure 7D–F</xref>), typically observed within 2–3 min following Cr application (with maximal effect from 2 to 8 min) and disappeared after 10–25 min washout. This could be repeated by a second application of Cr. The rheobase, defined as the minimal electrical current necessary to elicit an action potential, was increased during bath application of Cr (<xref ref-type="fig" rid="fig7">Figure 7H</xref>). The inhibitory effect was most obvious at near spike threshold. When a neuron was depolarized with a current of 50 pA above rheobase, the number of evoked spikes was decreased dramatically during Cr application (<xref ref-type="fig" rid="fig7">Figure 7I</xref>). Cr also mildly inhibited the input resistance (<xref ref-type="fig" rid="fig7">Figure 7J</xref>), slightly hyperpolarized resting membrane potential (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2C</xref>), or reduced amplitude of afterhyperpolarization (AHP) followed by the first evoked action potential (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2G</xref>). The spike threshold (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2D</xref>), amplitude (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2E</xref>) and half width (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2F</xref>) were not changed by Cr.</p><p>The remaining 35 neurons were not responsive to Cr (<xref ref-type="fig" rid="fig7">Figure 7C and G</xref>, <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>). Cr did not change electrical parameters tested, including evoked firing rates (<xref ref-type="fig" rid="fig7">Figure 7G</xref>, <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3A, B and D</xref>), rheobase (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2C</xref>), resting membrane potential (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2C</xref>), spike threshold amplitude (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2E</xref>), and half width (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2F</xref>). In addition, electrical properties of responsive neurons and unresponsive neurons were not significantly different. With the limited number of neurons recorded, the ratio of responsive neurons appeared higher in layer 4 or border of layer 4/5, than the deeper layer in layer 5 (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>).</p></sec><sec id="s2-8"><title>SLC6A8-dependent uptake of Cr into the synaptosomes</title><p>Along with enzymatic degradation, reuptake by transporters serves as an important way to remove neurotransmitters released into the synaptic cleft. As synaptosomes contain the apparatus for neurotransmission, they are often used for studying uptake of neurotransmitters (<xref ref-type="bibr" rid="bib112">Gulyássy et al., 2020</xref>).</p><p>To investigate whether Cr uptake into synaptosomes required SLC6A8, we first examined whether SLC6A8 was present in synaptosomes. Using <italic>Slc6a8<sup>HA</sup></italic> knockin mice and an anti-HA antibody, we found that Slc6a8-HA was present and enriched in crude synaptosomal fraction (P2 fraction in <xref ref-type="fig" rid="fig8">Figure 8A</xref>, enrichment score: P2/H = 1.76 ± 0.15, n = 4) and synaptosomal fraction prepared using a discontinuous Ficoll gradient (Sy and 4-Sy fractions in <xref ref-type="fig" rid="fig8">Figure 8A</xref>, enrichment score: Sy/H = 2.02 ± 0.14, n = 4). The integrity of synaptosomes was confirmed by multiple markers of the synaptosomes (<xref ref-type="bibr" rid="bib112">Gulyássy et al., 2020</xref>), including the presynaptic membrane marker SNAP25 (<xref ref-type="bibr" rid="bib15">Antonucci et al., 2016</xref>) and the SV marker Syp (synaptophysin Syp) (<xref ref-type="bibr" rid="bib128">Jahn et al., 1985</xref>; <xref ref-type="bibr" rid="bib263">Wiedenmann and Franke, 1985</xref>; <xref ref-type="bibr" rid="bib145">Leube et al., 1987</xref>; <xref ref-type="bibr" rid="bib242">Südhof et al., 1987</xref>) in presynaptic terminals, the postsynaptic density marker PSD95 (<xref ref-type="bibr" rid="bib264">Woods and Bryant, 1991</xref>; <xref ref-type="bibr" rid="bib57">Cho et al., 1992</xref>) and the postsynaptic membrane protein GluN1 (<xref ref-type="bibr" rid="bib65">Cserép et al., 2012</xref>), the synaptic membrane protein SNAP23 (<xref ref-type="bibr" rid="bib138">Kunii et al., 2021</xref>; <xref ref-type="bibr" rid="bib204">Ravichandran et al., 1996</xref>; <xref ref-type="bibr" rid="bib243">Suh et al., 2010</xref>), the plasma membrane marker Na<sup>+</sup>-K<sup>+</sup>-ATPase (<xref ref-type="bibr" rid="bib50">Cameron et al., 1994</xref>; <xref ref-type="bibr" rid="bib168">Mersel et al., 1987</xref>; <xref ref-type="bibr" rid="bib244">Sun et al., 1988</xref>), and the mitochondria marker VDAC (<xref ref-type="bibr" rid="bib112">Gulyássy et al., 2020</xref>). These were all enriched in our synaptosomal preparations. The cytosol marker GAPDH was also present in synaptosomes, whereas the oligodendrocyte marker MBP was nearly absent, suggesting that myelin pollution was largely avoided (<xref ref-type="bibr" rid="bib112">Gulyássy et al., 2020</xref>).</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Creatine (Cr) uptake into synaptosomes and synaptic vesicles (SVs).</title><p>(<bold>A</bold>) Markers for subcellular organelles detected in synaptosomes prepared from WT mice or mice with <italic>Slc6a8</italic> gene fused in frame to the HA epitope. SLC6A8-HA was enriched in synaptosomes (Sy or 4-Sy) or crude synaptosomes (P2) (see ‘Materials and methods’), as were other markers for the subcellular organelles in synaptosomes but not the marker for myelin (MBP). (<bold>B</bold>) Representative electron micrographs and histograms of size distribution in synaptosomes isolated from WT (<italic>Slc6a8<sup>+/Y</sup></italic>) and <italic>Slc6a8</italic> KO (<italic>Slc6a8<sup>-/Y</sup></italic>) mice by Ficoll density-gradient centrifugation. Sy, synaptosome; Mt, mitochondria; PSD, postsynaptic density. Bar, 20 nm. (<bold>C</bold>) Cr uptake into synaptosomes (n = 5 per group). The two left columns were results from WT mice and the two right columns from Slc6a8 knockout mice. The control baseline was [<sup>14</sup>C]-Cr uptake at 0°C at 10 min. Cr uptake into synaptosomes at 37°C measured at 10 min was observed in WT synaptosomes. Uptake into <italic>Slc6a8</italic> knockout synaptosomes was significantly reduced compared to the WT synaptosomes. ***p&lt;0.001, one-way ANOVA with Tukey’s correction. (<bold>D</bold>) uptake of [<sup>13</sup>C]-Cr into immunoisolated SVs in the presence or absence of ATP (n = 11 samples per group). *p&lt;0.05, paired <italic>t</italic>-test.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Original western blot files for <xref ref-type="fig" rid="fig8">Figure 8A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig8-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig8sdata2"><label>Figure 8—source data 2.</label><caption><title>Labelled western blot files for <xref ref-type="fig" rid="fig8">Figure 8A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig8-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig8sdata3"><label>Figure 8—source data 3.</label><caption><title>Labelled western blot files for <xref ref-type="fig" rid="fig8">Figure 8A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89317-fig8-data3-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89317-fig8-v1.tif"/></fig><p>We have also used EM to confirm the quality of our synaptosome preparations. As reported previously (<xref ref-type="bibr" rid="bib112">Gulyássy et al., 2020</xref>; <xref ref-type="bibr" rid="bib226">Schrimpf et al., 2005</xref>), synaptosomes were composed of membrane bounded structures (Sy in <xref ref-type="fig" rid="fig8">Figure 8B</xref>) filled with synaptic vesicles (SV in <xref ref-type="fig" rid="fig8">Figure 8B</xref>), sometimes with a segment of postsynaptic membrane along with the postsynaptic density (PSD in <xref ref-type="fig" rid="fig8">Figure 8B</xref>) and mitochondria (Mt in <xref ref-type="fig" rid="fig8">Figure 8B</xref>). The sizes of synaptosomes from WT mice and <italic>Slc6a8</italic> knockout mice were similar, with areas of 0.245 ± 0.01 μm<sup>2</sup> (n = 302 particles) and 0.247 ± 0.01 μm<sup>2</sup> (n = 317 particles), respectively (<xref ref-type="fig" rid="fig8">Figure 8B</xref>).</p><p>We then examined whether SLC6A8 participated in Cr uptake into the synaptosomes. A mixture of 18 μM [<sup>14</sup>C]-Cr (with a total radioactivity of 0.4 μCi) and 5 μM Cr was used, and uptake at 0°C measured at 10 min was the baseline (<xref ref-type="bibr" rid="bib100">Fykse and Fonnum, 1988</xref>). Cr uptake into synaptosomes from WT mice was stimulated approximately sevenfold at 37°C (Uptake, <xref ref-type="fig" rid="fig8">Figure 8C</xref>) compared to 0°C (Ctrl, <xref ref-type="fig" rid="fig8">Figure 8C</xref>). Cr uptake into synaptosomes from <italic>Slc6a8</italic> knockout mice was less than three times compared to its control, and was decreased to approximately 1/3 of that of WT mice (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). Thus, SLC6A8 is necessary for uptake of Cr into the synaptosomes.</p></sec><sec id="s2-9"><title>Cr uptake into SVs</title><p>Classical neurotransmitters were taken up in SVs in an ATP-dependent manner (<xref ref-type="bibr" rid="bib49">Burger et al., 1991</xref>; <xref ref-type="bibr" rid="bib58">Cidon and Sihra, 1989</xref>; <xref ref-type="bibr" rid="bib222">Schenck et al., 2009</xref>; <xref ref-type="bibr" rid="bib100">Fykse and Fonnum, 1988</xref>; <xref ref-type="bibr" rid="bib28">Bellocchio et al., 2000</xref>). We examined whether Cr could be transported into SVs.</p><p>We used 10 μg anti-Syp antibody to purify SVs from mouse brains. Purified SVs were preincubated for 30 min to allow sufficient leakage of endogenous Cr, before being mixed with 1 mM [<sup>13</sup>C]-Cr in the presence or absence of 4 mM ATP and placed at 25℃ for 10 min to allow adequate uptake. The SV content of [<sup>13</sup>C]-Cr was then examined by CE-MS and high-performance liquid chromatography-mass spectrometry (HPLC-MS). Significantly more [<sup>13</sup>C]-Cr were taken up by SVs in the presence of ATP, with about 10.3 pmol [<sup>13</sup>C]-Cr transported into SVs (1.03 pmol/μg α-Syp or transportation rate of 0.103 pmol/min, n = 11, <xref ref-type="fig" rid="fig8">Figure 8D</xref>).</p><p>In summary, Cr could be transported into SVs in an ATP-dependent manner. At this point, we do not know what is the transporter(s) on the SVs for Cr uptake. SLC6A8 is only found in plasma membrane, not on SVs, and is not a candidate for Cr uptake into SVs.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>While no neurotransmitter has been proven in a single paper, supportive evidence suggesting Cr as a possible new neurotransmitter has been presented here to the extent of any single previous papers.</p><p>At various times and by different researchers, taurine (<xref ref-type="bibr" rid="bib67">Curtis and Watkins, 1960</xref>; <xref ref-type="bibr" rid="bib218">Saransaari and Oja, 2008</xref>), proline (<xref ref-type="bibr" rid="bib96">Felix and Künzle, 1974</xref>), D-aspartic acid (<xref ref-type="bibr" rid="bib72">D’Aniello et al., 2011</xref>), hydrogen sulfide (<xref ref-type="bibr" rid="bib2">Abe and Kimura, 1996</xref>), agmatine (<xref ref-type="bibr" rid="bib205">Reis and Regunathan, 2000</xref>), DOPA (<xref ref-type="bibr" rid="bib170">Misu et al., 2002</xref>), estradiol (<xref ref-type="bibr" rid="bib20">Balthazart and Ball, 2006</xref>), β-alanine (<xref ref-type="bibr" rid="bib251">Tiedje et al., 2010</xref>), and protons (<xref ref-type="bibr" rid="bib82">Du et al., 2014</xref>) have been suspected as neurotransmitters, but they do not meet all the criteria. Some of the suspected molecules can be released upon stimulation or removed by transporters. Often, they have not been reproducibly found in SVs (<xref ref-type="bibr" rid="bib53">Chantranupong et al., 2020</xref>).</p><p>Our discovery of Cr in SVs significantly raised the priority of testing the candidacy of Cr, and our further investigations have led to more evidence suggesting Cr as a neurotransmitter: (1) Cr is stored in SVs; (2) Ca<sup>2+</sup>-dependent release of Cr upon stimulation has been observed; (3) both Cr storage in SVs and Cr release are reduced when either the gene for <italic>Slc6a8</italic> or the gene for <italic>Agat</italic> was deficient; and (4) Cr inhibits activities of pyramidal neurons in the neocortex; (5) Cr uptake into synaptosomes requires SLC6A8; and (6) Cr uptake into SVs was ATP-dependent.</p><p>Of the above results, 1, 3, 4, and 6 are reported for the first time in this article. Furthermore, we have demonstrated that detection of Cr in SVs was lower than those for Glu and GABA, but higher than those for ACh and 5-HT, placing Cr at a level in the middle of known central transmitters (<xref ref-type="fig" rid="fig1">Figures 1</xref>—<xref ref-type="fig" rid="fig3">3</xref>). The storage of Cr in SVs is dependent on preserved H<sup>+</sup> gradient (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>) and Cr can be transported into SVs (<xref ref-type="fig" rid="fig8">Figure 8D</xref>).</p><p>There was a single previous report of Ca<sup>2+</sup>-dependent release of [<sup>3</sup>H]Cr and endogenous Cr in response to electrical stimulation (<xref ref-type="bibr" rid="bib12">Almeida et al., 2006</xref>). We now provide evidence that Cr was released in response to extracellular K<sup>+</sup> stimulation (within 1–2 min) (<xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6</xref>). Furthermore, Cr release was reduced when either the <italic>Slc6a8</italic> or <italic>Agat</italic> gene was removed (<xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6</xref>). Although the Ca<sup>2+</sup>-dependent component of K<sup>+</sup>-evoked Cr release was smaller compared to those of Glu and GABA, it nevertheless existed and was totally abolished by <italic>Slc6a8</italic> knockout (<xref ref-type="fig" rid="fig5">Figure 5</xref>). The reported electrically evoked Cr release showed more Ca<sup>2+</sup> dependence (<xref ref-type="bibr" rid="bib12">Almeida et al., 2006</xref>). Taken together, our data and previous report (<xref ref-type="bibr" rid="bib12">Almeida et al., 2006</xref>) supported a role of Cr as a neurotransmitter. Our observation of extremely low efflux rates of 5-HT or ACh may have arisen from very limited numbers of cholinergic (<xref ref-type="bibr" rid="bib146">Li et al., 2018</xref>) or serotoninergic neurons (<xref ref-type="bibr" rid="bib125">Ishimura et al., 1988</xref>) in the sliced sections and rapid enzymatic degradation of these neurotransmitters.</p><p>Cr uptake from the extracellular space into the cells was reported twice previously, once with brain slices showing sodium-dependent uptake of [<sup>3</sup>H]Cr (<xref ref-type="bibr" rid="bib12">Almeida et al., 2006</xref>) and once with synaptosomes (<xref ref-type="bibr" rid="bib192">Peral et al., 2010</xref>). Our new results have not only replicated the synaptosome Cr uptake experiment but also shown the requirement of SLC6A8, a membrane transporter expressed in synaptosomes (<xref ref-type="fig" rid="fig8">Figure 8A</xref>), for Cr uptake into synaptosomes. Transportation of Cr into synaptosomes by Slc6A8 may function for both the clearance of Cr from the synaptic cleft and recycling of Cr into SVs residing in neurons (<xref ref-type="fig" rid="fig8">Figures 6D and 8B</xref>).</p><p>In summary, in addition to confirming and extending previous results which have stood alone for more than a decade without replication or follow-up, we have obtained entirely new results suggesting the candidacy of Cr as a neurotransmitter. We discuss below the criteria for a neurotransmitter, Cr as a neurotransmitter, and the implications of Cr as a neurotransmitter.</p><sec id="s3-1"><title>Criteria of a neurotransmitter</title><p>The criteria for establishing a non-peptide small molecule as a neurotransmitter have varied from time to time and from author to author.</p><p>Some textbooks simply state that a neurotransmitter is stored presynaptically, released upon stimulation, and active on postsynaptic neurons. The details of these three criteria can vary. For example, one textbook stipulates that “the substance must be present within the presynaptic neuron; the substance must be released in response to presynaptic depolarization, and the release must be Ca<sup>2+</sup> dependent; specific receptors for the substance be present on the postsynaptic cell” (<xref ref-type="bibr" rid="bib195">Purves et al., 2001</xref>; <xref ref-type="bibr" rid="bib196">Purves et al., 2016</xref>). Another states that “the molecule must be synthesized and stored in the presynaptic neuron; the molecule must be released by the presynaptic axon terminal upon stimulation; the molecule, when experimentally applied, must produce a response in the postsynaptic cell that mimics the response produced by the release of neurotransmitter from the presynaptic neuron” (<xref ref-type="bibr" rid="bib26">Bear et al., 2016</xref>).</p><p>The neuroscience textbook most widely used internationally for the last four decades lists four criteria for a neurotransmitter (<xref ref-type="bibr" rid="bib131">Kandel et al., 2013</xref>; <xref ref-type="bibr" rid="bib132">Kandel et al., 2021</xref>): it is synthesized in the presynaptic neuron; it is present within vesicles and is released in amounts sufficient to exert a defined action on the postsynaptic neuron or effector organ; when administered exogenously in reasonable concentrations, it mimics the action of the endogenous transmitter; and a specific mechanism usually exists for removing the substance from the synaptic cleft. These are similar, but not identical, to the classic textbook on neurotransmitters: a neurotransmitter “should be synthesized and released presynaptically; it must mimic the action of the endogenous compound that is release on nerve stimulation; and where possible, a pharmacological identity is required where drugs that either potentiate or block postsynaptic responses to the endogenously released agent also act identically to the suspected neurotransmitter that is administered” (<xref ref-type="bibr" rid="bib64">Cooper et al., 2002</xref>). The pharmacological criterion is listed in another textbook (<xref ref-type="bibr" rid="bib235">Squire et al., 2012</xref>).</p><p>Some authors note difficulties in establishing a CNS neurotransmitter. For example, a specialized neurotransmitter book states that “the candidate neurotransmitter should be present in the presynaptic terminal, be released when the presynaptic terminal is active, and when applied experimentally, induce faithful responses in the postsynaptic neuron. In practice, since central nervous system neurons continuously integrate diverse excitations and inhibitions, the last criterion is relaxed to demonstrating merely changes in such activity” (<xref ref-type="bibr" rid="bib210">Robinson, 2001</xref>).</p><p>Solomon Snyder, a leading scientist of classic neurotransmitters, neuropeptides and their receptors, wrote that “designating a molecule as a transmitter depends on the criteria employed, the most common of which are that the substance is synthesized in neurons, released by their terminals, mimics the effects of physiologic neurotransmission and possess a mechanism for inactivation. However, with each new candidate the rules have been modified and broadened” (<xref ref-type="bibr" rid="bib21">Barañano et al., 2001</xref>).</p></sec><sec id="s3-2"><title>Evidence supporting Cr as a neurotransmitter</title><p>Sixteen small molecules have been listed as neurotransmitters in the classic textbook (<xref ref-type="bibr" rid="bib131">Kandel et al., 2013</xref>; <xref ref-type="bibr" rid="bib132">Kandel et al., 2021</xref>). Among them, adenosine, arachidonic acid, nitric oxide, and carbon monoxide do not meet all four criteria at present. Cr appears to be better than these in meeting the criteria for a central neurotransmitter.</p><p>The results obtained by us in this article have satisfied the criteria of <xref ref-type="bibr" rid="bib210">Robinson, 2001</xref> for Cr to be a CNS neurotransmitter.</p><p>The four criteria of Snyder and colleagues (<xref ref-type="bibr" rid="bib21">Barañano et al., 2001</xref>) have been mostly met but the physiological neurotransmission would require more research because a specific synapse(s) would have to be defined and studied for putative creatinergic neurotransmission. This can take much longer in the CNS than the PNS. Some commonly accepted neurotransmitters have never satisfied this criterion in a strict sense. The mechanism of Cr removal criterion is met not only by the Cr uptake in brain slices (<xref ref-type="bibr" rid="bib12">Almeida et al., 2006</xref>) and in synaptosomes (<xref ref-type="bibr" rid="bib192">Peral et al., 2010</xref>), but also by our demonstration that SLC6A8 is required for synaptosome uptake of Cr.</p><p>The four criteria of <xref ref-type="bibr" rid="bib131">Kandel et al., 2013</xref> and <xref ref-type="bibr" rid="bib132">Kandel et al., 2021</xref> are mostly satisfied with some details requiring further research. The synthesis requirement is usually not strict because there are transmitters synthesized in some cells and transported into others where they function as transmitters. Our discovery of Cr in SVs can replace the synthesis requirement because the presence in neuronal SVs provide sufficient evidence that Cr is located in the right location to function as a neurotransmitter. The level of Cr in SVs is higher than those of ACh and 5-HT (<xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig2">2</xref>). The amount of released Cr is in the same order of magnitude as those of Glu and GABA (<xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6</xref>). The criterion of a specific mechanism of removal was met by Cr uptake experiments in slices (<xref ref-type="bibr" rid="bib12">Almeida et al., 2006</xref>) and in synaptosomes (<xref ref-type="bibr" rid="bib192">Peral et al., 2010</xref>), and further strengthened by our finding of SLC6A8 involvement in synaptosome uptake of Cr (<xref ref-type="fig" rid="fig8">Figure 8</xref>).</p><p>Here, we report that Cr, at a concentration comparable to classical neurotransmitters, inhibits pyramidal neurons in specific regions of the mouse brain, with approximate 1/3 of pyramidal neurons responding to 100 μM Cr (<xref ref-type="fig" rid="fig7">Figure 7</xref>). In previous reports, 100 μM to 2 mM of GABA (<xref ref-type="bibr" rid="bib47">Brown and Scholfield, 1979</xref>; <xref ref-type="bibr" rid="bib194">Pringle et al., 1996</xref>; <xref ref-type="bibr" rid="bib187">Osmanović and Shefner, 1990</xref>), 50 μM to 2 mM of Glu (<xref ref-type="bibr" rid="bib10">Akaike et al., 1987</xref>; <xref ref-type="bibr" rid="bib61">Cole et al., 1989</xref>), 1–100 μM of DA (<xref ref-type="bibr" rid="bib10">Akaike et al., 1987</xref>), and 0.1–100 μM of 5-HT (<xref ref-type="bibr" rid="bib27">Beck and Goldfarb, 1985</xref>; <xref ref-type="bibr" rid="bib206">Reynolds et al., 1988</xref>; <xref ref-type="bibr" rid="bib166">Mendiguren et al., 2022</xref>; <xref ref-type="bibr" rid="bib266">Xie et al., 2012</xref>; <xref ref-type="bibr" rid="bib106">Gorelova and Reiner, 1996</xref>; <xref ref-type="bibr" rid="bib184">Okuhara and Beck, 1994</xref>) were bath-applied to investigate the physiological functions of neurotransmitters. Our results revealed that, when bath-applied, Cr could inhibit cortical neurons at 100 μM within several minutes, with a time course similar to that of 5-HT (<xref ref-type="bibr" rid="bib229">Sizer et al., 1992</xref>; <xref ref-type="bibr" rid="bib266">Xie et al., 2012</xref>; <xref ref-type="bibr" rid="bib184">Okuhara and Beck, 1994</xref>) and DA (<xref ref-type="bibr" rid="bib10">Akaike et al., 1987</xref>), but significantly slower than that of Glu (<xref ref-type="bibr" rid="bib61">Cole et al., 1989</xref>), GABA (<xref ref-type="bibr" rid="bib208">Roberts and Frankel, 1950</xref>; <xref ref-type="bibr" rid="bib194">Pringle et al., 1996</xref>), and 5-HT (<xref ref-type="bibr" rid="bib166">Mendiguren et al., 2022</xref>).</p><p>In a recent report, knockout of the Slc6a8 gene increased excitation of cortical neurons (<xref ref-type="bibr" rid="bib103">Ghirardini et al., 2023</xref>). Electrophysiological characterization of pyramidal neurons in the prefrontal cortex (PFC) found increased evoked firing frequency. Because we have shown that Cr inhibit a fraction of pyramidal neurons in the neocortex (<xref ref-type="fig" rid="fig8">Figure 8</xref>), this article provides in vivo evidence consistent with the possibility of Cr as an inhibitory neurotransmitter.</p></sec><sec id="s3-3"><title>Differences between Cr and classic neurotransmitters</title><p>At this point, we do not have a molecularly defined receptor for Cr, only inferring its presence from the electrophysiological responses to Cr. We speculate that Cr may act on G-protein-coupled receptors (GPCRs), rather than the fast-acting ligand-gated ion channels, such as AMPA or NMDA receptors for Glu and GABA<sub>A</sub> receptor for GABA. There have been previous reports of Cr effects on neurons, including Cr as a partial agonist for GABA<sub>A</sub> receptors (<xref ref-type="bibr" rid="bib75">De Deyn and Macdonald, 1990</xref>; <xref ref-type="bibr" rid="bib76">De Deyn et al., 2001</xref>; <xref ref-type="bibr" rid="bib181">Neu et al., 2002</xref>; <xref ref-type="bibr" rid="bib136">Koga et al., 2005</xref>). These effects require very high concentrations of Cr (in the 10 mM range). There was also a report of the opposite effect: that Cr (at a concentration above 500 μM) increased neuronal excitability through NMDA receptors after incubation for 60 min, with a time course significantly slower than those of classic neurotransmitters (<xref ref-type="bibr" rid="bib213">Royes et al., 2008</xref>).</p><p>Ca<sup>2+</sup>-independent component of Cr release induced by extracellular K<sup>+</sup> was more prominent than those of Glu or GABA. One possibility was that Ca<sup>2+</sup>-independent Cr release came from glia because high GAMT levels were reported in astrocytes (<xref ref-type="bibr" rid="bib225">Schmidt, 2004</xref>) and oligodendrites (<xref ref-type="bibr" rid="bib225">Schmidt, 2004</xref>; <xref ref-type="bibr" rid="bib212">Rosko et al., 2023</xref>). As reported, other neuromodulators such as taurine can be released from astrocytes (<xref ref-type="bibr" rid="bib193">Philibert et al., 1989</xref>) or slices (<xref ref-type="bibr" rid="bib217">Saransaari and Oja, 2006</xref>) in a Ca<sup>2+</sup>-independent manner. In addition, in the absence of potassium stimulation, Ca<sup>2+</sup> depletion increased release of taurine in cultured astrocytes (<xref ref-type="bibr" rid="bib249">Takuma et al., 1996</xref>) or in striatum in vivo (<xref ref-type="bibr" rid="bib172">Molchanova et al., 2005</xref>). Similarly, in <italic>Slc6a8</italic> KO slices, Ca<sup>2+</sup> depletion (<xref ref-type="fig" rid="fig5">Figure 5G</xref>) also increased Cr baseline compared to that in normal ACSF (<xref ref-type="fig" rid="fig5">Figure 5D</xref>).</p><p>With much longer history of research, ACh and 5-HT now have more evidence in other aspects than Cr as a central transmitter, especially because there are many agonists and antagonists for ACh and 5-HT to prove an additional criterion that is required in some (<xref ref-type="bibr" rid="bib64">Cooper et al., 2002</xref>; <xref ref-type="bibr" rid="bib235">Squire et al., 2012</xref>), but not the majority of, textbooks for a neurotransmitter. The pharmacology criterion will take some time and effort because so far no effort has been made to find agonists or antagonists for Cr.</p></sec><sec id="s3-4"><title>Implications of SLC6A8 and Cr</title><p>It is notable that SLC6A8 belongs to the NTT family, with multiple members already shown to transport neurotransmitters (<xref ref-type="bibr" rid="bib188">Pacholczyk et al., 1991</xref>; <xref ref-type="bibr" rid="bib32">Blakely et al., 1991</xref>; <xref ref-type="bibr" rid="bib110">Guastella et al., 1992</xref>; <xref ref-type="bibr" rid="bib59">Clark et al., 1992</xref>; <xref ref-type="bibr" rid="bib34">Borden et al., 1992</xref>; <xref ref-type="bibr" rid="bib153">Lopez-Corcuera et al., 1992</xref>; <xref ref-type="bibr" rid="bib104">Giros et al., 1991</xref>; <xref ref-type="bibr" rid="bib135">Kilty et al., 1991</xref>; <xref ref-type="bibr" rid="bib227">Shimada et al., 1991</xref>; <xref ref-type="bibr" rid="bib119">Hoffman et al., 1991</xref>; <xref ref-type="bibr" rid="bib232">Smith et al., 1992</xref>; <xref ref-type="bibr" rid="bib151">Liu et al., 1992</xref>).</p><p>The uptake experiments by others and us indicate that SLC6A8 transports Cr into neurons within the brain. AGAT is also expressed in the brain, but in cells not expressing SLC6A8 (<xref ref-type="bibr" rid="bib38">Braissant and Henry, 2008</xref>; <xref ref-type="bibr" rid="bib39">Braissant et al., 2010</xref>). Cr and its precursor were thought to be transported between different cells in the nervous system. When SLC6A8 was completely missing, such as in homozygous <italic>SLC6A8</italic>-deficient patients, Cr treatment was not effective. But if SLC6A8 was partially active, Cr was effective (<xref ref-type="bibr" rid="bib84">Dunbar et al., 2014</xref>). Intractable epilepsy in a female with heterozygous <italic>SLC6A8</italic> mutation was completely treated by Cr (<xref ref-type="bibr" rid="bib167">Mercimek-Mahmutoglu et al., 2010</xref>). Our data of inhibitory effect of creatine on cortical neurons might provide a new mechanism to its anti-epileptic activity (<xref ref-type="bibr" rid="bib102">Gerbatin et al., 2019</xref>).</p><p>The absence of SLC6A8 expression in astrocytes whose endfeet lining microcapillary endothelial cells (MCEC) form the blood–brain barrier (BBB) indicates that Cr in the brain does not rely on import from the periphery and is instead mainly synthesized in the brain (<xref ref-type="bibr" rid="bib40">Braissant et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Braissant et al., 2001</xref>; <xref ref-type="bibr" rid="bib41">Braissant, 2012</xref>). SLC6A8 functions within the brain to transport Cr and its precursors not as a major contributor of Cr transport across the BBB. It is thought to mediate Cr uptake into the presynaptic terminal based on studies of synaptosomes (<xref ref-type="fig" rid="fig8">Figure 8</xref>; <xref ref-type="bibr" rid="bib192">Peral et al., 2010</xref>).</p><p>Cr is known to have effects other than an energy source, and Cr supplement has been thought to be beneficial for children, pregnant and lactating women, and old people (<xref ref-type="bibr" rid="bib259">Wallimann et al., 2011</xref>; <xref ref-type="bibr" rid="bib45">Brosnan and Brosnan, 2016</xref>). Cr has been reported to improve human mental performance (<xref ref-type="bibr" rid="bib261">Watanabe et al., 2002</xref>; <xref ref-type="bibr" rid="bib201">Rae et al., 2003</xref>; <xref ref-type="bibr" rid="bib164">McMorris et al., 2006</xref>; <xref ref-type="bibr" rid="bib165">McMorris et al., 2007</xref>; <xref ref-type="bibr" rid="bib202">Rae and Bröer, 2015</xref>; <xref ref-type="bibr" rid="bib260">Wallimann and Harris, 2016</xref>). Cr has been used as potential treatment in animal models of neurodegenerative diseases (<xref ref-type="bibr" rid="bib13">Andreassen et al., 2001</xref>; <xref ref-type="bibr" rid="bib14">Andres et al., 2005</xref>).</p><p>Our work will stimulate further research to distinguish which of the previously suspected effects of Cr is not attributed to its role as an energy storage, but can be attributed to its role as a neurotransmitter.</p></sec><sec id="s3-5"><title>Search for new neurotransmitters</title><p>Our work may stimulate the search for more neurotransmitters. Our discovery indicates that the hunt for neurotransmitters stopped decades ago because of technical difficulties not due to the absence of more neurotransmitters. The fact that most of the known small-molecule neurotransmitters have been found because of their peripheral effects also argues that what is missing is the concerted efforts to uncover central neurotransmitters with no peripheral effects. New neurotransmitters may be discovered from candidates which have been long suspected and from previously unsuspected molecules or even previously unknown molecules.</p><p>Innovative approaches should be taken to uncover molecules with no previous suspicions or hints. Highly purified SVs, SVs from different regions of the brain, and SVs with specific SLCs offer some of the starting points for future research.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Generation of knockout and knockin mice</title><p><italic>Slc6a8</italic> knockout and knockin mice were generated using CRISPR-Cas9-mediated genome engineering techniques by Beijing Biocytogen (Beijing, China). <italic>Agat</italic> ‘knockout-first’ (<xref ref-type="bibr" rid="bib230">Skarnes et al., 2011</xref>) mice were purchased from CAM-SU GRC (Suzhou, China). All mutations were validated by Southern blot analysis, tail junction PCR, and DNA sequencing. Transgenic mice will be provided upon request.</p></sec><sec id="s4-2"><title>RT-PCR and qPCR</title><p>Total RNA of whole brains from mice of different genotypes was extracted using the Buffer RZ (Tiangen, no. RK14, Beijing, China) and reverse transcribed into complementary DNA (cDNA) using the RevertAid First-Strand cDNA synthesis kit (Thermo Scientific, K1622). qPCR was performed using the Taq Pro Universal SYBR qPCR Master Mix (Vazyme, Q712-02) on Bio-Rad CFX-96 Touch Real-time PCR System (Bio-Rad, USA). Glyceraldehyde-3-phosphate dehydrogenase (<italic>Gapdh</italic>) was used as an internal control. ΔCt (difference in cycle threshold) was calculated for each sample (ΔCt = Ct <sub>Target gene</sub> − Ct <sub>GAPDH</sub>) for further evaluation of relative mRNA expression levels in different genotypes. The sequence specificities of the primers were examined. Three pairs of primers targeting different genes were used: <italic>Slc6a8</italic> forward, 5′-<named-content content-type="sequence">GTCTGGTGACGAGAAGAAGGG</named-content>-3′, <italic>Slc6a8</italic> reverse, 5′-<named-content content-type="sequence">CCACGCACGACATGATGAAGT</named-content>-3′; <italic>Agat</italic> forward, 5′-<named-content content-type="sequence">cacagtggaggtgaaggccaatacatat</named-content>-3′, <italic>Agat</italic> reverse, 5′-<named-content content-type="sequence">ccgcctcacggtcactcct</named-content>-3′; <italic>Gapdh</italic> forward, 5′- <named-content content-type="sequence">AGGTCGGTGTGAACGGATTTG</named-content>-3′, <italic>Gapdh</italic> reverse, 5′-<named-content content-type="sequence">TGTAGACCATGTAGTTGAGGTCA</named-content>-3′.</p><p>Primers for reverse PCR were designed to obtain complete coding sequences based on information obtained from the National Center for Biotechnology Information (NCBI): <italic>Slc6a8</italic> forward, 5′-<named-content content-type="sequence">atggcgaaaaagagcgctgaaaacg</named-content>-3′; <italic>Slc6a8</italic> reverse, 5′-<named-content content-type="sequence">ttacatgacactctccaccacgacgacc</named-content>-3′; <italic>Agat</italic> forward, <sc>5′-</sc> <named-content content-type="sequence">atgctacgggtgcggtgtct</named-content><sc>-3′;</sc> <italic>Agat</italic> reverse, 5′-<named-content content-type="sequence">tcagtcaaagtaggactgaagggtgcct</named-content>-3′. PCR products were electrophoresed on 1% agarose gels, stained with GelRed, visualized under UV illumination, and photographed.</p></sec><sec id="s4-3"><title>Immunoblot analysis</title><p>Samples were loaded onto 10% polyacrylamide gels with the PAGE system (#1610183, Bio-Rad Laboratories, USA) and run in the SDS running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.8) for 25 min at 80 V followed by 25–45 min at 200 V. Afterward, proteins were transferred to immobilon NC transfer membranes (HATF00010, Millipore) at 400 mA for 2 hr in transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol). Membranes were blocked in 5% fat-free milk powder in TBST (25 mM Tris, 150 mM NaCl, 0.2% Tween-20 [P1397, Sigma, St. Louis, MO], pH 7.4 adjusted with HCl) and incubated overnight with the indicated primary antibodies dissolved in TBST containing 2% BSA.</p><p>Primary antibodies are listed below: rabbit anti-synaptophysin (dilution 1:5000, cat. no. 101002, synaptic systems [SySy], Goettingen, Germany), rabbit anti-synaptotagmin1/2 (dilution 1:2000, cat. no. 105002, SySy), rabbit anti-proton ATPase (dilution 1:1000, cat. no. 109002, SySy), rabbit anti-synaptobrevin 2 (dilution 1:5000, cat. no. 104202, SySy), rabbit anti-SV2A (dilution 1:2000, cat. no. 109003, SySy), rabbit anti-VGlut1 (dilution 1:4000, 135302, SySy), rabbit anti-VGlut2 (dilution 1:2000, 135402, SySy), rabbit anti-VGAT (dilution 1:4000, 131002, SySy), rabbit anti-SNAP23 (dilution 1:2000, cat. no. 111202, SySy), mouse anti-PSD95 (dilution 1:5000, cat. no. 75028, NeuroMab, Davis, CA), mouse anti-GluN1(dilution 1:5000, cat. no. 114011, SySy), rabbit anti-GM130 (dilution 1:1000, cat. no. ab52649, Abcam), rabbit anti-Golgin-97 (dilution 1:2000, cat. no. 13192, Cell Signaling Technology, MA), rabbit anti-EEA1 (dilution 1:2000, cat. no. 3288, Cell Signaling Technology), rabbit anti-LC3B (dilution 1:1000, cat. no. 2775S, Cell Signaling Technology), goat anti-CathepsinB (dilution 1:2000, AF965, R&amp;D Systems, Minneapolis, MN), rabbit anti-GAPDH (dilution 1:1000, cat. no. 2118S, Cell Signaling Technology), rabbit anti-GluT4 (dilution 1:1000, ab33780, Abcam, Cambridge, UK), rabbit anti-CACNA1A (dilution 1:300, 152103, SySy), rabbit anti-VDAC (dilution 1:1000, cat. no. 4661S, Cell Signaling Technology), rabbit anti-MBP (1:1000, cat. no. 295003, SySy), mouse anti-Creatine Kinase B (dilution 1:5000, cat. no. MAB9076, R&amp;D Systems), rabbit anti-HA (dilution 1:2000, CST3724, Cell Signaling Technology), and rabbit anti SNAP25 (dilution 1:2000, ab109105, Abcam, UK) antibodies.</p><p>Membranes were washed in three washing steps in TBST (each for 5 min) and incubated with peroxidase-conjugated secondary antibodies for 2–3 hr at 4°C. The second antibodies used were anti-rabbit (dilution 1:5000, A6154, Sigma), anti-mouse (dilution 1:5000, 715-035-150, Jackson ImmunoResearch, West Grove, Philadelphia, USA) or rabbit anti-goat IgG secondary antibodies (dilution 1:1000, cat. no. ab6741, Abcam). After repeated washing, signals were visualized using a <ext-link ext-link-type="uri" xlink:href="http://www.baidu.com/link?url=b4UL19czFvaNCvReaStuM98Tcf_QcWKiuw0Qsym0KRVtwPdPfbKCbY-WCZWhzMl0-KnTC9ei_boC2hgbkre1VB5jwk5lFuqDeA3iXcvrbUm">ChemiDoc XRS </ext-link><ext-link ext-link-type="uri" xlink:href="http://www.baidu.com/link?url=b4UL19czFvaNCvReaStuM98Tcf_QcWKiuw0Qsym0KRVtwPdPfbKCbY-WCZWhzMl0-KnTC9ei_boC2hgbkre1VB5jwk5lFuqDeA3iXcvrbUm">+ System</ext-link> (Bio-Rad Laboratories).</p></sec><sec id="s4-4"><title>Isolation of synaptic vesicles</title><p>Our purification procedures for SVs were based on previously established immunoisolation methods (<xref ref-type="bibr" rid="bib48">Burger et al., 1989</xref>; <xref ref-type="bibr" rid="bib158">Martineau et al., 2013</xref>). Protein G magnetic beads (cat. no. 88848, Thermo Fisher Scientific, Waltham, MA) were washed three times with IP buffer (100 mM potassium tartrate, 4 mM HEPES-KOH, 2 mM MgCl<sub>2</sub>, pH 7.4) supplemented with<ext-link ext-link-type="uri" xlink:href="http://www.baidu.com/baidu.php?url=0f00000uEDLSpLgiC_BNw9IkUwf4lgYZRcgWHiL63_en8LMvfrJHgvzMJZO_I3ENSgpXGDE6zOoW3OrW4Z7YtJuFnuHKT1gvRn-2qBy9nDS_enP4cG4ICAWqZ4NngQHFcvXSgknEjTNj1xjcdnoScM4ve4Y8RseyDngUWOoQX_pTBdcCw_MagICg61ItP6sR_8MFVaF6CiH11_jMOr6WgW-Ju2Qp.7R_NR2Ar5Od663rj6tCLlVQQPAlutPgFKt54mrAJavauYPimQPv1xbLSP---xX7YNK5wfmVl32AM-9uY3vglCh5qUCpb3T-hxjb_tZgKfYt8-P1tA-BZZjdsRP5QAeKPa-BqM76l32AM-9I7fH7fmhIjRha1I_L4POWuuugdsRP5QfHPGm9IGkYRYD3T-MGCFuWH9zy5BJxXS6lUjb_9IjvYAgYN2s1f_TxZFgyC.U1Y10ZDqTZFEIAN9TvR-nWKGUh9Gmh-YULc-nWKWUvPoIA7GU0Kspynqn0KY5yPEUgK_ugw-FHcsTZFEIAN9TvR-nWKGUh9Gmh-YULc-nWKWUvPoIA7GU0KGUHYznWR0u1dEugK1nfKdpHdBmy-bIfKspyfqnfKWpyfqn16d0AdY5HDsnH-xnH0kPdtznjRkg1nsnjFxn1msnfKopHYs0ZFY5HfsP6KBpHYkPH9xnW0Yg1RsnsKVm1YkrjmzPWTdn1bsg1D4njbdrHmLPWFxnW0dnNtknjFxn0KkTA-b5H00TyPGujYs0ZFMIA7M5H00mycqn7ts0ANzu1Yz0ZKs5H00UMus5H08nj0snj0snj00Ugws5H00uAwETjYs0ZFJ5H00uANv5gKW0AuY5H00TA6qn0KET1Ys0AFL5HDs0A4Y5H00TLCq0A71gv-bm1dsTzdWUfKGuAnqiDFK0ZKCIZbq0Zw9ThI-IjYvndtsg1Ddn6KYIgnqrjm4n1msrHbYnHbkn10zP1TzPsKzug7Y5HDvPj0vPHRLPWD3P1R0Tv-b5ywhPWmvPvF-nj0sPvDLnWR0mLPV5HcdPRwanDwDfWw7nHIjrRR0mynqnfKsUWYs0Z7VIjYs0Z7VT1Ys0ZGY5H00UyPxuMFEUHYsg1Kxn7tsg100uA78IyF-gLK_my4GuZnqn7tsg1KxnHnkPjnsnNts0ZK9I7qhUA7M5H00uAPGujYs0ANYpyfqQHD0mgPsmvnqn0KdTA-8mvnqn0KkUymqn0KhmLNY5H00pgPWUjYs0A7buhk9u1Yk0Akhm1Ys0AwWmvfq0Zwzmyw-5Hm1njcsn6KBuA-b5H04wDu7nRc4wHFafWmvf1w7wWRsnHPKn1TvP1DsnRRk0AFY5H00Uv7YI1Ys0AqY5H00ULFsIjYsc10Wc10Wnansc108nj0snj0sc10WnansczYWna3snj0snj0Wni3snj0knj00XZPYIHYvnH0Ln1nz0Z7xIWYsQWf1g108njKxna3sn7tsQWcvg108nHNxna34r7tsQWDLg100mMPxTZFEuA-b5H00ThqGuhk9u1Ys0APv5fKGTdqWTADqn0KWTjYs0AN1IjYs0APzm1Ydnj6dP0&amp;us=newvui&amp;xst=mWYsrRwAwH7arRRzfbcvPbnYwRmdnjD1fHnLPWTknj77nf715HDvnjbLPWmLrH61rjcYn1mdn1f4g1czPNtz0gTqmvqVTAk-IAR6TZFEIAN9TvR6py4CpyFGIAqzcAPEmvVYmy-_0gDqTZFEIAN9TvR6py4CpyFGIAqzcAPEmvVYmy-_0gRqPWDsP1n1n67Y5HDvPj0vPHRLPWcKUgDqn0cs0BYKmv6quhPxTAnKUZRqn07WUWdBmy-bIfD3rHTkPjbdPjT&amp;word=&amp;ck=8019.13.1640655772130.0.0.685.324.0&amp;shh=www.baidu.com&amp;sht=baidu&amp;wd="> a complete protease inhibitor cocktail</ext-link> (Roche, Basel, Switzerland). Then, 5 μg monoclonal anti-Syp antibody directed against a cytoplasmic epitope (cat. no. 101011, SySy) or control mouse IgG (10400C, Thermo Fisher Scientific) was used to incubate with 20–30 μl beads for 30 min at RT in 2% BSA dissolved in IP buffer. Under this condition, 4–4.5 μg of antibody was coupled, as determined by western blot and <ext-link ext-link-type="uri" xlink:href="http://www.baidu.com/link?url=NF7xx9fjAPjrynzWED8kjLh26WMYz0BJuys0_QMwCk4j3ixOwQb-rkEIK0YM7MHy6l6Qg63lhOx4j51aX8jHnfEJH_Qwpap0oktD3SC_gla">Coomassie Blue staining</ext-link>. Immunoisolation of SVs was carried out at 0–2°C to prevent vesicular content leakage (with RT as a control). Briefly, the whole mouse brain was homogenized in 3 ml of IP buffer with a glass/Teflon homogenizer (20 strokes at 2000 rpm, WHEATON, USA, and WIGGENS WB2000-M, Germany) immediately after decapitation. Homogenates were centrifuged for 25 min at 35,000 × <italic>g,</italic> and the supernatant was adjusted to approximately 3 mg/ml protein (NanoDrop 2000C, Thermo Fisher Scientific). To capture the SVs for content detection, about 200 μl of supernatants (per 5 μg anti-Syp/IgG) was incubated with pre-coupled beads for 2.25 hr under slow rotation at 2°C. Beads were washed six times for further western blot analysis and vesicular content detection. For pharmacological blockade of H<sup>+</sup>-gradient across SV membrane, the mix of supernatants and pre-coupled beads was diluted into 1.2 ml before the addition of inhibitors.</p></sec><sec id="s4-5"><title>Determination of vesicular contents</title><p>To extract SV contents, immunoisolates were treated with 50 μl ultra-pure water. Then, 100 μl methanol together with 100 μl acetonitrile was added to precipitate proteins in samples. After centrifugation for 20 min at 16,8000 × <italic>g</italic>, supernatants were collected and centrifuged for 20 min at 2000 × <italic>g</italic> to remove beads and proteins. Samples were pre-frozen with liquid nitrogen and vacuum dried at –45°C overnight. Dried samples were kept frozen and resuspended with 50 μl of 0.2 μM <sup>13</sup>C-creatine (internal control) immediately before detection.</p><p>CE-MS was used to verify and quantify small molecules. CE/MS detection was applied with the coupling of PA800 plus CE system (Beckman Coulter, Brea, CA) and mass spectrometry (TRIPLE QUAD 5500, AB SCIEX or Q Exactive HF-X, Thermo Scientific). Before SV content detection, we optimized MS detection of classical neurotransmitters, Cr, and amino acids in positive ion mode. Firstly, the fragment ions (Q3) for a given molecule (precursor ions, Q1) were determined by either systematic scanning of standard sample solution (0.1 μM in 10% acetate acid) or referring to database (<ext-link ext-link-type="uri" xlink:href="https://www.mzcloud.org">https://www.mzcloud.org</ext-link>). Secondly, optimal values of collision energy (CE), collision cell exit potential (CXP), and declustering potentials (DP) were determined for each pair of Q1/Q3. Thirdly, optimal combination of parameters (Q1/Q3, CE, CXP, DP) was chosen for each molecule. In addition, parameters were adjusted every 2–3 mo for best signal-to-noise ratios.</p><p>CE/MS separations were carried out by capillaries (OptiMS silica surface cartridge, Beckman Coulter). The CE background electrolyte was 10% acetate acid. Each new separation capillary was activated with rinsing under 100 psi sequentially with methanol for 10 min (forward), methanol for 3 min (reverse), H<sub>2</sub>O for 10 min (forward), H<sub>2</sub>O for 3 min (reverse), 0.1 M NaOH for 10 min (forward), water for 5 min (reverse), 0.1 M HCl for 10 min (forward), followed by water for 10 min and then 10% acetate acid for 10 min (forward) and 3 min (reverse), prior to the first use. Between analyses, the capillary was rinsed with 10% acetate acid under a 100 psi pressure for 5 min (forward) flowed by 75 psi for 4 min. The sample (50 μl) was injected with 2.5–4 psi for 30 s. Separation voltage of 25 kV was applied for 25 min. To maintain stably spray during CE separation, ion spray voltage was applied at 1.7–1.9 kV. MS data were collected 5 min after CE separation. Finally, the capillary was washed with 10% acetate acid for 10 min, followed by methanol for 20 min and then 10% acetate acid for 20 min.</p><p>Standard solutions of 0.2 μM <sup>13</sup>C-Cr (internal control) and analytes were used to plot standard curves. Linear standard curves (R<sup>2</sup> &gt; 0.98, for most cases, R<sup>2</sup> &gt; 0.99), calculated from peak area ratios corresponding to analytes and internal standards, were obtained for all molecules tested. The concentration ranges used for standards of Glu, GABA, ACh, 5-HT, Cr, and alanine were 0.03–10 μM, 0.003–1 μM, 0.0003–0.1 μM, 0.003–1 μM, 0.03–1 μM, and 0.03–1 μM, respectively. Standard curves were made at least twice for a given capillary. Analytes of SV contents were calculated using the standard curves and normalized to the amount of anti-Syp antibody conjugated to the beads.</p></sec><sec id="s4-6"><title>Electron microscopy</title><p>All EM grids were glow discharged for 30 s using a plasma cleaner (Harrick PDC-32G-2, plasma cleaners, Ithaca, NY). To free SVs from beads, 25 μl 0.1 M glycine-HCl (PH = 2) was incubated for 1 min and quickly neutralized with 25 μl 0.1 M Tris (pH = 10). Beads were quickly removed and 2–4 μl aliquots of SVs were applied to the carbon-coated copper grids (Zhong Jing Ke Yi, Beijing, China). After 1 min, the grid was dried with a filter paper (Whatman No. 1), and placed in the water, and then immediately stained using 2% uranyl acetate for 30 s. At last uranyl acetate was removed and the grid was air dried. The grids were examined on a JEM-F200 electron microscope (JEOL, Tokyo, Japan) operated at 200 kV. Images were recorded using a 4k × 4k COMS One view camera (Gatan, Abingdon, UK). Fixation of synaptosomal pellets was performed by immersion with pre-warmed 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) at RT for 2 hr. After washing four times with 0.1 M phosphate buffer (pH 7.4) every 15 min, samples were post-fixed with 1% osmium tetroxide (w/v) at 4°C for 1 hr and then washed three times. Following en bloc staining with 2% uranyl acetate (w/v) at 4°C overnight, samples were dehydrated and embedded in fresh resin, polymerized at 65°C for 24 hr. Ultrathin (70 nm) sections were obtained using Leica UC7 ultramicrotome (Leica Microsystems, Wetzlar, Germany) and recorded on 80 kV in a JEOL Jem-1400 transmission electron-microscope (JEOL) using a CMOS camera (XAROSA, EMSIS, Munster, Germany).</p></sec><sec id="s4-7"><title>Immunohistochemistry</title><p>Adult mice were anesthetized by i.p. injection with 2% 2,2,2-tribromoethanol (T48402, Sigma) in saline at a dose of 400 mg/kg and perfused trancardially with 0.9% saline, followed by 4% PFA in PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na<sub>2</sub>HPO<sub>4</sub>, 1.8 mM KH<sub>2</sub>PO<sub>4</sub>, pH = 7.4).</p><p>Brains were cryoprotected with 30% sucrose in 30% sucrose 0.1 M PB (81 mM Na<sub>2</sub>HPO<sub>4,</sub> 19 mM NaH<sub>2</sub>PO<sub>4</sub>) and sectioned in the coronal plane (40 μm thick) using a Cryostat (Leica 3050S). For anti-HA immunostaining, we used a rabbit monoclonal anti-HA antibody (1:500 in 0.3% Triton in PBS; 48 hr incubation at 4°C; #3724, Cell Signaling Technology), followed by a goat anti-rabbit Alexa Fluor 546 secondary antibody (1:1000; overnight at 4°C; # A-11035, Invitrogen, Waltham, MA). Sections were mounted in a medium containing 50% glycerol, cover-slipped, and sealed with nail polish. Images were acquired using virtual slide microscope (Olympus VS120-S6-W, Tokyo, Japan) and a laser-scanning confocal microscope (Zeiss 710, Cambridge, UK) and brain structures inferred with an established mouse brain atlas (<xref ref-type="bibr" rid="bib191">Paxinos and Franklin., 2013</xref>).</p></sec><sec id="s4-8"><title>Preparations of brain slices</title><p>Male C57 mice (of 30–38 days old) were anesthetized with pentobarbital (250 mg/kg) and decapitated. Brains were quickly removed and placed into ice-cold, low-calcium, high-magnesium artificial cerebrospinal fluid (ACSF) with sodium replaced by choline. The medium consisted of 120 mM choline chloride, 2.5 mM KCl, 7 mM MgSO<sub>4</sub>, 0.5 mM CaCl<sub>2</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 5 mM sodium ascorbate, 3 mM sodium pyruvate, 26 mM NaHCO<sub>3</sub>, and 25 mM D-(+)-glucose, and was pre-equilibrated with 95% O<sub>2</sub>–5% CO<sub>2</sub>. Coronal brain slices (300 μm thick) were cut with a vibratome (Leica VT1200S). Slices were incubated for 1 hr at 34°C with oxygenated ACSF containing 124 mM NaCl, 2.5 mM KCl, 2 mM MgSO<sub>4</sub>, 2.5 mM CaCl<sub>2</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 26 mM NaHCO<sub>3</sub>, and 10 mM D-(+)-glucose.</p></sec><sec id="s4-9"><title>Evoked release from brain slices</title><p>Coronal brain slices (each 300 μm thick, typically with a wet weight of 17–20 mg) were transferred into a specially designed superfusion chamber with a volume of approximately 200 μl, containing freshly 95% O<sub>2</sub>/5% CO<sub>2</sub> oxygenated ACSF. Slices were equilibrated for 10 min in ACSF at a superfusion rate of 0.9–1.25 ml/min. The ‘control’ sample was collected for 1 min just before high K<sup>+</sup> stimulation (K-ACSF, 70 mM KCl replacing equal amount of NaCl). We waited for 30 s to allow K<sup>+</sup> stimulus to immerse the slices (dead volume for solution transition of 200 μl and chamber volume of 200 μl), then the sample ‘70 mM K’ in response to K-ACSF was collected for another 1 min. Following 10 min of washout period, we collected the third sample of ‘wash’ for 1 min.</p><p>To detect Ca<sup>2+</sup>-dependent release, slices were pre-incubated for 10 min with normal ACSF and equilibrated with Ca<sup>2+</sup>-free ACSF (containing 1 mM EGTA to chelate extracellular Ca<sup>2+</sup>) for 10 min. The baseline sample ‘0 Ca<sup>2+</sup> ACSF’ was collected for 1 min. Superfusion solution was changed to Ca<sup>2+</sup>-free K-ACSF for 2 min and sample ‘0 Ca<sup>2+</sup> 70 mM K’ was collected (dead volume for solution transition of 400 μl and chamber volume of 200 μl). Then, the solution was changed back to normal ACSF for 10 min and K-ACSF for 2 min. The sample ‘2.5 mM Ca 70 mM K’ for the last minute was collected.</p><p>Samples were subjected to CE-MS in a method similar to SV content detection, except for the following: (1) standards were dissolved in ACSF or other buffers used in release experiment; (2) concentration ranges used for standards of Glu was from 0.003 to 1 μM; and (3) to protect the MS from salt pollution, data were collected from 10 to 20 min during CE separation.</p></sec><sec id="s4-10"><title>Patch-clamp recordings</title><p>Slices were transferred to a recording chamber on an upright fluorescent microscope equipped with differential interference contrast optics (DIC; Olympus BX51WI). Slices were submerged and superfused with ACSF at about 2.8 ml/min at 24–26°C. Whole-cell patch recordings were routinely achieved from layer 4/5 medium-sized pyramidal neurons from the somatosensory cortex. Patch pipettes (3–5 MΩ) contained 140 mM K-gluconate, 10 mM HEPES, 0.5 mM EGTA, 5 mM KCl, 3 mM Na<sub>2</sub>-ATP, 0.5 mM Na<sub>3</sub>GTP, and 4 mM MgCl<sub>2</sub> (with pH adjusted to 7.3 and osmolarity of 290 mOsm/kg). Current-clamp recordings were carried out with a computer-controlled amplifier (Multiclamp 700B, Molecular Devices) and traces were digitized at 10 kHz (DigiData 1550B, Molecular Devices). Data were collected and analyzed using Clampfitor Clampex 10 software (Molecular Devices).</p><p>Cells were characterized by their membrane responses and firing patterns during hyperpolarizing and depolarizing current steps (–100 to +500 pA, increment: 50 pA or 25 pA, 500 ms). Regular spiking pyramidal neurons were identified by moderate maximal spiking frequencies (20–60 Hz, i.e., 10–30 spikes per 500 ms, <xref ref-type="fig" rid="fig7">Figure 7E–G</xref>), increasing of inter-spike intervals during depolarizing step (<xref ref-type="fig" rid="fig7">Figure 7B</xref>, <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3A</xref>), high action amplitude (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2E</xref>), and large half width (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2F</xref>; <xref ref-type="bibr" rid="bib220">Scala et al., 2019</xref>; <xref ref-type="bibr" rid="bib241">Stumpf et al., 2018</xref>). After the mean firing frequency evoked by current injections reached the steady state for at least 5 min (typically 20–30 min following the formation of whole-cell configuration), 100 μM Cr was bath-applied for 6 min. Typically, Cr was applied for a second time following washout to reconfirm the effects.</p></sec><sec id="s4-11"><title>Synaptosome preparation</title><p>Synaptosomes were isolated by Ficoll/sucrose density-gradient centrifugation (<xref ref-type="bibr" rid="bib112">Gulyássy et al., 2020</xref>; <xref ref-type="bibr" rid="bib226">Schrimpf et al., 2005</xref>; <xref ref-type="bibr" rid="bib192">Peral et al., 2010</xref>; <xref ref-type="bibr" rid="bib33">Booth and Clark, 1978</xref>). Whole brains from adult male mice were homogenized with 15 strokes at 900 rpm in buffer A (320 mM sucrose, 1 mM EDTA, 1 mM EGTA, 10 mM Tris–HCl, pH 7.4, with<ext-link ext-link-type="uri" xlink:href="http://www.baidu.com/baidu.php?url=0f00000uEDLSpLgiC_BNw9IkUwf4lgYZRcgWHiL63_en8LMvfrJHgvzMJZO_I3ENSgpXGDE6zOoW3OrW4Z7YtJuFnuHKT1gvRn-2qBy9nDS_enP4cG4ICAWqZ4NngQHFcvXSgknEjTNj1xjcdnoScM4ve4Y8RseyDngUWOoQX_pTBdcCw_MagICg61ItP6sR_8MFVaF6CiH11_jMOr6WgW-Ju2Qp.7R_NR2Ar5Od663rj6tCLlVQQPAlutPgFKt54mrAJavauYPimQPv1xbLSP---xX7YNK5wfmVl32AM-9uY3vglCh5qUCpb3T-hxjb_tZgKfYt8-P1tA-BZZjdsRP5QAeKPa-BqM76l32AM-9I7fH7fmhIjRha1I_L4POWuuugdsRP5QfHPGm9IGkYRYD3T-MGCFuWH9zy5BJxXS6lUjb_9IjvYAgYN2s1f_TxZFgyC.U1Y10ZDqTZFEIAN9TvR-nWKGUh9Gmh-YULc-nWKWUvPoIA7GU0Kspynqn0KY5yPEUgK_ugw-FHcsTZFEIAN9TvR-nWKGUh9Gmh-YULc-nWKWUvPoIA7GU0KGUHYznWR0u1dEugK1nfKdpHdBmy-bIfKspyfqnfKWpyfqn16d0AdY5HDsnH-xnH0kPdtznjRkg1nsnjFxn1msnfKopHYs0ZFY5HfsP6KBpHYkPH9xnW0Yg1RsnsKVm1YkrjmzPWTdn1bsg1D4njbdrHmLPWFxnW0dnNtknjFxn0KkTA-b5H00TyPGujYs0ZFMIA7M5H00mycqn7ts0ANzu1Yz0ZKs5H00UMus5H08nj0snj0snj00Ugws5H00uAwETjYs0ZFJ5H00uANv5gKW0AuY5H00TA6qn0KET1Ys0AFL5HDs0A4Y5H00TLCq0A71gv-bm1dsTzdWUfKGuAnqiDFK0ZKCIZbq0Zw9ThI-IjYvndtsg1Ddn6KYIgnqrjm4n1msrHbYnHbkn10zP1TzPsKzug7Y5HDvPj0vPHRLPWD3P1R0Tv-b5ywhPWmvPvF-nj0sPvDLnWR0mLPV5HcdPRwanDwDfWw7nHIjrRR0mynqnfKsUWYs0Z7VIjYs0Z7VT1Ys0ZGY5H00UyPxuMFEUHYsg1Kxn7tsg100uA78IyF-gLK_my4GuZnqn7tsg1KxnHnkPjnsnNts0ZK9I7qhUA7M5H00uAPGujYs0ANYpyfqQHD0mgPsmvnqn0KdTA-8mvnqn0KkUymqn0KhmLNY5H00pgPWUjYs0A7buhk9u1Yk0Akhm1Ys0AwWmvfq0Zwzmyw-5Hm1njcsn6KBuA-b5H04wDu7nRc4wHFafWmvf1w7wWRsnHPKn1TvP1DsnRRk0AFY5H00Uv7YI1Ys0AqY5H00ULFsIjYsc10Wc10Wnansc108nj0snj0sc10WnansczYWna3snj0snj0Wni3snj0knj00XZPYIHYvnH0Ln1nz0Z7xIWYsQWf1g108njKxna3sn7tsQWcvg108nHNxna34r7tsQWDLg100mMPxTZFEuA-b5H00ThqGuhk9u1Ys0APv5fKGTdqWTADqn0KWTjYs0AN1IjYs0APzm1Ydnj6dP0&amp;us=newvui&amp;xst=mWYsrRwAwH7arRRzfbcvPbnYwRmdnjD1fHnLPWTknj77nf715HDvnjbLPWmLrH61rjcYn1mdn1f4g1czPNtz0gTqmvqVTAk-IAR6TZFEIAN9TvR6py4CpyFGIAqzcAPEmvVYmy-_0gDqTZFEIAN9TvR6py4CpyFGIAqzcAPEmvVYmy-_0gRqPWDsP1n1n67Y5HDvPj0vPHRLPWcKUgDqn0cs0BYKmv6quhPxTAnKUZRqn07WUWdBmy-bIfD3rHTkPjbdPjT&amp;word=&amp;ck=8019.13.1640655772130.0.0.685.324.0&amp;shh=www.baidu.com&amp;sht=baidu&amp;wd="> a complete protease inhibitor cocktail;</ext-link> Roche). The homogenate (H fraction) was centrifuged at 1000 × <italic>g</italic> for 10 min to precipitate the membrane fragments and nuclei (P1 fraction). Supernatant was centrifuged again at 1000 × <italic>g</italic> for 10 min, and the resulting supernatant (S1) was centrifuged at 12,000 × <italic>g</italic> for 20 min. Supernatant was the S2 fraction, and the pellet was resuspended with buffer A and centrifuged at 12,000 × <italic>g</italic> for 20 min. The resulting pellet was crude synaptosomes (P2 fraction), containing synaptosomes with mitochondria and microsomes.</p><p>Crude synaptosomes (P2 fraction) was resuspended with 150–200 μl buffer B (320 mM sucrose and 10 mM Tris–HCI [pH 7.4]). The sample was carefully overlaid on the top of a gradient of 2 ml of 7.5% (wt/vol in buffer B) Ficoll and 1.8 ml of 13% (wt/vol in buffer B) Ficoll and centrifuged at 98,000 × <italic>g</italic> for 45 min at 2–4°C in a swinging-bucket rotor. A myelin band was present near the surface, and the synaptosomes band (fraction Sy) was present at the interface between the 13 and 7.5% Ficoll layers, with the mitochondria being pelleted at the bottom. For further western analysis, the supernatant was divided into six fractions (600 μl for each fraction) and the mitochondria pellet was discarded. The isolated synaptosomes was included in fraction 4.</p><p>For western analysis, fractions H, S1, P1, S2, P2, and Sy were adjusted to 0.5 mg/ml by bicinchoninic acid assay (BCA) method with reference to NanoDrop 2000 Spectrophotometers. 3.35 μg protein was loaded for each lane. Fractions 1–6 were loaded with the same volume (10 μl composed of 6.7 μl sample and 3.3 μl loading buffer) for each lane.</p></sec><sec id="s4-12"><title>Creatine uptake into synaptosomes</title><p>To remove Ficoll, we diluted the synaptosomal band (480 μl) with 4.3 ml of a pH 7.4 buffer C containing (in mM) 240 mannitol, 10 glucose, 4.8 potassium gluconate, 2.2 calcium gluconate, 1.2 MgSO<sub>4</sub>, 1.2 KH<sub>2</sub>PO<sub>4</sub>, and 25 HEPES-Tris. The sample was then centrifuged at 12,000 × <italic>g,</italic> and the pellet was resuspended with buffer C. Uptake experiments were either performed at 37°C or at 0°C (control). For each sample, 25–43 μg of synaptosomes (with a volume of 40–50 μl) were added to 360 μl buffer containing (in mmol/l) 100 NaCl, 40 mannitol, 10 glucose, 4.8 potassium gluconate, 2.2 calcium gluconate, 1.2 MgSO<sub>4</sub>, 1.2 KH<sub>2</sub>PO<sub>4</sub>, 25 HEPES, and 25 Tris (pH adjusted to 7.4). A mixture of 18 μM [<sup>14</sup>C]-creatine (0.4 μCi) and 5 μM creatine was quickly added. After 10 min, uptake was terminated by the addition of 1 ml of NaCl-free ice-cold buffer C. Samples were immediately filtered, under vacuum, through a Whatman GF/C glass filter (1825-025) pre-wetted with buffer C. Filters were further washed with 10 ml of ice-cold buffer C, dissolved in scintillation fluid, and the radioactivity determined by liquid scintillation spectrometry.</p></sec><sec id="s4-13"><title>Creatine uptake into SVs</title><p>The uptake of <sup>13</sup>C-creatine was assayed according to a conventional procedure (<xref ref-type="bibr" rid="bib117">Hell et al., 1988</xref>) with slight modifications: the immunoisolated SVs by 10 μg Syp antibody (101011, SySy) were resuspended with the uptake buffer (150 mM meglumine-tartrate, 4 mM KCl, 4 mM MgSO<sub>4</sub>, 10 mM HEPES-KOH [pH 7.4], and cOmplete EDTA-free protease inhibitor cocktail) containing 4 mM Mg-ATP or additional 4 mM MgSO<sub>4</sub>, followed by preincubation for 30 min at 25℃. The uptake reaction was started by addition of 1 mM <sup>13</sup>C-creatine dissolved in the uptake buffer with a final volume of 125 μl (pH at 6.8). After 10 min at 25℃, 1 ml of ice-cold uptake buffer was added to the incubation to stop the reaction, followed by five more times washing. The SV contents were extracted using the protocol described in the determination of vesicular contents part. Then, 100 nM Cr was used as the internal control. CE-MS and LC-MS were used to verify and quantify the creatine contents of samples. A Vanquish UHPLC system coupled to a Q Exactive HF-X mass spectrometer (both instrument from Thermo Fisher Scientific) was used for LC-MS analysis along with SeQuant ZIC-HILIC column (150 mm × 2.1 mm, 3.5 μm, Merck Millipore, 150442) in the positive mode and SeQuant ZIC-pHILIC column (150 mm × 2.1 mm, 5 μm, Merck Millipore, 150460) in the negative mode. For ZIC-HILIC column, the mobile phase A was 0.1% formic acid in water and the mobile phase B was 0.1% formic acid in acetonitrile. The linear gradient was as follows: 0 min, 80% B; 6 min, 50% B; 13 min, 50% B; 14 min, 20% B; 18 min, 20% B; 18.5 min, 80% B; and 30 min, 80% B. The flow rate used was 300 μl/min and the column temperature was maintained at 30°C. For ZIC-pHILIC column, the mobile phase A is 20 mM ammonium carbonate in water, adjusted to pH 9.0 with 0.1% ammonium hydroxide solution (25%), and the mobile phase B is 100% acetonitrile. The linear gradient was as follows: 0 min, 80% B; 2 min, 80% B; 19 min, 20% B; 20 min, 80% B; and 30 min, 80% B. The flow rate used was 150 μl/min, and the column temperature was 25°C. Samples were maintained at 4°C in Vanquish autosampler. Then, 3 µl of extracted metabolites were injected for each run. IP samples were subjected to ZIC-HILIC column in positive mode for major metabolites detection, and then subject to ZIC-pHILIC column in negative mode for orthogonal detection.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing, designed the experiments, improved the methods, carried out experiments and supervised technicians to carry out the experiments for this paper</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Validation, Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing, designed the experiment and reproducibly found Cr in SVs</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con6"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con7"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Investigation, Writing – original draft, Project administration, Writing – review and editing, YR conceived the idea of searching for new neurotransmitters and supervised the project</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal procedures were approved by the Animal Center of Peking University and Animal Care. Experiments were carried out in accordance with the guidelines of Institutional Animal Care and Use Committee (IACUC) of Peking University (LSC-RaoY-9 and LSC-RaoY-10).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-89317-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting file.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We are grateful to Drs. Xiaohui Zhang, Xinxiang Zhang, Minmin Luo, Qingchun Guo, Yiqun Liu, Yingchun Hu, and Wuping Ge for discussion, suggestions, and technical support; Jiang Chen, Jing Cai, Yulin Jiang, Jinhuan Ou, Xiaomeng Deng, Jiawen Liu, and Meng Wu for technical assistance; and CIBR, Peking-Tsinghua Center for Life Sciences, Changping Laboratory, Chinese Academy of Medical Sciences (2019RU003), and National Natural Science Foundation of China (Project 32061143017 to YR and 81473189) for support. Research in the Rao lab has never been contaminated by the Chinese Brain Initiative.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdulla</surname><given-names>ZI</given-names></name><name><surname>Pahlevani</surname><given-names>B</given-names></name><name><surname>Lundgren</surname><given-names>KH</given-names></name><name><surname>Pennington</surname><given-names>JL</given-names></name><name><surname>Udobi</surname><given-names>KC</given-names></name><name><surname>Seroogy</surname><given-names>KB</given-names></name><name><surname>Skelton</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Deletion of the creatine transporter (Slc6a8) in dopaminergic neurons leads to hyperactivity in mice</article-title><source>Journal of Molecular Neuroscience</source><volume>70</volume><fpage>102</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1007/s12031-019-01405-w</pub-id><pub-id pub-id-type="pmid">31520365</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The possible role of hydrogen sulfide as an endogenous neuromodulator</article-title><source>The Journal of Neuroscience</source><volume>16</volume><fpage>1066</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-03-01066.1996</pub-id><pub-id pub-id-type="pmid">8558235</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abel</surname><given-names>JJ</given-names></name><name><surname>Crawford</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="1897">1897</year><article-title>On the blood pressure raising constituent of the suprarenal capsule</article-title><source>Johns Hopkins Hospital Bulletin</source><volume>8</volume><fpage>151</fpage><lpage>157</lpage></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abel</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="1898">1898</year><article-title>On epinephrin, the active constituent of the suprarenal capsule and its compounds</article-title><source>Proceedings of the American Physiological Society</source><volume>3</volume><fpage>4</fpage><lpage>5</lpage></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abel</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="1899">1899</year><article-title>Ueber den blutdruckerregenden Bestandtheil der Nebenniere, das Epinephrin</article-title><source>Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie</source><volume>28</volume><fpage>318</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1515/bchm2.1899.28.3-4.318</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abel</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="1901">1901</year><article-title>Further observations on epinephrine</article-title><source>Johns Hopkins Hospital Bulletin</source><volume>12</volume><fpage>80</fpage><lpage>84</lpage></element-citation></ref><ref id="bib7"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Addison</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1855">1855</year><source>On the Constitutional and Local Effects of Disease of the Supra-Renal Capsules</source><publisher-name>Highley</publisher-name></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahier</surname><given-names>A</given-names></name><name><surname>Jarriault</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Simultaneous expression of multiple proteins under a single promoter in <italic>Caenorhabditis elegans</italic> via a versatile 2A-based toolkit</article-title><source>Genetics</source><volume>196</volume><fpage>605</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1534/genetics.113.160846</pub-id><pub-id pub-id-type="pmid">24361941</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Holt</surname><given-names>M</given-names></name><name><surname>Riedel</surname><given-names>D</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Small-scale isolation of synaptic vesicles from mammalian brain</article-title><source>Nature Protocols</source><volume>8</volume><fpage>998</fpage><lpage>1009</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.053</pub-id><pub-id pub-id-type="pmid">23619891</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akaike</surname><given-names>A</given-names></name><name><surname>Ohno</surname><given-names>Y</given-names></name><name><surname>Sasa</surname><given-names>M</given-names></name><name><surname>Takaori</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Excitatory and inhibitory effects of dopamine on neuronal activity of the caudate nucleus neurons in vitro</article-title><source>Brain Research</source><volume>418</volume><fpage>262</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(87)90094-1</pub-id><pub-id pub-id-type="pmid">2890403</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldrich</surname><given-names>TB</given-names></name></person-group><year iso-8601-date="1901">1901</year><article-title>A preliminary report on the active principle of the suprarenal gland</article-title><source>American Journal of Physiology-Legacy Content</source><volume>5</volume><fpage>457</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1152/ajplegacy.1901.5.7.457</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>LS</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>Hogenboom</surname><given-names>F</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name><name><surname>Schoffelmeer</surname><given-names>ANM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Exocytotic release of creatine in rat brain</article-title><source>Synapse</source><volume>60</volume><fpage>118</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1002/syn.20280</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Dedeoglu</surname><given-names>A</given-names></name><name><surname>Ferrante</surname><given-names>RJ</given-names></name><name><surname>Jenkins</surname><given-names>BG</given-names></name><name><surname>Ferrante</surname><given-names>KL</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Friedlich</surname><given-names>A</given-names></name><name><surname>Browne</surname><given-names>SE</given-names></name><name><surname>Schilling</surname><given-names>G</given-names></name><name><surname>Borchelt</surname><given-names>DR</given-names></name><name><surname>Hersch</surname><given-names>SM</given-names></name><name><surname>Ross</surname><given-names>CA</given-names></name><name><surname>Beal</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington’s disease</article-title><source>Neurobiology of Disease</source><volume>8</volume><fpage>479</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1006/nbdi.2001.0406</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andres</surname><given-names>RH</given-names></name><name><surname>Huber</surname><given-names>AW</given-names></name><name><surname>Schlattner</surname><given-names>U</given-names></name><name><surname>Pérez-Bouza</surname><given-names>A</given-names></name><name><surname>Krebs</surname><given-names>SH</given-names></name><name><surname>Seiler</surname><given-names>RW</given-names></name><name><surname>Wallimann</surname><given-names>T</given-names></name><name><surname>Widmer</surname><given-names>HR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue</article-title><source>Neuroscience</source><volume>133</volume><fpage>701</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.03.004</pub-id><pub-id pub-id-type="pmid">15890457</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonucci</surname><given-names>F</given-names></name><name><surname>Corradini</surname><given-names>I</given-names></name><name><surname>Fossati</surname><given-names>G</given-names></name><name><surname>Tomasoni</surname><given-names>R</given-names></name><name><surname>Menna</surname><given-names>E</given-names></name><name><surname>Matteoli</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SNAP-25, a known presynaptic protein with emerging postsynaptic functions</article-title><source>Frontiers in Synaptic Neuroscience</source><volume>8</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.3389/fnsyn.2016.00007</pub-id><pub-id pub-id-type="pmid">27047369</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname><given-names>A</given-names></name><name><surname>Corbella</surname><given-names>M</given-names></name><name><surname>Fons</surname><given-names>C</given-names></name><name><surname>Sempere</surname><given-names>A</given-names></name><name><surname>García-Villoria</surname><given-names>J</given-names></name><name><surname>Ormazabal</surname><given-names>A</given-names></name><name><surname>Poo</surname><given-names>P</given-names></name><name><surname>Pineda</surname><given-names>M</given-names></name><name><surname>Vilaseca</surname><given-names>MA</given-names></name><name><surname>Campistol</surname><given-names>J</given-names></name><name><surname>Briones</surname><given-names>P</given-names></name><name><surname>Pàmpols</surname><given-names>T</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>Ribes</surname><given-names>A</given-names></name><name><surname>Artuch</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening</article-title><source>Clinical Biochemistry</source><volume>40</volume><fpage>1328</fpage><lpage>1331</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2007.07.010</pub-id><pub-id pub-id-type="pmid">17825809</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axelrod</surname><given-names>J</given-names></name><name><surname>Weil-Malherbe</surname><given-names>H</given-names></name><name><surname>Tomchick</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1959">1959</year><article-title>The physiological disposition of H3-epinephrine and its metabolite metanephrine</article-title><source>The Journal of Pharmacology and Experimental Therapeutics</source><volume>127</volume><fpage>251</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">13795315</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baeyer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1867">1867</year><article-title>Mittheilungen aus dem organischen Laboratorium de Gewerbeacademie zu Berlin. I. Über das Neurin (Notes from the organic laboratory of the Gewerbeacademie in Berlin. I on the neurin)</article-title><source>Justus Liebig’s Annalen Der Chemie</source><volume>142</volume><fpage>322</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1002/jlac.18671420311</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajjalieh</surname><given-names>SM</given-names></name><name><surname>Peterson</surname><given-names>K</given-names></name><name><surname>Shinghal</surname><given-names>R</given-names></name><name><surname>Scheller</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>SV2, a brain synaptic vesicle protein homologous to bacterial transporters</article-title><source>Science</source><volume>257</volume><fpage>1271</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1126/science.1519064</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balthazart</surname><given-names>J</given-names></name><name><surname>Ball</surname><given-names>GF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Is brain estradiol a hormone or a neurotransmitter?</article-title><source>Trends in Neurosciences</source><volume>29</volume><fpage>241</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2006.03.004</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barañano</surname><given-names>DE</given-names></name><name><surname>Ferris</surname><given-names>CD</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Atypical neural messengers</article-title><source>Trends in Neurosciences</source><volume>24</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/S0166-2236(00)01716-1</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barger</surname><given-names>G</given-names></name><name><surname>Dale</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="1910">1910</year><article-title>Chemical structure and sympathomimetic action of amines</article-title><source>The Journal of Physiology</source><volume>41</volume><fpage>19</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1910.sp001392</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnwell</surname><given-names>LF</given-names></name><name><surname>Chaudhuri</surname><given-names>G</given-names></name><name><surname>Townsel</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Cloning and sequencing of a cDNA encoding a novel member of the human brain GABA/noradrenaline neurotransmitter transporter family</article-title><source>Gene</source><volume>159</volume><fpage>287</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/0378-1119(95)00104-e</pub-id><pub-id pub-id-type="pmid">7622069</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baroncelli</surname><given-names>L</given-names></name><name><surname>Molinaro</surname><given-names>A</given-names></name><name><surname>Cacciante</surname><given-names>F</given-names></name><name><surname>Alessandrì</surname><given-names>MG</given-names></name><name><surname>Napoli</surname><given-names>D</given-names></name><name><surname>Putignano</surname><given-names>E</given-names></name><name><surname>Tola</surname><given-names>J</given-names></name><name><surname>Leuzzi</surname><given-names>V</given-names></name><name><surname>Cioni</surname><given-names>G</given-names></name><name><surname>Pizzorusso</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A mouse model for creatine transporter deficiency reveals early onset cognitive impairment and neuropathology associated with brain aging</article-title><source>Human Molecular Genetics</source><volume>25</volume><fpage>4186</fpage><lpage>4200</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw252</pub-id><pub-id pub-id-type="pmid">27466184</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battini</surname><given-names>R</given-names></name><name><surname>Chilosi</surname><given-names>AM</given-names></name><name><surname>Casarano</surname><given-names>M</given-names></name><name><surname>Moro</surname><given-names>F</given-names></name><name><surname>Comparini</surname><given-names>A</given-names></name><name><surname>Alessandrì</surname><given-names>MG</given-names></name><name><surname>Leuzzi</surname><given-names>V</given-names></name><name><surname>Tosetti</surname><given-names>M</given-names></name><name><surname>Cioni</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Language disorder with mild intellectual disability in a child affected by a novel mutation of SLC6A8 gene</article-title><source>Molecular Genetics and Metabolism</source><volume>102</volume><fpage>153</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2010.11.005</pub-id><pub-id pub-id-type="pmid">21144783</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bear</surname><given-names>MF</given-names></name><name><surname>Connors</surname><given-names>BW</given-names></name><name><surname>Paradiso</surname><given-names>MAN</given-names></name></person-group><year iso-8601-date="2016">2016</year><source>Neuroscience, Exploring the Brain</source><publisher-name>Wolters Kluwer</publisher-name></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>SG</given-names></name><name><surname>Goldfarb</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Serotonin produces a reversible concentration dependent decrease of population spikes in rat hippocampal slices</article-title><source>Life Sciences</source><volume>36</volume><fpage>557</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/0024-3205(85)90637-X</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellocchio</surname><given-names>EE</given-names></name><name><surname>Reimer</surname><given-names>RJ</given-names></name><name><surname>Fremeau</surname><given-names>RT</given-names></name><name><surname>Edwards</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter</article-title><source>Science</source><volume>289</volume><fpage>957</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1126/science.289.5481.957</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bernard</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1857">1857</year><source>Leçons Sur Les Effets Des Substances Toxiques et Médicamenteuses</source><publisher-loc>Paris</publisher-loc><publisher-name>JB Baillière</publisher-name><pub-id pub-id-type="doi">10.5962/bhl.title.1834</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>MC</given-names></name><name><surname>Tosetti</surname><given-names>M</given-names></name><name><surname>Fornai</surname><given-names>F</given-names></name><name><surname>Alessandri’</surname><given-names>MG</given-names></name><name><surname>Cipriani</surname><given-names>P</given-names></name><name><surname>De Vito</surname><given-names>G</given-names></name><name><surname>Canapicchi</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Reversible brain creatine deficiency in two sisters with normal blood creatine level</article-title><source>Annals of Neurology</source><volume>47</volume><fpage>511</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">10762163</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Björklund</surname><given-names>A</given-names></name><name><surname>Ehinger</surname><given-names>B</given-names></name><name><surname>Falck</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1968">1968</year><article-title>A method for differentiating dopamine from noradrenaline in tissue sections by microspectrofluorometry</article-title><source>The Journal of Histochemistry and Cytochemistry</source><volume>16</volume><fpage>263</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1177/16.4.263</pub-id><pub-id pub-id-type="pmid">5656462</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blakely</surname><given-names>RD</given-names></name><name><surname>Berson</surname><given-names>HE</given-names></name><name><surname>Fremeau</surname><given-names>RT</given-names><suffix>Jr</suffix></name><name><surname>Caron</surname><given-names>MG</given-names></name><name><surname>Peek</surname><given-names>MM</given-names></name><name><surname>Prince</surname><given-names>HK</given-names></name><name><surname>Bradley</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Cloning and expression of a functional serotonin transporter from rat brain</article-title><source>Nature</source><volume>354</volume><fpage>66</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1038/354066a0</pub-id><pub-id pub-id-type="pmid">1944572</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>RFG</given-names></name><name><surname>Clark</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>A rapid method for the preparation of relatively pure metabolically competent synaptosomes from rat brain</article-title><source>The Biochemical Journal</source><volume>176</volume><fpage>365</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1042/bj1760365</pub-id><pub-id pub-id-type="pmid">743245</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borden</surname><given-names>LA</given-names></name><name><surname>Smith</surname><given-names>KE</given-names></name><name><surname>Hartig</surname><given-names>PR</given-names></name><name><surname>Branchek</surname><given-names>TA</given-names></name><name><surname>Weinshank</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Molecular heterogeneity of the gamma-aminobutyric acid (GABA) transport system. Cloning of two novel high affinity GABA transporters from rat brain</article-title><source>The Journal of Biological Chemistry</source><volume>267</volume><fpage>21098</fpage><lpage>21104</lpage><pub-id pub-id-type="pmid">1400419</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradberry</surname><given-names>MM</given-names></name><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>McKetney</surname><given-names>JM</given-names></name><name><surname>Vestling</surname><given-names>MM</given-names></name><name><surname>Coon</surname><given-names>JJ</given-names></name><name><surname>Chapman</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Rapid and Gentle immunopurification of brain synaptic vesicles</article-title><source>The Journal of Neuroscience</source><volume>42</volume><fpage>3512</fpage><lpage>3522</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2521-21.2022</pub-id><pub-id pub-id-type="pmid">35296545</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braissant</surname><given-names>O</given-names></name><name><surname>Henry</surname><given-names>H</given-names></name><name><surname>Loup</surname><given-names>M</given-names></name><name><surname>Eilers</surname><given-names>B</given-names></name><name><surname>Bachmann</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study</article-title><source>Brain Research. Molecular Brain Research</source><volume>86</volume><fpage>193</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/s0169-328x(00)00269-2</pub-id><pub-id pub-id-type="pmid">11165387</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braissant</surname><given-names>O</given-names></name><name><surname>Bachmann</surname><given-names>C</given-names></name><name><surname>Henry</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Expression and function of AGAT, GAMT and CT1 in the mammalian brain</article-title><source>Sub-Cellular Biochemistry</source><volume>46</volume><fpage>67</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1007/978-1-4020-6486-9_4</pub-id><pub-id pub-id-type="pmid">18652072</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braissant</surname><given-names>O</given-names></name><name><surname>Henry</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: A review</article-title><source>Journal of Inherited Metabolic Disease</source><volume>31</volume><fpage>230</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1007/s10545-008-0826-9</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braissant</surname><given-names>O</given-names></name><name><surname>Béard</surname><given-names>E</given-names></name><name><surname>Torrent</surname><given-names>C</given-names></name><name><surname>Henry</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes</article-title><source>Neurobiology of Disease</source><volume>37</volume><fpage>423</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2009.10.022</pub-id><pub-id pub-id-type="pmid">19879361</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braissant</surname><given-names>O</given-names></name><name><surname>Henry</surname><given-names>H</given-names></name><name><surname>Béard</surname><given-names>E</given-names></name><name><surname>Uldry</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Creatine deficiency syndromes and the importance of creatine synthesis in the brain</article-title><source>Amino Acids</source><volume>40</volume><fpage>1315</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1007/s00726-011-0852-z</pub-id><pub-id pub-id-type="pmid">21390529</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braissant</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers</article-title><source>Journal of Inherited Metabolic Disease</source><volume>35</volume><fpage>655</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1007/s10545-011-9433-2</pub-id><pub-id pub-id-type="pmid">22252611</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bröer</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The SLC6 orphans are forming a family of amino acid transporters</article-title><source>Neurochemistry International</source><volume>48</volume><fpage>559</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2005.11.021</pub-id><pub-id pub-id-type="pmid">16540203</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bröer</surname><given-names>S</given-names></name><name><surname>Gether</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The solute carrier 6 family of transporters</article-title><source>British Journal of Pharmacology</source><volume>167</volume><fpage>256</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2012.01975.x</pub-id><pub-id pub-id-type="pmid">22519513</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brosnan</surname><given-names>JT</given-names></name><name><surname>Brosnan</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Creatine: endogenous metabolite, dietary, and therapeutic supplement</article-title><source>Annual Review of Nutrition</source><volume>27</volume><fpage>241</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1146/annurev.nutr.27.061406.093621</pub-id><pub-id pub-id-type="pmid">17430086</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brosnan</surname><given-names>ME</given-names></name><name><surname>Brosnan</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The role of dietary creatine</article-title><source>Amino Acids</source><volume>48</volume><fpage>1785</fpage><lpage>1791</lpage><pub-id pub-id-type="doi">10.1007/s00726-016-2188-1</pub-id><pub-id pub-id-type="pmid">26874700</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>GL</given-names></name><name><surname>Feldberg</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1936">1936</year><article-title>The acetyloholine metabolism of a sympathetic ganglion</article-title><source>The Journal of Physiology</source><volume>88</volume><fpage>265</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1936.sp003439</pub-id><pub-id pub-id-type="pmid">16994823</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>DA</given-names></name><name><surname>Scholfield</surname><given-names>CN</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Depolarization of neurones in the isolated olfactory cortex of the guinea-pig by gamma-aminobutyric acid</article-title><source>British Journal of Pharmacology</source><volume>65</volume><fpage>339</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.1979.tb07835.x</pub-id><pub-id pub-id-type="pmid">216454</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burger</surname><given-names>PM</given-names></name><name><surname>Mehl</surname><given-names>E</given-names></name><name><surname>Cameron</surname><given-names>PL</given-names></name><name><surname>Maycox</surname><given-names>PR</given-names></name><name><surname>Baumert</surname><given-names>M</given-names></name><name><surname>Lottspeich</surname><given-names>F</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Synaptic vesicles immunoisolated from rat cerebral cortex contain high levels of glutamate</article-title><source>Neuron</source><volume>3</volume><fpage>715</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(89)90240-7</pub-id><pub-id pub-id-type="pmid">2577130</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burger</surname><given-names>PM</given-names></name><name><surname>Hell</surname><given-names>J</given-names></name><name><surname>Mehl</surname><given-names>E</given-names></name><name><surname>Krasel</surname><given-names>C</given-names></name><name><surname>Lottspeich</surname><given-names>F</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>GABA and glycine in synaptic vesicles: storage and transport characteristics</article-title><source>Neuron</source><volume>7</volume><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(91)90267-4</pub-id><pub-id pub-id-type="pmid">1678614</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>L</given-names></name><name><surname>Shyjan</surname><given-names>AW</given-names></name><name><surname>Rakic</surname><given-names>P</given-names></name><name><surname>Levenson</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Neurons and astroglia express distinct subsets of Na,K-ATPase α and β subunits</article-title><source>Molecular Brain Research</source><volume>21</volume><fpage>333</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/0169-328X(94)90264-X</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannon</surname><given-names>WB</given-names></name><name><surname>Rosenblueth</surname><given-names>ASE</given-names></name><name><surname>Sympathin</surname><given-names>I</given-names></name></person-group><year iso-8601-date="1933">1933</year><article-title>Studies on conditions of activity in endocrine organs</article-title><source>American Journal of Physiology-Legacy Content</source><volume>104</volume><fpage>557</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1152/ajplegacy.1933.104.3.557</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>A</given-names></name><name><surname>Falck</surname><given-names>B</given-names></name><name><surname>Hillarp</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="1962">1962</year><article-title>Cellular localization of brain monoamines</article-title><source>Acta Physiologica Scandinavica</source><volume>56</volume><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1111/j.1748-1716.1962.tb02561.x</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chantranupong</surname><given-names>L</given-names></name><name><surname>Saulnier</surname><given-names>JL</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Jones</surname><given-names>DR</given-names></name><name><surname>Pacold</surname><given-names>ME</given-names></name><name><surname>Sabatini</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Rapid purification and metabolomic profiling of synaptic vesicles from mammalian brain</article-title><source>eLife</source><volume>9</volume><elocation-id>e59699</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.59699</pub-id><pub-id pub-id-type="pmid">33043885</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheillan</surname><given-names>D</given-names></name><name><surname>Joncquel-Chevalier Curt</surname><given-names>M</given-names></name><name><surname>Briand</surname><given-names>G</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>Mention-Mulliez</surname><given-names>K</given-names></name><name><surname>Dobbelaere</surname><given-names>D</given-names></name><name><surname>Cuisset</surname><given-names>J-M</given-names></name><name><surname>Lion-François</surname><given-names>L</given-names></name><name><surname>Portes</surname><given-names>VD</given-names></name><name><surname>Chabli</surname><given-names>A</given-names></name><name><surname>Valayannopoulos</surname><given-names>V</given-names></name><name><surname>Benoist</surname><given-names>J-F</given-names></name><name><surname>Pinard</surname><given-names>J-M</given-names></name><name><surname>Simard</surname><given-names>G</given-names></name><name><surname>Douay</surname><given-names>O</given-names></name><name><surname>Deiva</surname><given-names>K</given-names></name><name><surname>Afenjar</surname><given-names>A</given-names></name><name><surname>Héron</surname><given-names>D</given-names></name><name><surname>Rivier</surname><given-names>F</given-names></name><name><surname>Chabrol</surname><given-names>B</given-names></name><name><surname>Prieur</surname><given-names>F</given-names></name><name><surname>Cartault</surname><given-names>F</given-names></name><name><surname>Pitelet</surname><given-names>G</given-names></name><name><surname>Goldenberg</surname><given-names>A</given-names></name><name><surname>Bekri</surname><given-names>S</given-names></name><name><surname>Gerard</surname><given-names>M</given-names></name><name><surname>Delorme</surname><given-names>R</given-names></name><name><surname>Tardieu</surname><given-names>M</given-names></name><name><surname>Porchet</surname><given-names>N</given-names></name><name><surname>Vianey-Saban</surname><given-names>C</given-names></name><name><surname>Vamecq</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Screening for primary creatine deficiencies in French patients with unexplained neurological symptoms</article-title><source>Orphanet Journal of Rare Diseases</source><volume>7</volume><elocation-id>96</elocation-id><pub-id pub-id-type="doi">10.1186/1750-1172-7-96</pub-id><pub-id pub-id-type="pmid">23234264</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N-H</given-names></name><name><surname>Reith</surname><given-names>MEA</given-names></name><name><surname>Quick</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6</article-title><source>Pflugers Archiv</source><volume>447</volume><fpage>519</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1007/s00424-003-1064-5</pub-id><pub-id pub-id-type="pmid">12719981</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chevreul</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1835">1835</year><article-title>Sur la composition chimique du bouillon de viandes</article-title><source>J Pharm Sci Access</source><volume>21</volume><fpage>231</fpage><lpage>242</lpage></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>KO</given-names></name><name><surname>Hunt</surname><given-names>CA</given-names></name><name><surname>Kennedy</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>The rat brain postsynaptic density fraction contains a homolog of the <italic>Drosophila</italic> discs-large tumor suppressor protein</article-title><source>Neuron</source><volume>9</volume><fpage>929</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(92)90245-9</pub-id><pub-id pub-id-type="pmid">1419001</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cidon</surname><given-names>S</given-names></name><name><surname>Sihra</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Characterization of a H+-ATPase in rat brain synaptic vesicles</article-title><source>Journal of Biological Chemistry</source><volume>264</volume><fpage>8281</fpage><lpage>8288</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)83180-5</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>JA</given-names></name><name><surname>Deutch</surname><given-names>AY</given-names></name><name><surname>Gallipoli</surname><given-names>PZ</given-names></name><name><surname>Amara</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Functional expression and CNS distribution of a beta-alanine-sensitive neuronal GABA transporter</article-title><source>Neuron</source><volume>9</volume><fpage>337</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(92)90172-a</pub-id><pub-id pub-id-type="pmid">1497897</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>AJ</given-names></name><name><surname>Rosenberg</surname><given-names>EH</given-names></name><name><surname>Almeida</surname><given-names>LS</given-names></name><name><surname>Wood</surname><given-names>TC</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name><name><surname>Stevenson</surname><given-names>RE</given-names></name><name><surname>Schwartz</surname><given-names>CE</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology</article-title><source>Human Genetics</source><volume>119</volume><fpage>604</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1007/s00439-006-0162-9</pub-id><pub-id pub-id-type="pmid">16738945</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>AE</given-names></name><name><surname>ffench-Mullen</surname><given-names>JM</given-names></name><name><surname>Fisher</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Fade of the response to prolonged glutamate application in the rat hippocampal slice</article-title><source>Synapse</source><volume>4</volume><fpage>11</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1002/syn.890040103</pub-id><pub-id pub-id-type="pmid">2570466</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collier</surname><given-names>B</given-names></name><name><surname>Mitchell</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="1966">1966</year><article-title>The central release of acetylcholine during stimulation of the visual pathway</article-title><source>The Journal of Physiology</source><volume>184</volume><fpage>239</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1966.sp007913</pub-id><pub-id pub-id-type="pmid">5921540</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collier</surname><given-names>B</given-names></name><name><surname>Mitchell</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="1967">1967</year><article-title>The central release of acetylcholine during consciousness and after brain lesions</article-title><source>The Journal of Physiology</source><volume>188</volume><fpage>83</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1967.sp008125</pub-id><pub-id pub-id-type="pmid">6032200</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>JR</given-names></name><name><surname>Bloom</surname><given-names>FE</given-names></name><name><surname>Roth</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2002">2002</year><source>The Biochemical Basis of Neuropharmacology</source><publisher-name>Oxford University Press</publisher-name><pub-id pub-id-type="doi">10.1093/oso/9780195140071.001.0001</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cserép</surname><given-names>C</given-names></name><name><surname>Szabadits</surname><given-names>E</given-names></name><name><surname>Szőnyi</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Freund</surname><given-names>TF</given-names></name><name><surname>Nyiri</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NMDA receptors in GABAergic synapses during postnatal development</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e37753</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0037753</pub-id><pub-id pub-id-type="pmid">22662211</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>DR</given-names></name><name><surname>Phillis</surname><given-names>JW</given-names></name><name><surname>Watkins</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="1959">1959</year><article-title>Chemical excitation of spinal neurones</article-title><source>Nature</source><volume>183</volume><fpage>611</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1038/183611a0</pub-id><pub-id pub-id-type="pmid">13632811</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>DR</given-names></name><name><surname>Watkins</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="1960">1960</year><article-title>The excitation and depression of spinal neurones by structurally related amino acids</article-title><source>Journal of Neurochemistry</source><volume>6</volume><fpage>117</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1960.tb13458.x</pub-id><pub-id pub-id-type="pmid">13718948</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>DR</given-names></name><name><surname>Watkins</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="1963">1963</year><article-title>Acidic amino acids with strong excitatory actions on mammalian neurones</article-title><source>The Journal of Physiology</source><volume>166</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1963.sp007087</pub-id><pub-id pub-id-type="pmid">14024354</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="1914">1914</year><article-title>The action of certain esters and ethers of choline, and their relation to muscarine</article-title><source>Journal of Pharmacology and Experimental Therapeutics</source><volume>6</volume><fpage>147</fpage><lpage>190</lpage></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>HH</given-names></name><name><surname>Dudley</surname><given-names>HW</given-names></name></person-group><year iso-8601-date="1929">1929</year><article-title>The presence of histamine and acetylcholine in the spleen of the ox and the horse</article-title><source>The Journal of Physiology</source><volume>68</volume><fpage>97</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1929.sp002598</pub-id><pub-id pub-id-type="pmid">16994063</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>HH</given-names></name><name><surname>Feldberg</surname><given-names>W</given-names></name><name><surname>Vogt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1936">1936</year><article-title>Release of acetylcholine at voluntary motor nerve endings</article-title><source>The Journal of Physiology</source><volume>86</volume><fpage>353</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1936.sp003371</pub-id><pub-id pub-id-type="pmid">16994763</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Aniello</surname><given-names>S</given-names></name><name><surname>Somorjai</surname><given-names>I</given-names></name><name><surname>Garcia‐Fernàndez</surname><given-names>J</given-names></name><name><surname>Topo</surname><given-names>E</given-names></name><name><surname>D’Aniello</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>D‐Aspartic acid is a novel endogenous neurotransmitter</article-title><source>The FASEB Journal</source><volume>25</volume><fpage>1014</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1096/fj.10-168492</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniels</surname><given-names>RW</given-names></name><name><surname>Rossano</surname><given-names>AJ</given-names></name><name><surname>Macleod</surname><given-names>GT</given-names></name><name><surname>Ganetzky</surname><given-names>B</given-names></name><name><surname>McCabe</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Expression of multiple transgenes from a single construct using viral 2A peptides in <italic>Drosophila</italic></article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e100637</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0100637</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Camilli</surname><given-names>P</given-names></name><name><surname>Harris</surname><given-names>SM</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Synapsin I (Protein I), a nerve terminal-specific phosphoprotein. II. Its specific association with synaptic vesicles demonstrated by immunocytochemistry in agarose-embedded synaptosomes</article-title><source>The Journal of Cell Biology</source><volume>96</volume><fpage>1355</fpage><lpage>1373</lpage><pub-id pub-id-type="doi">10.1083/jcb.96.5.1355</pub-id><pub-id pub-id-type="pmid">6404911</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Deyn</surname><given-names>PP</given-names></name><name><surname>Macdonald</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture</article-title><source>Annals of Neurology</source><volume>28</volume><fpage>627</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1002/ana.410280505</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Deyn</surname><given-names>PP</given-names></name><name><surname>D’Hooge</surname><given-names>R</given-names></name><name><surname>Van Bogaert</surname><given-names>P-P</given-names></name><name><surname>Marescau</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Endogenous guanidino compounds as uremic neurotoxins</article-title><source>Kidney International</source><volume>59</volume><fpage>S77</fpage><lpage>S83</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1755.2001.59780077.x</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Castillo</surname><given-names>J</given-names></name><name><surname>Katz</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1954">1954</year><article-title>Quantal components of the end-plate potential</article-title><source>The Journal of Physiology</source><volume>124</volume><fpage>560</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1954.sp005129</pub-id><pub-id pub-id-type="pmid">13175199</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>del Castillo</surname><given-names>J</given-names></name><name><surname>Katz</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1956">1956</year><article-title>Biophysical aspects of neuro-muscular transmission</article-title><source>Progress in Biophysics and Biophysical Chemistry</source><volume>6</volume><fpage>121</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/S0096-4174(18)30106-9</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Robertis</surname><given-names>EDP</given-names></name><name><surname>Bennett</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="1954">1954</year><article-title>Sub-microscopic vesicle component in the synapse</article-title><source>Federation Proceedings</source><volume>13</volume><elocation-id>35</elocation-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Robertis</surname><given-names>ED</given-names></name><name><surname>Bennett</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="1955">1955</year><article-title>Some features of the submicroscopic morphology of synapses in frog and earthworm</article-title><source>The Journal of Biophysical and Biochemical Cytology</source><volume>1</volume><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1083/jcb.1.1.47</pub-id><pub-id pub-id-type="pmid">14381427</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DesRoches</surname><given-names>C-L</given-names></name><name><surname>Patel</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Minassian</surname><given-names>B</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>Marshall</surname><given-names>CR</given-names></name><name><surname>Mercimek-Mahmutoglu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Estimated carrier frequency of creatine transporter deficiency in females in the general population using functional characterization of novel missense variants in the SLC6A8 gene</article-title><source>Gene</source><volume>565</volume><fpage>187</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2015.04.011</pub-id><pub-id pub-id-type="pmid">25861866</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Reznikov</surname><given-names>LR</given-names></name><name><surname>Price</surname><given-names>MP</given-names></name><name><surname>Zha</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Moninger</surname><given-names>TO</given-names></name><name><surname>Wemmie</surname><given-names>JA</given-names></name><name><surname>Welsh</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Protons are a neurotransmitter that regulates synaptic plasticity in the lateral amygdala</article-title><source>PNAS</source><volume>111</volume><fpage>8961</fpage><lpage>8966</lpage><pub-id pub-id-type="doi">10.1073/pnas.1407018111</pub-id><pub-id pub-id-type="pmid">24889629</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Du Bois-Reymond</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1877">1877</year><source>Gesammelte Abhandlungen Zur Allgemeinen Muskel-Und Nervenphysik</source><publisher-name>Veit &amp; Co</publisher-name><pub-id pub-id-type="doi">10.1515/9783112343265</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunbar</surname><given-names>M</given-names></name><name><surname>Jaggumantri</surname><given-names>S</given-names></name><name><surname>Sargent</surname><given-names>M</given-names></name><name><surname>Stockler-Ipsiroglu</surname><given-names>S</given-names></name><name><surname>van Karnebeek</surname><given-names>CDM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases</article-title><source>Molecular Genetics and Metabolism</source><volume>112</volume><fpage>259</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2014.05.011</pub-id><pub-id pub-id-type="pmid">24953403</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duran-Trio</surname><given-names>L</given-names></name><name><surname>Fernandes-Pires</surname><given-names>G</given-names></name><name><surname>Simicic</surname><given-names>D</given-names></name><name><surname>Grosse</surname><given-names>J</given-names></name><name><surname>Roux-Petronelli</surname><given-names>C</given-names></name><name><surname>Bruce</surname><given-names>SJ</given-names></name><name><surname>Binz</surname><given-names>P-A</given-names></name><name><surname>Sandi</surname><given-names>C</given-names></name><name><surname>Cudalbu</surname><given-names>C</given-names></name><name><surname>Braissant</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism</article-title><source>Scientific Reports</source><volume>11</volume><elocation-id>1636</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-80824-x</pub-id><pub-id pub-id-type="pmid">33452333</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egashira</surname><given-names>Y</given-names></name><name><surname>Takase</surname><given-names>M</given-names></name><name><surname>Takamori</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Monitoring of vacuolar-type H+ ATPase-mediated proton influx into synaptic vesicles</article-title><source>The Journal of Neuroscience</source><volume>35</volume><fpage>3701</fpage><lpage>3710</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4160-14.2015</pub-id><pub-id pub-id-type="pmid">25716867</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egashira</surname><given-names>Y</given-names></name><name><surname>Takase</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Ishida</surname><given-names>J</given-names></name><name><surname>Fukamizu</surname><given-names>A</given-names></name><name><surname>Kaneko</surname><given-names>R</given-names></name><name><surname>Yanagawa</surname><given-names>Y</given-names></name><name><surname>Takamori</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Unique pH dynamics in GABAergic synaptic vesicles illuminates the mechanism and kinetics of GABA loading</article-title><source>PNAS</source><volume>113</volume><fpage>10702</fpage><lpage>10707</lpage><pub-id pub-id-type="doi">10.1073/pnas.1604527113</pub-id><pub-id pub-id-type="pmid">27601664</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eliseeva</surname><given-names>ZV</given-names></name><name><surname>Durinian</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>Projections of the somatosensory areas of the cerebral cortex into the thalamic nuclei</article-title><source>Biulleten’ Eksperimental’noi Biologii i Meditsiny</source><volume>80</volume><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">1227606</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliot</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="1904">1904</year><article-title>On the action of adrenalin</article-title><source>The Journal of Physiology</source><volume>31</volume><fpage>xx</fpage><lpage>xxi</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1904.sp001055</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="1905">1905</year><article-title>The action of adrenalin</article-title><source>The Journal of Physiology</source><volume>32</volume><fpage>401</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1905.sp001093</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewins</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="1914">1914</year><article-title>Acetylcholine, a new active principle of Ergot</article-title><source>The Biochemical Journal</source><volume>8</volume><fpage>44</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1042/bj0080044</pub-id><pub-id pub-id-type="pmid">16742288</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatt</surname><given-names>P</given-names></name><name><surname>Katz</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1950">1950</year><article-title>Some observations on biological noise</article-title><source>Nature</source><volume>166</volume><fpage>597</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1038/166597a0</pub-id><pub-id pub-id-type="pmid">14780165</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatt</surname><given-names>P</given-names></name><name><surname>Katz</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1952">1952</year><article-title>Spontaneous subthreshold activity at motor nerve endings</article-title><source>The Journal of Physiology</source><volume>117</volume><fpage>109</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">14946732</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feil</surname><given-names>R</given-names></name><name><surname>Wagner</surname><given-names>J</given-names></name><name><surname>Metzger</surname><given-names>D</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains</article-title><source>Biochemical and Biophysical Research Communications</source><volume>237</volume><fpage>752</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1997.7124</pub-id><pub-id pub-id-type="pmid">9299439</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldberg</surname><given-names>W</given-names></name><name><surname>Gaddum</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="1934">1934</year><article-title>The chemical transmitter at synapses in a sympathetic ganglion</article-title><source>The Journal of Physiology</source><volume>81</volume><fpage>305</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1934.sp003137</pub-id><pub-id pub-id-type="pmid">16994545</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felix</surname><given-names>D</given-names></name><name><surname>Künzle</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>Iontophoretic and autoradiographic studies on the role of proline in nervous transmission</article-title><source>Pflugers Archiv</source><volume>350</volume><fpage>135</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1007/BF00586233</pub-id><pub-id pub-id-type="pmid">4368845</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florey</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1954">1954</year><article-title>An inhibitory and an excitatory factor of mammalian central nervous system, and their action on a single sensory neuron</article-title><source>Archives Internationales de Physiologie</source><volume>62</volume><fpage>33</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.3109/13813455409145367</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florey</surname><given-names>E</given-names></name><name><surname>McLennan</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1955">1955</year><article-title>The release of an inhibitory substance from mammalian brain, and its effect on peripheral synaptic transmission</article-title><source>The Journal of Physiology</source><volume>129</volume><fpage>384</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1955.sp005361</pub-id><pub-id pub-id-type="pmid">13252630</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fons</surname><given-names>C</given-names></name><name><surname>Campistol</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Creatine defects and central nervous system</article-title><source>Seminars in Pediatric Neurology</source><volume>23</volume><fpage>285</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/j.spen.2016.11.003</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fykse</surname><given-names>EM</given-names></name><name><surname>Fonnum</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Uptake of γ‐Aminobutyric acid by a synaptic vesicle fraction isolated from rat brain</article-title><source>Journal of Neurochemistry</source><volume>50</volume><fpage>1237</fpage><lpage>1242</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1988.tb10599.x</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geppert</surname><given-names>M</given-names></name><name><surname>Goda</surname><given-names>Y</given-names></name><name><surname>Hammer</surname><given-names>RE</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Rosahl</surname><given-names>TW</given-names></name><name><surname>Stevens</surname><given-names>CF</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse</article-title><source>Cell</source><volume>79</volume><fpage>717</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90556-8</pub-id><pub-id pub-id-type="pmid">7954835</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerbatin</surname><given-names>RR</given-names></name><name><surname>Silva</surname><given-names>LFA</given-names></name><name><surname>Hoffmann</surname><given-names>MS</given-names></name><name><surname>Della-Pace</surname><given-names>ID</given-names></name><name><surname>do Nascimento</surname><given-names>PS</given-names></name><name><surname>Kegler</surname><given-names>A</given-names></name><name><surname>de Zorzi</surname><given-names>VN</given-names></name><name><surname>Cunha</surname><given-names>JM</given-names></name><name><surname>Botelho</surname><given-names>P</given-names></name><name><surname>Neto</surname><given-names>JBT</given-names></name><name><surname>Furian</surname><given-names>AF</given-names></name><name><surname>Oliveira</surname><given-names>MS</given-names></name><name><surname>Fighera</surname><given-names>MR</given-names></name><name><surname>Royes</surname><given-names>LFF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Delayed creatine supplementation counteracts reduction of GABAergic function and protects against seizures susceptibility after traumatic brain injury in rats</article-title><source>Progress in Neuro-Psychopharmacology and Biological Psychiatry</source><volume>92</volume><fpage>328</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2019.02.004</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghirardini</surname><given-names>E</given-names></name><name><surname>Sagona</surname><given-names>G</given-names></name><name><surname>Marquez-Galera</surname><given-names>A</given-names></name><name><surname>Calugi</surname><given-names>F</given-names></name><name><surname>Navarron</surname><given-names>CM</given-names></name><name><surname>Cacciante</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Di Vetta</surname><given-names>F</given-names></name><name><surname>Dadà</surname><given-names>L</given-names></name><name><surname>Mazziotti</surname><given-names>R</given-names></name><name><surname>Lupori</surname><given-names>L</given-names></name><name><surname>Putignano</surname><given-names>E</given-names></name><name><surname>Baldi</surname><given-names>P</given-names></name><name><surname>Lopez-Atalaya</surname><given-names>JP</given-names></name><name><surname>Pizzorusso</surname><given-names>T</given-names></name><name><surname>Baroncelli</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Cell-specific vulnerability to metabolic failure: the crucial role of parvalbumin expressing neurons in creatine transporter deficiency</article-title><source>Acta Neuropathologica Communications</source><volume>11</volume><elocation-id>34</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-023-01533-w</pub-id><pub-id pub-id-type="pmid">36882863</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giros</surname><given-names>B</given-names></name><name><surname>el Mestikawy</surname><given-names>S</given-names></name><name><surname>Bertrand</surname><given-names>L</given-names></name><name><surname>Caron</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Cloning and functional characterization of a cocaine-sensitive dopamine transporter</article-title><source>FEBS Letters</source><volume>295</volume><fpage>149</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(91)81406-x</pub-id><pub-id pub-id-type="pmid">1765147</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>AM</given-names></name><name><surname>Uhl</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>“Choline/orphan V8-2-1/creatine transporter” mRNA is expressed in nervous, renal and gastrointestinal systems</article-title><source>Brain Research. Molecular Brain Research</source><volume>23</volume><fpage>266</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/0169-328x(94)90233-x</pub-id><pub-id pub-id-type="pmid">8057783</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorelova</surname><given-names>N</given-names></name><name><surname>Reiner</surname><given-names>PB</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Role of the afterhyperpolarization in control of discharge properties of septal cholinergic neurons in vitro</article-title><source>Journal of Neurophysiology</source><volume>75</volume><fpage>695</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1152/jn.1996.75.2.695</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>KJ</given-names></name><name><surname>Chan</surname><given-names>EK</given-names></name><name><surname>Lung</surname><given-names>CC</given-names></name><name><surname>Hamel</surname><given-names>JC</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Miyachi</surname><given-names>K</given-names></name><name><surname>Fritzler</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Molecular cloning of a novel 97-kd Golgi complex autoantigen associated with Sjögren’s syndrome</article-title><source>Arthritis and Rheumatism</source><volume>40</volume><fpage>1693</fpage><lpage>1702</lpage><pub-id pub-id-type="doi">10.1002/art.1780400920</pub-id><pub-id pub-id-type="pmid">9324025</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Zou</surname><given-names>YR</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting</article-title><source>Cell</source><volume>73</volume><fpage>1155</fpage><lpage>1164</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90644-6</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guastella</surname><given-names>J</given-names></name><name><surname>Nelson</surname><given-names>N</given-names></name><name><surname>Nelson</surname><given-names>H</given-names></name><name><surname>Czyzyk</surname><given-names>L</given-names></name><name><surname>Keynan</surname><given-names>S</given-names></name><name><surname>Miedel</surname><given-names>MC</given-names></name><name><surname>Davidson</surname><given-names>N</given-names></name><name><surname>Lester</surname><given-names>HA</given-names></name><name><surname>Kanner</surname><given-names>BI</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Cloning and expression of a rat brain GABA transporter</article-title><source>Science</source><volume>249</volume><fpage>1303</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.1126/science.1975955</pub-id><pub-id pub-id-type="pmid">1975955</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guastella</surname><given-names>J</given-names></name><name><surname>Brecha</surname><given-names>N</given-names></name><name><surname>Weigmann</surname><given-names>C</given-names></name><name><surname>Lester</surname><given-names>HA</given-names></name><name><surname>Davidson</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Cloning, expression, and localization of a rat brain high-affinity glycine transporter</article-title><source>PNAS</source><volume>89</volume><fpage>7189</fpage><lpage>7193</lpage><pub-id pub-id-type="doi">10.1073/pnas.89.15.7189</pub-id><pub-id pub-id-type="pmid">1353889</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimbal</surname><given-names>C</given-names></name><name><surname>Kilimann</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression</article-title><source>The Journal of Biological Chemistry</source><volume>268</volume><fpage>8418</fpage><lpage>8421</lpage><pub-id pub-id-type="pmid">8473283</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulyássy</surname><given-names>P</given-names></name><name><surname>Puska</surname><given-names>G</given-names></name><name><surname>Györffy</surname><given-names>BA</given-names></name><name><surname>Todorov-Völgyi</surname><given-names>K</given-names></name><name><surname>Juhász</surname><given-names>G</given-names></name><name><surname>Drahos</surname><given-names>L</given-names></name><name><surname>Kékesi</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Proteomic comparison of different synaptosome preparation procedures</article-title><source>Amino Acids</source><volume>52</volume><fpage>1529</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1007/s00726-020-02912-6</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guthmiller</surname><given-names>P</given-names></name><name><surname>Van Pilsum</surname><given-names>JF</given-names></name><name><surname>Boen</surname><given-names>JR</given-names></name><name><surname>McGuire</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Cloning and sequencing of rat kidney L-arginine:glycine amidinotransferase. Studies on the mechanism of regulation by growth hormone and creatine</article-title><source>Journal of Biological Chemistry</source><volume>269</volume><fpage>17556</fpage><lpage>17560</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(17)32477-8</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamberger</surname><given-names>AC</given-names></name><name><surname>Chiang</surname><given-names>GH</given-names></name><name><surname>Nylén</surname><given-names>ES</given-names></name><name><surname>Scheff</surname><given-names>SW</given-names></name><name><surname>Cotman</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="1979">1979a</year><article-title>Glutamate as a CNS transmitter. I. Evaluation of glucose and glutamine as precursors for the synthesis of preferentially released glutamate</article-title><source>Brain Research</source><volume>168</volume><fpage>513</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(79)90306-8</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamberger</surname><given-names>A</given-names></name><name><surname>Han Chiang</surname><given-names>G</given-names></name><name><surname>Sandoval</surname><given-names>E</given-names></name><name><surname>Cotman</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="1979">1979b</year><article-title>Glutamate as a CNS transmitter. II. Regulation of synthesis in the releasable pool</article-title><source>Brain Research</source><volume>168</volume><fpage>531</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(79)90307-X</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Happe</surname><given-names>HK</given-names></name><name><surname>Murrin</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>In situ hybridization analysis of CHOT1, a creatine transporter, in the rat central nervous system</article-title><source>The Journal of Comparative Neurology</source><volume>351</volume><fpage>94</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1002/cne.903510109</pub-id><pub-id pub-id-type="pmid">7896942</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hell</surname><given-names>JW</given-names></name><name><surname>Maycox</surname><given-names>PR</given-names></name><name><surname>Stadler</surname><given-names>H</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Uptake of GABA by rat brain synaptic vesicles isolated by a new procedure</article-title><source>The EMBO Journal</source><volume>7</volume><fpage>3023</fpage><lpage>3029</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1988.tb03166.x</pub-id><pub-id pub-id-type="pmid">2903047</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herculano-Houzel</surname><given-names>S</given-names></name><name><surname>Mota</surname><given-names>B</given-names></name><name><surname>Lent</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cellular scaling rules for rodent brains</article-title><source>PNAS</source><volume>103</volume><fpage>12138</fpage><lpage>12143</lpage><pub-id pub-id-type="doi">10.1073/pnas.0604911103</pub-id><pub-id pub-id-type="pmid">16880386</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>BJ</given-names></name><name><surname>Mezey</surname><given-names>E</given-names></name><name><surname>Brownstein</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Cloning of a serotonin transporter affected by antidepressants</article-title><source>Science</source><volume>254</volume><fpage>579</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1126/science.1948036</pub-id><pub-id pub-id-type="pmid">1948036</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Höglund</surname><given-names>PJ</given-names></name><name><surname>Adzic</surname><given-names>D</given-names></name><name><surname>Scicluna</surname><given-names>SJ</given-names></name><name><surname>Lindblom</surname><given-names>J</given-names></name><name><surname>Fredriksson</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The repertoire of solute carriers of family 6: identification of new human and rodent genes</article-title><source>Biochemical and Biophysical Research Communications</source><volume>336</volume><fpage>175</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2005.08.048</pub-id><pub-id pub-id-type="pmid">16125675</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1900">1900</year><article-title>Note on a blood pressure lowering body in the suprarenal gland</article-title><source>The American Journal of Physiology</source><volume>3</volume><fpage>xviii</fpage><lpage>xix</lpage></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>R</given-names></name><name><surname>Taveau</surname><given-names>RDM</given-names></name></person-group><year iso-8601-date="1906">1906</year><article-title>On the physiological action of certain cholin derivatives and new methods for detecting cholin</article-title><source>British Medical Journal</source><fpage>1788</fpage><lpage>1789</lpage></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huttner</surname><given-names>WB</given-names></name><name><surname>Schiebler</surname><given-names>W</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation</article-title><source>The Journal of Cell Biology</source><volume>96</volume><fpage>1374</fpage><lpage>1388</lpage><pub-id pub-id-type="doi">10.1083/jcb.96.5.1374</pub-id><pub-id pub-id-type="pmid">6404912</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Indra</surname><given-names>AK</given-names></name><name><surname>Warot</surname><given-names>X</given-names></name><name><surname>Brocard</surname><given-names>J</given-names></name><name><surname>Bornert</surname><given-names>J-M</given-names></name><name><surname>Xiao</surname><given-names>J-H</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name><name><surname>Metzger</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ERT and Cre-ERT2 recombinases</article-title><source>Nucleic Acids Research</source><volume>27</volume><fpage>4324</fpage><lpage>4327</lpage><pub-id pub-id-type="doi">10.1093/nar/27.22.4324</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishimura</surname><given-names>K</given-names></name><name><surname>Takeuchi</surname><given-names>Y</given-names></name><name><surname>Fujiwara</surname><given-names>K</given-names></name><name><surname>Tominaga</surname><given-names>M</given-names></name><name><surname>Yoshioka</surname><given-names>H</given-names></name><name><surname>Sawada</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Quantitative analysis of the distribution of serotonin-immunoreactive cell bodies in the mouse brain</article-title><source>Neuroscience Letters</source><volume>91</volume><fpage>265</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(88)90691-x</pub-id><pub-id pub-id-type="pmid">3185964</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Item</surname><given-names>CB</given-names></name><name><surname>Stöckler-Ipsiroglu</surname><given-names>S</given-names></name><name><surname>Stromberger</surname><given-names>C</given-names></name><name><surname>Mühl</surname><given-names>A</given-names></name><name><surname>Alessandrì</surname><given-names>MG</given-names></name><name><surname>Bianchi</surname><given-names>MC</given-names></name><name><surname>Tosetti</surname><given-names>M</given-names></name><name><surname>Fornai</surname><given-names>F</given-names></name><name><surname>Cioni</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans</article-title><source>American Journal of Human Genetics</source><volume>69</volume><fpage>1127</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1086/323765</pub-id><pub-id pub-id-type="pmid">11555793</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iversen</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Neurotransmitter transporters and their impact on the development of psychopharmacology</article-title><source>British Journal of Pharmacology</source><volume>147 Suppl 1</volume><fpage>S82</fpage><lpage>S88</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0706428</pub-id><pub-id pub-id-type="pmid">16402124</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Schiebler</surname><given-names>W</given-names></name><name><surname>Ouimet</surname><given-names>C</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>A 38,000-dalton membrane protein (p38) present in synaptic vesicles</article-title><source>PNAS</source><volume>82</volume><fpage>4137</fpage><lpage>4141</lpage><pub-id pub-id-type="doi">10.1073/pnas.82.12.4137</pub-id><pub-id pub-id-type="pmid">3923488</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Sudhof</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Synaptic vesicles and exocytosis</article-title><source>Annual Review of Neuroscience</source><volume>17</volume><fpage>219</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1146/annurev.ne.17.030194.001251</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joncquel-Chevalier Curt</surname><given-names>M</given-names></name><name><surname>Voicu</surname><given-names>P-M</given-names></name><name><surname>Fontaine</surname><given-names>M</given-names></name><name><surname>Dessein</surname><given-names>A-F</given-names></name><name><surname>Porchet</surname><given-names>N</given-names></name><name><surname>Mention-Mulliez</surname><given-names>K</given-names></name><name><surname>Dobbelaere</surname><given-names>D</given-names></name><name><surname>Soto-Ares</surname><given-names>G</given-names></name><name><surname>Cheillan</surname><given-names>D</given-names></name><name><surname>Vamecq</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Creatine biosynthesis and transport in health and disease</article-title><source>Biochimie</source><volume>119</volume><fpage>146</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2015.10.022</pub-id><pub-id pub-id-type="pmid">26542286</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kandel</surname><given-names>ER</given-names></name><name><surname>Schwartz</surname><given-names>JM</given-names></name><name><surname>Jessell</surname><given-names>TM</given-names></name><name><surname>Siegelbaum</surname><given-names>SA</given-names></name><name><surname>Hudspeth</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><source>Principles of Neural Sciences</source><publisher-name>McGraw-Hill</publisher-name></element-citation></ref><ref id="bib132"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kandel</surname><given-names>ER</given-names></name><name><surname>Koester</surname><given-names>JD</given-names></name><name><surname>Mack</surname><given-names>SH</given-names></name><name><surname>Siegelbaum</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2021">2021</year><source>Principles of Neural Sciences</source><publisher-name>McGraw-Hill</publisher-name></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keith</surname><given-names>RA</given-names></name><name><surname>Horn</surname><given-names>MB</given-names></name><name><surname>Piser</surname><given-names>TM</given-names></name><name><surname>Mangano</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Effects of stimulus intensity on the inhibition by omega-conotoxin GVIA and neomycin of K(+_-evoked [3H]norepinephrine release from hippocampal brain slices and synaptosomal calcium influx</article-title><source>Biochemical Pharmacology</source><volume>45</volume><fpage>165</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(93)90389-e</pub-id><pub-id pub-id-type="pmid">8381003</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Yuan</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetic diversity and natural selection footprints of the glycine amidinotransferase gene in various human populations</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>18755</elocation-id><pub-id pub-id-type="doi">10.1038/srep18755</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilty</surname><given-names>JE</given-names></name><name><surname>Lorang</surname><given-names>D</given-names></name><name><surname>Amara</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Cloning and expression of a cocaine-sensitive rat dopamine transporter</article-title><source>Science</source><volume>254</volume><fpage>578</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1126/science.1948035</pub-id><pub-id pub-id-type="pmid">1948035</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koga</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Oikawa</surname><given-names>D</given-names></name><name><surname>Tachibana</surname><given-names>T</given-names></name><name><surname>Denbow</surname><given-names>DM</given-names></name><name><surname>Furuse</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Brain creatine functions to attenuate acute stress responses through GABAnergic system in chicks</article-title><source>Neuroscience</source><volume>132</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.01.004</pub-id><pub-id pub-id-type="pmid">15780467</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolodziej</surname><given-names>PA</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Epitope tagging and protein surveillance</article-title><source>Methods in Enzymology</source><volume>194</volume><fpage>508</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(91)94038-e</pub-id><pub-id pub-id-type="pmid">1706460</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunii</surname><given-names>M</given-names></name><name><surname>Noguchi</surname><given-names>Y</given-names></name><name><surname>Yoshimura</surname><given-names>S-I</given-names></name><name><surname>Kanda</surname><given-names>S</given-names></name><name><surname>Iwano</surname><given-names>T</given-names></name><name><surname>Avriyanti</surname><given-names>E</given-names></name><name><surname>Atik</surname><given-names>N</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Ogawa</surname><given-names>M</given-names></name><name><surname>Harada</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SNAP23 deficiency causes severe brain dysplasia through the loss of radial glial cell polarity</article-title><source>The Journal of Cell Biology</source><volume>220</volume><elocation-id>e201910080</elocation-id><pub-id pub-id-type="doi">10.1083/jcb.201910080</pub-id><pub-id pub-id-type="pmid">33332551</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurosawa</surname><given-names>Y</given-names></name><name><surname>Degrauw</surname><given-names>TJ</given-names></name><name><surname>Lindquist</surname><given-names>DM</given-names></name><name><surname>Blanco</surname><given-names>VM</given-names></name><name><surname>Pyne-Geithman</surname><given-names>GJ</given-names></name><name><surname>Daikoku</surname><given-names>T</given-names></name><name><surname>Chambers</surname><given-names>JB</given-names></name><name><surname>Benoit</surname><given-names>SC</given-names></name><name><surname>Clark</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency</article-title><source>The Journal of Clinical Investigation</source><volume>122</volume><fpage>2837</fpage><lpage>2846</lpage><pub-id pub-id-type="doi">10.1172/JCI59373</pub-id><pub-id pub-id-type="pmid">22751104</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langley</surname><given-names>JN</given-names></name><name><surname>Dickinson</surname><given-names>WL</given-names></name></person-group><year iso-8601-date="1890">1890</year><article-title>III. On the local paralysis of peripheral ganglia, and on the connexion of different classes of nerve fibres with them</article-title><source>Proceedings of the Royal Society of London</source><volume>46</volume><fpage>423</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1098/rspl.1889.0051</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langley</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="1901">1901a</year><article-title>Observations on the physiological action of extracts of the supra-renal bodies</article-title><source>The Journal of Physiology</source><volume>27</volume><fpage>237</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1901.sp000869</pub-id><pub-id pub-id-type="pmid">16992585</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langley</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="1901">1901b</year><article-title>On the stimulation and paralysis of nerve‐cells and of nerve‐endings</article-title><source>The Journal of Physiology</source><volume>27</volume><fpage>224</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1901.sp000868</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langley</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="1905">1905</year><article-title>On the reaction of cells and of nerve‐endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari</article-title><source>The Journal of Physiology</source><volume>33</volume><fpage>374</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1905.sp001128</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langley</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="1906">1906</year><article-title>Croonian Lecture, 1906.—On nerve endings and on special excitable substances in cells</article-title><source>Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character</source><volume>78</volume><fpage>170</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1098/rspb.1906.0056</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leube</surname><given-names>RE</given-names></name><name><surname>Kaiser</surname><given-names>P</given-names></name><name><surname>Seiter</surname><given-names>A</given-names></name><name><surname>Zimbelmann</surname><given-names>R</given-names></name><name><surname>Franke</surname><given-names>WW</given-names></name><name><surname>Rehm</surname><given-names>H</given-names></name><name><surname>Knaus</surname><given-names>P</given-names></name><name><surname>Prior</surname><given-names>P</given-names></name><name><surname>Betz</surname><given-names>H</given-names></name><name><surname>Reinke</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Synaptophysin: molecular organization and mRNA expression as determined from cloned cDNA</article-title><source>The EMBO Journal</source><volume>6</volume><fpage>3261</fpage><lpage>3268</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1987.tb02644.x</pub-id><pub-id pub-id-type="pmid">3123215</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Madisen</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>Q</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Qiu</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Generation of a whole-brain atlas for the cholinergic system and mesoscopic projectome analysis of basal forebrain cholinergic neurons</article-title><source>PNAS</source><volume>115</volume><fpage>415</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1073/pnas.1703601115</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1847">1847</year><article-title>Kreatin und Kreatinin, Bestandtheile des Harns der Menschen</article-title><source>Journal Für Praktische Chemie</source><volume>40</volume><fpage>288</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1002/prac.18470400170</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebreich</surname><given-names>O</given-names></name></person-group><year iso-8601-date="1865">1865</year><article-title>Ueber die chemische Beschaffenheit der Gehirnsubstanz</article-title><source>Justus Liebigs Annalen Der Chemie</source><volume>134</volume><fpage>29</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1002/jlac.18651340107</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Link</surname><given-names>E</given-names></name><name><surname>Edelmann</surname><given-names>L</given-names></name><name><surname>Chou</surname><given-names>JH</given-names></name><name><surname>Binz</surname><given-names>T</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name><name><surname>Eisel</surname><given-names>U</given-names></name><name><surname>Baumert</surname><given-names>M</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Niemann</surname><given-names>H</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Tetanus toxin action: Inhibition of neurotransmitter release linked to synaptobrevin proteolysis</article-title><source>Biochemical and Biophysical Research Communications</source><volume>189</volume><fpage>1017</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(92)92305-H</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lion-François</surname><given-names>L</given-names></name><name><surname>Cheillan</surname><given-names>D</given-names></name><name><surname>Pitelet</surname><given-names>G</given-names></name><name><surname>Acquaviva-Bourdain</surname><given-names>C</given-names></name><name><surname>Bussy</surname><given-names>G</given-names></name><name><surname>Cotton</surname><given-names>F</given-names></name><name><surname>Guibaud</surname><given-names>L</given-names></name><name><surname>Gérard</surname><given-names>D</given-names></name><name><surname>Rivier</surname><given-names>C</given-names></name><name><surname>Vianey-Saban</surname><given-names>C</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>des Portes</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>High frequency of creatine deficiency syndromes in patients with unexplained mental retardation</article-title><source>Neurology</source><volume>67</volume><fpage>1713</fpage><lpage>1714</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000239153.39710.81</pub-id><pub-id pub-id-type="pmid">17101918</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>QR</given-names></name><name><surname>Nelson</surname><given-names>H</given-names></name><name><surname>Mandiyan</surname><given-names>S</given-names></name><name><surname>López-Corcuera</surname><given-names>B</given-names></name><name><surname>Nelson</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Cloning and expression of a glycine transporter from mouse brain</article-title><source>FEBS Letters</source><volume>305</volume><fpage>110</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(92)80875-h</pub-id><pub-id pub-id-type="pmid">1618338</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loewi</surname><given-names>O</given-names></name></person-group><year iso-8601-date="1921">1921</year><article-title>Über humorale übertragbarkeit der Herznervenwirkung</article-title><source>Pflügers Archiv Für Die Gesamte Physiologie Des Menschen Und Der Tiere</source><volume>189</volume><fpage>239</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1007/BF01738910</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Corcuera</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>QR</given-names></name><name><surname>Mandiyan</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>H</given-names></name><name><surname>Nelson</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Expression of a mouse brain cDNA encoding novel gamma-aminobutyric acid transporter</article-title><source>The Journal of Biological Chemistry</source><volume>267</volume><fpage>17491</fpage><lpage>17493</lpage><pub-id pub-id-type="pmid">1517200</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>MTJ</given-names></name><name><surname>Faull</surname><given-names>RLM</given-names></name><name><surname>Christie</surname><given-names>DL</given-names></name><name><surname>Waldvogel</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity</article-title><source>The Journal of Comparative Neurology</source><volume>523</volume><fpage>699</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1002/cne.23667</pub-id><pub-id pub-id-type="pmid">25159005</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname><given-names>CSW</given-names></name><name><surname>Waldvogel</surname><given-names>HJ</given-names></name><name><surname>Dodd</surname><given-names>JR</given-names></name><name><surname>Gilbert</surname><given-names>RT</given-names></name><name><surname>Lowe</surname><given-names>MTJ</given-names></name><name><surname>Birch</surname><given-names>NP</given-names></name><name><surname>Faull</surname><given-names>RLM</given-names></name><name><surname>Christie</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Immunohistochemical localisation of the creatine transporter in the rat brain</article-title><source>Neuroscience</source><volume>163</volume><fpage>571</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.06.065</pub-id><pub-id pub-id-type="pmid">19580854</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>M</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Live imaging of synaptic vesicle release and retrieval in dopaminergic neurons</article-title><source>Frontiers in Neural Circuits</source><volume>3</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.3389/neuro.04.003.2009</pub-id><pub-id pub-id-type="pmid">19521540</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margherita Mancardi</surname><given-names>M</given-names></name><name><surname>Caruso</surname><given-names>U</given-names></name><name><surname>Cristina Schiaffino</surname><given-names>M</given-names></name><name><surname>Giuseppina Baglietto</surname><given-names>M</given-names></name><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>Maria Battaglia</surname><given-names>F</given-names></name><name><surname>Sophi Salomons</surname><given-names>G</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name><name><surname>Zara</surname><given-names>F</given-names></name><name><surname>Veneselli</surname><given-names>E</given-names></name><name><surname>Gaggero</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Severe epilepsy in X‐linked creatine transporter defect (CRTR‐D)</article-title><source>Epilepsia</source><volume>48</volume><fpage>1211</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01148.x</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martineau</surname><given-names>M</given-names></name><name><surname>Shi</surname><given-names>T</given-names></name><name><surname>Puyal</surname><given-names>J</given-names></name><name><surname>Knolhoff</surname><given-names>AM</given-names></name><name><surname>Dulong</surname><given-names>J</given-names></name><name><surname>Gasnier</surname><given-names>B</given-names></name><name><surname>Klingauf</surname><given-names>J</given-names></name><name><surname>Sweedler</surname><given-names>JV</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Mothet</surname><given-names>J-P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Storage and uptake of D-serine into astrocytic synaptic-like vesicles specify gliotransmission</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>3413</fpage><lpage>3423</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3497-12.2013</pub-id><pub-id pub-id-type="pmid">23426669</pub-id></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthew</surname><given-names>WD</given-names></name><name><surname>Tsavaler</surname><given-names>L</given-names></name><name><surname>Reichardt</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Identification of a synaptic vesicle-specific membrane protein with a wide distribution in neuronal and neurosecretory tissue</article-title><source>The Journal of Cell Biology</source><volume>91</volume><fpage>257</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1083/jcb.91.1.257</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maycox</surname><given-names>PR</given-names></name><name><surname>Link</surname><given-names>E</given-names></name><name><surname>Reetz</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>SA</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Clathrin-coated vesicles in nervous tissue are involved primarily in synaptic vesicle recycling</article-title><source>The Journal of Cell Biology</source><volume>118</volume><fpage>1379</fpage><lpage>1388</lpage><pub-id pub-id-type="doi">10.1083/jcb.118.6.1379</pub-id><pub-id pub-id-type="pmid">1325974</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayser</surname><given-names>W</given-names></name><name><surname>Schloss</surname><given-names>P</given-names></name><name><surname>Betz</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Primary structure and functional expression of a choline transporter expressed in the rat nervous system</article-title><source>FEBS Letters</source><volume>305</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(92)80649-2</pub-id><pub-id pub-id-type="pmid">1633856</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>WJ</given-names></name><name><surname>Flint</surname><given-names>RS</given-names></name><name><surname>Ciancone</surname><given-names>MT</given-names></name><name><surname>Murphy</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>In vitro release of endogenous monoamines and amino acids from several CNS regions of the rat</article-title><source>Neurochemical Research</source><volume>8</volume><fpage>245</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1007/BF00963924</pub-id><pub-id pub-id-type="pmid">6856029</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntire</surname><given-names>SL</given-names></name><name><surname>Reimer</surname><given-names>RJ</given-names></name><name><surname>Schuske</surname><given-names>K</given-names></name><name><surname>Edwards</surname><given-names>RH</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Identification and characterization of the vesicular GABA transporter</article-title><source>Nature</source><volume>389</volume><fpage>870</fpage><lpage>876</lpage><pub-id pub-id-type="doi">10.1038/39908</pub-id><pub-id pub-id-type="pmid">9349821</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMorris</surname><given-names>T</given-names></name><name><surname>Harris</surname><given-names>RC</given-names></name><name><surname>Swain</surname><given-names>J</given-names></name><name><surname>Corbett</surname><given-names>J</given-names></name><name><surname>Collard</surname><given-names>K</given-names></name><name><surname>Dyson</surname><given-names>RJ</given-names></name><name><surname>Dye</surname><given-names>L</given-names></name><name><surname>Hodgson</surname><given-names>C</given-names></name><name><surname>Draper</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol</article-title><source>Psychopharmacology</source><volume>185</volume><fpage>93</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1007/s00213-005-0269-z</pub-id><pub-id pub-id-type="pmid">16416332</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMorris</surname><given-names>T</given-names></name><name><surname>Harris</surname><given-names>RC</given-names></name><name><surname>Howard</surname><given-names>AN</given-names></name><name><surname>Langridge</surname><given-names>G</given-names></name><name><surname>Hall</surname><given-names>B</given-names></name><name><surname>Corbett</surname><given-names>J</given-names></name><name><surname>Dicks</surname><given-names>M</given-names></name><name><surname>Hodgson</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior</article-title><source>Physiology &amp; Behavior</source><volume>90</volume><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2006.08.024</pub-id><pub-id pub-id-type="pmid">17046034</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendiguren</surname><given-names>A</given-names></name><name><surname>Aostri</surname><given-names>E</given-names></name><name><surname>Alberdi</surname><given-names>E</given-names></name><name><surname>Pérez-Samartín</surname><given-names>A</given-names></name><name><surname>Pineda</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Functional characterization of cannabidiol effect on the serotonergic neurons of the dorsal raphe nucleus in rat brain slices</article-title><source>Frontiers in Pharmacology</source><volume>13</volume><elocation-id>956886</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2022.956886</pub-id><pub-id pub-id-type="pmid">36147343</pub-id></element-citation></ref><ref id="bib167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercimek-Mahmutoglu</surname><given-names>S</given-names></name><name><surname>Connolly</surname><given-names>MB</given-names></name><name><surname>Poskitt</surname><given-names>KJ</given-names></name><name><surname>Horvath</surname><given-names>GA</given-names></name><name><surname>Lowry</surname><given-names>N</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>Casey</surname><given-names>B</given-names></name><name><surname>Sinclair</surname><given-names>G</given-names></name><name><surname>Davis</surname><given-names>C</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name><name><surname>Stockler-Ipsiroglu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Treatment of intractable epilepsy in a female with SLC6A8 deficiency</article-title><source>Molecular Genetics and Metabolism</source><volume>101</volume><fpage>409</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2010.08.016</pub-id><pub-id pub-id-type="pmid">20846889</pub-id></element-citation></ref><ref id="bib168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mersel</surname><given-names>M</given-names></name><name><surname>Lelong</surname><given-names>I</given-names></name><name><surname>Hindelang</surname><given-names>C</given-names></name><name><surname>Sarlieve</surname><given-names>L</given-names></name><name><surname>Vincendon</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Isolation of plasma membranes from neurons grown in primary culture</article-title><source>Analytical Biochemistry</source><volume>166</volume><fpage>246</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(87)90571-9</pub-id><pub-id pub-id-type="pmid">2829651</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>HS</given-names></name><name><surname>Schwarz</surname><given-names>D</given-names></name><name><surname>Wimmer</surname><given-names>VC</given-names></name><name><surname>Schmitt</surname><given-names>AC</given-names></name><name><surname>Kerr</surname><given-names>JND</given-names></name><name><surname>Sakmann</surname><given-names>B</given-names></name><name><surname>Helmstaedter</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Inhibitory interneurons in a cortical column form hot zones of inhibition in layers 2 and 5A</article-title><source>PNAS</source><volume>108</volume><fpage>16807</fpage><lpage>16812</lpage><pub-id pub-id-type="doi">10.1073/pnas.1113648108</pub-id></element-citation></ref><ref id="bib170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misu</surname><given-names>Y</given-names></name><name><surname>Goshima</surname><given-names>Y</given-names></name><name><surname>Miyamae</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Is DOPA a neurotransmitter?</article-title><source>Trends in Pharmacological Sciences</source><volume>23</volume><fpage>262</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/s0165-6147(02)02013-8</pub-id><pub-id pub-id-type="pmid">12084631</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="1963">1963</year><article-title>The spontaneous and evoked release of acetylcholine from the cerebral cortex</article-title><source>The Journal of Physiology</source><volume>165</volume><fpage>98</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1963.sp007045</pub-id></element-citation></ref><ref id="bib172"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molchanova</surname><given-names>SM</given-names></name><name><surname>Oja</surname><given-names>SS</given-names></name><name><surname>Saransaari</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mechanisms of enhanced taurine release under Ca2+ depletion</article-title><source>Neurochemistry International</source><volume>47</volume><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2005.04.027</pub-id><pub-id pub-id-type="pmid">15982785</pub-id></element-citation></ref><ref id="bib173"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molinaro</surname><given-names>A</given-names></name><name><surname>Alessandrì</surname><given-names>MG</given-names></name><name><surname>Putignano</surname><given-names>E</given-names></name><name><surname>Leuzzi</surname><given-names>V</given-names></name><name><surname>Cioni</surname><given-names>G</given-names></name><name><surname>Baroncelli</surname><given-names>L</given-names></name><name><surname>Pizzorusso</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A nervous system-specific model of creatine transporter deficiency recapitulates the cognitive endophenotype of the disease: A longitudinal study</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>62</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-37303-1</pub-id><pub-id pub-id-type="pmid">30635645</pub-id></element-citation></ref><ref id="bib174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mott</surname><given-names>FW</given-names></name><name><surname>Halliburton</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="1899">1899</year><article-title>On the physiological action of choline and neurine</article-title><source>British Medical Journal</source><volume>1</volume><fpage>1082</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1136/bmj.1.2001.1082</pub-id><pub-id pub-id-type="pmid">20758460</pub-id></element-citation></ref><ref id="bib175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>FT</given-names></name><name><surname>Callaghan</surname><given-names>JM</given-names></name><name><surname>Steele-Mortimer</surname><given-names>O</given-names></name><name><surname>Stenmark</surname><given-names>H</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Campbell</surname><given-names>PL</given-names></name><name><surname>McCluskey</surname><given-names>J</given-names></name><name><surname>Yeo</surname><given-names>JP</given-names></name><name><surname>Tock</surname><given-names>EP</given-names></name><name><surname>Toh</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine “fingers” and contains a calmodulin-binding IQ motif</article-title><source>The Journal of Biological Chemistry</source><volume>270</volume><fpage>13503</fpage><lpage>13511</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.22.13503</pub-id><pub-id pub-id-type="pmid">7768953</pub-id></element-citation></ref><ref id="bib176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadler</surname><given-names>JV</given-names></name><name><surname>White</surname><given-names>WF</given-names></name><name><surname>Vaca</surname><given-names>KW</given-names></name><name><surname>Redburn</surname><given-names>DA</given-names></name><name><surname>Cotman</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Characterization of putative amino acid transmitter release from slices of rat dentate gyrus</article-title><source>Journal of Neurochemistry</source><volume>29</volume><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1977.tb09620.x</pub-id><pub-id pub-id-type="pmid">18560</pub-id></element-citation></ref><ref id="bib177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>A</given-names></name><name><surname>Baker</surname><given-names>RR</given-names></name><name><surname>Morris</surname><given-names>SJ</given-names></name><name><surname>Whittaker</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>The preparation and characterization of synaptic vesicles of high purity</article-title><source>Brain Research</source><volume>109</volume><fpage>285</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(76)90531-x</pub-id><pub-id pub-id-type="pmid">132227</pub-id></element-citation></ref><ref id="bib178"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Rabouille</surname><given-names>C</given-names></name><name><surname>Watson</surname><given-names>R</given-names></name><name><surname>Nilsson</surname><given-names>T</given-names></name><name><surname>Hui</surname><given-names>N</given-names></name><name><surname>Slusarewicz</surname><given-names>P</given-names></name><name><surname>Kreis</surname><given-names>TE</given-names></name><name><surname>Warren</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Characterization of a cis-Golgi matrix protein, GM130</article-title><source>The Journal of Cell Biology</source><volume>131</volume><fpage>1715</fpage><lpage>1726</lpage><pub-id pub-id-type="doi">10.1083/jcb.131.6.1715</pub-id></element-citation></ref><ref id="bib179"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nash</surname><given-names>SR</given-names></name><name><surname>Giros</surname><given-names>B</given-names></name><name><surname>Kingsmore</surname><given-names>SF</given-names></name><name><surname>Rochelle</surname><given-names>JM</given-names></name><name><surname>Suter</surname><given-names>ST</given-names></name><name><surname>Gregor</surname><given-names>P</given-names></name><name><surname>Seldin</surname><given-names>MF</given-names></name><name><surname>Caron</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Cloning, pharmacological characterization, and genomic localization of the human creatine transporter</article-title><source>Receptors &amp; Channels</source><volume>2</volume><fpage>165</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">7953292</pub-id></element-citation></ref><ref id="bib180"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The family of Na+/Cl- neurotransmitter transporters</article-title><source>Journal of Neurochemistry</source><volume>71</volume><fpage>1785</fpage><lpage>1803</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.1998.71051785.x</pub-id><pub-id pub-id-type="pmid">9798903</pub-id></element-citation></ref><ref id="bib181"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neu</surname><given-names>A</given-names></name><name><surname>Neuhoff</surname><given-names>H</given-names></name><name><surname>Trube</surname><given-names>G</given-names></name><name><surname>Fehr</surname><given-names>S</given-names></name><name><surname>Ullrich</surname><given-names>K</given-names></name><name><surname>Roeper</surname><given-names>J</given-names></name><name><surname>Isbrandt</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Activation of GABAA receptors by guanidinoacetate: A novel pathophysiological mechanism</article-title><source>Neurobiology of Disease</source><volume>11</volume><fpage>298</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1006/nbdi.2002.0547</pub-id></element-citation></ref><ref id="bib182"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newmeyer</surname><given-names>A</given-names></name><name><surname>Cecil</surname><given-names>KM</given-names></name><name><surname>Schapiro</surname><given-names>M</given-names></name><name><surname>Clark</surname><given-names>JF</given-names></name><name><surname>Degrauw</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging</article-title><source>Journal of Developmental and Behavioral Pediatrics</source><volume>26</volume><fpage>276</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1097/00004703-200508000-00003</pub-id><pub-id pub-id-type="pmid">16100500</pub-id></element-citation></ref><ref id="bib183"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohtsuki</surname><given-names>S</given-names></name><name><surname>Tachikawa</surname><given-names>M</given-names></name><name><surname>Takanaga</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Hosoya</surname><given-names>K-I</given-names></name><name><surname>Terasaki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain</article-title><source>Journal of Cerebral Blood Flow and Metabolism</source><volume>22</volume><fpage>1327</fpage><lpage>1335</lpage><pub-id pub-id-type="doi">10.1097/01.WCB.0000033966.83623.7D</pub-id><pub-id pub-id-type="pmid">12439290</pub-id></element-citation></ref><ref id="bib184"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuhara</surname><given-names>DY</given-names></name><name><surname>Beck</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>5-HT1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells</article-title><source>Journal of Neurophysiology</source><volume>71</volume><fpage>2161</fpage><lpage>2167</lpage><pub-id pub-id-type="doi">10.1152/jn.1994.71.6.2161</pub-id><pub-id pub-id-type="pmid">7931509</pub-id></element-citation></ref><ref id="bib185"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olbrich</surname><given-names>HG</given-names></name><name><surname>Braak</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Ratio of pyramidal cells versus non-pyramidal cells in sector CA1 of the human Ammon’s horn</article-title><source>Anatomy and Embryology</source><volume>173</volume><fpage>105</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1007/BF00707308</pub-id><pub-id pub-id-type="pmid">4073527</pub-id></element-citation></ref><ref id="bib186"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>G</given-names></name><name><surname>Schäfer</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="1895">1895</year><article-title>The physiological effects of extracts of the suprarenal capsules</article-title><source>The Journal of Physiology</source><volume>18</volume><fpage>230</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1895.sp000564</pub-id><pub-id pub-id-type="pmid">16992252</pub-id></element-citation></ref><ref id="bib187"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osmanović</surname><given-names>SS</given-names></name><name><surname>Shefner</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>gamma-Aminobutyric acid responses in rat locus coeruleus neurones in vitro: A current-clamp and voltage-clamp study</article-title><source>The Journal of Physiology</source><volume>421</volume><fpage>151</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1990.sp017938</pub-id><pub-id pub-id-type="pmid">2348390</pub-id></element-citation></ref><ref id="bib188"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacholczyk</surname><given-names>T</given-names></name><name><surname>Blakely</surname><given-names>RD</given-names></name><name><surname>Amara</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter</article-title><source>Nature</source><volume>350</volume><fpage>350</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1038/350350a0</pub-id><pub-id pub-id-type="pmid">2008212</pub-id></element-citation></ref><ref id="bib189"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palade</surname><given-names>GE</given-names></name><name><surname>Palay</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="1954">1954</year><article-title>Electron microscope observations of interneuronal and neuromuscular synapses</article-title><source>The Anatomical Record</source><volume>118</volume><fpage>335</fpage><lpage>336</lpage></element-citation></ref><ref id="bib190"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palay</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="1954">1954</year><article-title>Electron microscope study of the cytoplasm of neurons</article-title><source>The Anatomical Record</source><volume>118</volume><elocation-id>336</elocation-id></element-citation></ref><ref id="bib191"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G</given-names></name><name><surname>Franklin.</surname><given-names>KBJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><source>Paxinos and Franklin’s the Mouse Brain in Stereotaxic Coordinates</source><publisher-name>Elsevier/Academic Press</publisher-name></element-citation></ref><ref id="bib192"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peral</surname><given-names>MJ</given-names></name><name><surname>Vázquez-Carretero</surname><given-names>MD</given-names></name><name><surname>Ilundain</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Na(+)/Cl(-)/creatine transporter activity and expression in rat brain synaptosomes</article-title><source>Neuroscience</source><volume>165</volume><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.10.001</pub-id><pub-id pub-id-type="pmid">19804817</pub-id></element-citation></ref><ref id="bib193"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philibert</surname><given-names>RA</given-names></name><name><surname>Rogers</surname><given-names>KL</given-names></name><name><surname>Dutton</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>K+-evoked taurine efflux from cerebellar astrocytes: on the roles of Ca2+ and Na+</article-title><source>Neurochemical Research</source><volume>14</volume><fpage>43</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1007/BF00969756</pub-id><pub-id pub-id-type="pmid">2469025</pub-id></element-citation></ref><ref id="bib194"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pringle</surname><given-names>AK</given-names></name><name><surname>Gardner</surname><given-names>CR</given-names></name><name><surname>Walker</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Reduction of cerebellar GABAA responses by interleukin-1 (IL-1) through an indomethacin insensitive mechanism</article-title><source>Neuropharmacology</source><volume>35</volume><fpage>147</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/0028-3908(95)00161-1</pub-id><pub-id pub-id-type="pmid">8734482</pub-id></element-citation></ref><ref id="bib195"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Purves</surname><given-names>D</given-names></name><name><surname>Augustine</surname><given-names>GJ</given-names></name><name><surname>Firzpatrick</surname><given-names>D</given-names></name><name><surname>Katz</surname><given-names>L</given-names></name><name><surname>LaMantia</surname><given-names>AS</given-names></name><name><surname>McNamara</surname><given-names>JO</given-names></name><name><surname>Williamss</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2001">2001</year><source>Neuroscience</source><publisher-name>Sinauer Associates</publisher-name></element-citation></ref><ref id="bib196"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Purves</surname><given-names>D</given-names></name><name><surname>Augustine</surname><given-names>GJ</given-names></name><name><surname>Fitzpatrick</surname><given-names>D</given-names></name><name><surname>Hall</surname><given-names>WC</given-names></name><name><surname>LaManita</surname><given-names>AS</given-names></name><name><surname>Mooney</surname><given-names>RD</given-names></name><name><surname>Platt</surname><given-names>ML</given-names></name><name><surname>White</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2016">2016</year><source>Neuroscience</source><publisher-name>Sinauer Associates</publisher-name><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-18-07160.2003</pub-id><pub-id pub-id-type="pmid">12904476</pub-id></element-citation></ref><ref id="bib197"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puusepp</surname><given-names>H</given-names></name><name><surname>Kall</surname><given-names>K</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>Talvik</surname><given-names>I</given-names></name><name><surname>Männamaa</surname><given-names>M</given-names></name><name><surname>Rein</surname><given-names>R</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name><name><surname>Õunap</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The screening of SLC6A8 deficiency among Estonian families with X-linked mental retardation</article-title><source>Journal of Inherited Metabolic Disease</source><volume>33 Suppl 3</volume><fpage>S5</fpage><lpage>S11</lpage><pub-id pub-id-type="doi">10.1007/s10545-008-1063-y</pub-id><pub-id pub-id-type="pmid">24137762</pub-id></element-citation></ref><ref id="bib198"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Rao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Localization, proteomics, and metabolite profiling reveal a putative vesicular transporter for UDP-glucose</article-title><source>eLife</source><volume>10</volume><elocation-id>e65417</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.65417</pub-id><pub-id pub-id-type="pmid">34269178</pub-id></element-citation></ref><ref id="bib199"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radian</surname><given-names>R</given-names></name><name><surname>Kanner</surname><given-names>BI</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Reconstitution and purification of the sodium- and chloride-coupled gamma-aminobutyric acid transporter from rat brain</article-title><source>The Journal of Biological Chemistry</source><volume>260</volume><fpage>11859</fpage><lpage>11865</lpage><pub-id pub-id-type="pmid">4044581</pub-id></element-citation></ref><ref id="bib200"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radian</surname><given-names>R</given-names></name><name><surname>Bendahan</surname><given-names>A</given-names></name><name><surname>Kanner</surname><given-names>BI</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Purification and identification of the functional sodium- and chloride-coupled gamma-aminobutyric acid transport glycoprotein from rat brain</article-title><source>The Journal of Biological Chemistry</source><volume>261</volume><fpage>15437</fpage><lpage>15441</lpage><pub-id pub-id-type="pmid">3536902</pub-id></element-citation></ref><ref id="bib201"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rae</surname><given-names>C</given-names></name><name><surname>Digney</surname><given-names>AL</given-names></name><name><surname>McEwan</surname><given-names>SR</given-names></name><name><surname>Bates</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial</article-title><source>Proceedings. Biological Sciences</source><volume>270</volume><fpage>2147</fpage><lpage>2150</lpage><pub-id pub-id-type="doi">10.1098/rspb.2003.2492</pub-id><pub-id pub-id-type="pmid">14561278</pub-id></element-citation></ref><ref id="bib202"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rae</surname><given-names>CD</given-names></name><name><surname>Bröer</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Creatine as a booster for human brain function. How might it work?</article-title><source>Neurochemistry International</source><volume>89</volume><fpage>249</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2015.08.010</pub-id><pub-id pub-id-type="pmid">26297632</pub-id></element-citation></ref><ref id="bib203"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The first hormone: Adrenaline</article-title><source>Trends in Endocrinology and Metabolism</source><volume>30</volume><fpage>331</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2019.03.005</pub-id><pub-id pub-id-type="pmid">31064696</pub-id></element-citation></ref><ref id="bib204"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravichandran</surname><given-names>V</given-names></name><name><surname>Chawla</surname><given-names>A</given-names></name><name><surname>Roche</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Identification of a novel syntaxin- and synaptobrevin/VAMP-binding protein, SNAP-23, expressed in non-neuronal tissues</article-title><source>Journal of Biological Chemistry</source><volume>271</volume><fpage>13300</fpage><lpage>13303</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.23.13300</pub-id></element-citation></ref><ref id="bib205"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reis</surname><given-names>DJ</given-names></name><name><surname>Regunathan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Is agmatine a novel neurotransmitter in brain?</article-title><source>Trends in Pharmacological Sciences</source><volume>21</volume><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/s0165-6147(00)01460-7</pub-id><pub-id pub-id-type="pmid">10785653</pub-id></element-citation></ref><ref id="bib206"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>JN</given-names></name><name><surname>Baskys</surname><given-names>A</given-names></name><name><surname>Carlen</surname><given-names>PL</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>The effects of serotonin on N-methyl-D-aspartate and synaptically evoked depolarizations in rat neocortical neurons</article-title><source>Brain Research</source><volume>456</volume><fpage>286</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(88)90230-2</pub-id></element-citation></ref><ref id="bib207"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robbins</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1958">1958</year><article-title>The effects of amino acids on the crustacean neuro-muscular system</article-title><source>The Anatomical Record</source><volume>132</volume><fpage>492</fpage><lpage>493</lpage></element-citation></ref><ref id="bib208"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>E</given-names></name><name><surname>Frankel</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1950">1950</year><article-title>gamma-Aminobutyric acid in brain: its formation from glutamic acid</article-title><source>The Journal of Biological Chemistry</source><volume>187</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">14794689</pub-id></element-citation></ref><ref id="bib209"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="1953">1953</year><article-title>Ultrastructure of two invertebrate synapses</article-title><source>Proceedings of the Society for Experimental Biology and Medicine</source><volume>82</volume><fpage>219</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.3181/00379727-82-20071</pub-id><pub-id pub-id-type="pmid">13037850</pub-id></element-citation></ref><ref id="bib210"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2001">2001</year><source>Mechanisms of Synaptic Transmission. Bridging the Gaps</source><publisher-name>Oxford University Press</publisher-name><pub-id pub-id-type="doi">10.1093/acprof:oso/9780195137613.001.0001</pub-id></element-citation></ref><ref id="bib211"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>EH</given-names></name><name><surname>Almeida</surname><given-names>LS</given-names></name><name><surname>Kleefstra</surname><given-names>T</given-names></name><name><surname>deGrauw</surname><given-names>RS</given-names></name><name><surname>Yntema</surname><given-names>HG</given-names></name><name><surname>Bahi</surname><given-names>N</given-names></name><name><surname>Moraine</surname><given-names>C</given-names></name><name><surname>Ropers</surname><given-names>H-H</given-names></name><name><surname>Fryns</surname><given-names>J-P</given-names></name><name><surname>deGrauw</surname><given-names>TJ</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>High prevalence of SLC6A8 deficiency in X-linked mental retardation</article-title><source>The American Journal of Human Genetics</source><volume>75</volume><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1086/422102</pub-id></element-citation></ref><ref id="bib212"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosko</surname><given-names>LM</given-names></name><name><surname>Gentile</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>VN</given-names></name><name><surname>Manavi</surname><given-names>Z</given-names></name><name><surname>Melchor</surname><given-names>GS</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Shults</surname><given-names>NV</given-names></name><name><surname>Albanese</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Rodriguez</surname><given-names>O</given-names></name><name><surname>Huang</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Cerebral creatine deficiency affects the timing of oligodendrocyte myelination</article-title><source>The Journal of Neuroscience</source><volume>43</volume><fpage>1143</fpage><lpage>1153</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2120-21.2022</pub-id><pub-id pub-id-type="pmid">36732069</pub-id></element-citation></ref><ref id="bib213"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Royes</surname><given-names>LFF</given-names></name><name><surname>Fighera</surname><given-names>MR</given-names></name><name><surname>Furian</surname><given-names>AF</given-names></name><name><surname>Oliveira</surname><given-names>MS</given-names></name><name><surname>Fiorenza</surname><given-names>NG</given-names></name><name><surname>Ferreira</surname><given-names>J</given-names></name><name><surname>da Silva</surname><given-names>AC</given-names></name><name><surname>Priel</surname><given-names>MR</given-names></name><name><surname>Ueda</surname><given-names>ÉS</given-names></name><name><surname>Calixto</surname><given-names>JB</given-names></name><name><surname>Cavalheiro</surname><given-names>EA</given-names></name><name><surname>Mello</surname><given-names>CF</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Neuromodulatory effect of creatine on extracellular action potentials in rat hippocampus: Role of NMDA receptors</article-title><source>Neurochemistry International</source><volume>53</volume><fpage>33</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2008.04.008</pub-id></element-citation></ref><ref id="bib214"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>MD</given-names></name><name><surname>King</surname><given-names>AM</given-names></name><name><surname>Thomas</surname><given-names>GP</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence</article-title><source>The Journal of General Virology</source><volume>72 (Pt 11)</volume><fpage>2727</fpage><lpage>2732</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-72-11-2727</pub-id><pub-id pub-id-type="pmid">1658199</pub-id></element-citation></ref><ref id="bib215"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>van Dooren</surname><given-names>SJM</given-names></name><name><surname>Verhoeven</surname><given-names>NM</given-names></name><name><surname>Cecil</surname><given-names>KM</given-names></name><name><surname>Ball</surname><given-names>WS</given-names></name><name><surname>Degrauw</surname><given-names>TJ</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome</article-title><source>The American Journal of Human Genetics</source><volume>68</volume><fpage>1497</fpage><lpage>1500</lpage><pub-id pub-id-type="doi">10.1086/320595</pub-id></element-citation></ref><ref id="bib216"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saltarelli</surname><given-names>MD</given-names></name><name><surname>Bauman</surname><given-names>AL</given-names></name><name><surname>Moore</surname><given-names>KR</given-names></name><name><surname>Bradley</surname><given-names>CC</given-names></name><name><surname>Blakely</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Expression of the rat brain creatine transporter in situ and in transfected HeLa cells</article-title><source>Developmental Neuroscience</source><volume>18</volume><fpage>524</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1159/000111450</pub-id><pub-id pub-id-type="pmid">8940628</pub-id></element-citation></ref><ref id="bib217"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saransaari</surname><given-names>P</given-names></name><name><surname>Oja</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Characteristics of taurine release in slices from adult and developing mouse brain stem</article-title><source>Amino Acids</source><volume>31</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1007/s00726-006-0290-5</pub-id></element-citation></ref><ref id="bib218"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Saransaari</surname><given-names>P</given-names></name><name><surname>Oja</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2008">2008</year><chapter-title>Taurine in neurotransmission</chapter-title><person-group person-group-type="editor"><name><surname>Lajtha</surname><given-names>A</given-names></name><name><surname>Vizi</surname><given-names>ES</given-names></name></person-group><source>Handbook of Neurochemistry and Molecular Neurobiology</source><publisher-name>Springer</publisher-name><fpage>325</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1007/978-0-387-30382-6_13</pub-id></element-citation></ref><ref id="bib219"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauer</surname><given-names>B</given-names></name><name><surname>Henderson</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome</article-title><source>Nucleic Acids Research</source><volume>17</volume><fpage>147</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1093/nar/17.1.147</pub-id><pub-id pub-id-type="pmid">2783482</pub-id></element-citation></ref><ref id="bib220"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scala</surname><given-names>F</given-names></name><name><surname>Kobak</surname><given-names>D</given-names></name><name><surname>Shan</surname><given-names>S</given-names></name><name><surname>Bernaerts</surname><given-names>Y</given-names></name><name><surname>Laturnus</surname><given-names>S</given-names></name><name><surname>Cadwell</surname><given-names>CR</given-names></name><name><surname>Hartmanis</surname><given-names>L</given-names></name><name><surname>Froudarakis</surname><given-names>E</given-names></name><name><surname>Castro</surname><given-names>JR</given-names></name><name><surname>Tan</surname><given-names>ZH</given-names></name><name><surname>Papadopoulos</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>SS</given-names></name><name><surname>Sandberg</surname><given-names>R</given-names></name><name><surname>Berens</surname><given-names>P</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Tolias</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Layer 4 of mouse neocortex differs in cell types and circuit organization between sensory areas</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>4174</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-12058-z</pub-id></element-citation></ref><ref id="bib221"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schäfer</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="1908">1908</year><article-title>On the present condition of our knowledge regarding the functions of the suprarenal capsules</article-title><source>British Medical Journal</source><volume>1</volume><fpage>1277</fpage><lpage>1281</lpage><pub-id pub-id-type="doi">10.1136/bmj.1.2474.1277</pub-id></element-citation></ref><ref id="bib222"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenck</surname><given-names>S</given-names></name><name><surname>Wojcik</surname><given-names>SM</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Takamori</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A chloride conductance in VGLUT1 underlies maximal glutamate loading into synaptic vesicles</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>156</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1038/nn.2248</pub-id><pub-id pub-id-type="pmid">19169251</pub-id></element-citation></ref><ref id="bib223"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiavo</surname><given-names>G</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name><name><surname>Poulain</surname><given-names>B</given-names></name><name><surname>Rossetto</surname><given-names>O</given-names></name><name><surname>Polverino de Laureto</surname><given-names>P</given-names></name><name><surname>DasGupta</surname><given-names>BR</given-names></name><name><surname>Montecucco</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin</article-title><source>Nature</source><volume>359</volume><fpage>832</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1038/359832a0</pub-id><pub-id pub-id-type="pmid">1331807</pub-id></element-citation></ref><ref id="bib224"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schloss</surname><given-names>P</given-names></name><name><surname>Mayser</surname><given-names>W</given-names></name><name><surname>Betz</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>The putative rat choline transporter CHOT1 transports creatine and is highly expressed in neural and muscle-rich tissues</article-title><source>Biochemical and Biophysical Research Communications</source><volume>198</volume><fpage>637</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1994.1093</pub-id><pub-id pub-id-type="pmid">8297374</pub-id></element-citation></ref><ref id="bib225"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency</article-title><source>Human Molecular Genetics</source><volume>13</volume><fpage>905</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddh112</pub-id></element-citation></ref><ref id="bib226"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrimpf</surname><given-names>SP</given-names></name><name><surname>Meskenaite</surname><given-names>V</given-names></name><name><surname>Brunner</surname><given-names>E</given-names></name><name><surname>Rutishauser</surname><given-names>D</given-names></name><name><surname>Walther</surname><given-names>P</given-names></name><name><surname>Eng</surname><given-names>J</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name><name><surname>Sonderegger</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Proteomic analysis of synaptosomes using isotope-coded affinity tags and mass spectrometry</article-title><source>Proteomics</source><volume>5</volume><fpage>2531</fpage><lpage>2541</lpage><pub-id pub-id-type="doi">10.1002/pmic.200401198</pub-id><pub-id pub-id-type="pmid">15984043</pub-id></element-citation></ref><ref id="bib227"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimada</surname><given-names>S</given-names></name><name><surname>Kitayama</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>CL</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Nanthakumar</surname><given-names>E</given-names></name><name><surname>Gregor</surname><given-names>P</given-names></name><name><surname>Kuhar</surname><given-names>M</given-names></name><name><surname>Uhl</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA</article-title><source>Science</source><volume>254</volume><fpage>576</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1126/science.1948034</pub-id><pub-id pub-id-type="pmid">1948034</pub-id></element-citation></ref><ref id="bib228"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>A</given-names></name><name><surname>Sapru</surname><given-names>HN</given-names></name></person-group><year iso-8601-date="2011">2011</year><source>Essential Neuroscience</source><publisher-name>Wolters Kluwer</publisher-name></element-citation></ref><ref id="bib229"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sizer</surname><given-names>AR</given-names></name><name><surname>Kilpatrick</surname><given-names>GJ</given-names></name><name><surname>Roberts</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>A post-synaptic depressant modulatory action of 5-hydroxytryptamine on excitatory amino acid responses in rat entorhinal cortex in vitro</article-title><source>Neuropharmacology</source><volume>31</volume><fpage>531</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1016/0028-3908(92)90184-q</pub-id><pub-id pub-id-type="pmid">1407393</pub-id></element-citation></ref><ref id="bib230"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skarnes</surname><given-names>WC</given-names></name><name><surname>Rosen</surname><given-names>B</given-names></name><name><surname>West</surname><given-names>AP</given-names></name><name><surname>Koutsourakis</surname><given-names>M</given-names></name><name><surname>Bushell</surname><given-names>W</given-names></name><name><surname>Iyer</surname><given-names>V</given-names></name><name><surname>Mujica</surname><given-names>AO</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Harrow</surname><given-names>J</given-names></name><name><surname>Cox</surname><given-names>T</given-names></name><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Severin</surname><given-names>J</given-names></name><name><surname>Biggs</surname><given-names>P</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Nefedov</surname><given-names>M</given-names></name><name><surname>de Jong</surname><given-names>PJ</given-names></name><name><surname>Stewart</surname><given-names>AF</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A conditional knockout resource for the genome-wide study of mouse gene function</article-title><source>Nature</source><volume>474</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/nature10163</pub-id></element-citation></ref><ref id="bib231"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skelton</surname><given-names>MR</given-names></name><name><surname>Schaefer</surname><given-names>TL</given-names></name><name><surname>Graham</surname><given-names>DL</given-names></name><name><surname>Degrauw</surname><given-names>TJ</given-names></name><name><surname>Clark</surname><given-names>JF</given-names></name><name><surname>Williams</surname><given-names>MT</given-names></name><name><surname>Vorhees</surname><given-names>CV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e16187</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0016187</pub-id><pub-id pub-id-type="pmid">21249153</pub-id></element-citation></ref><ref id="bib232"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>KE</given-names></name><name><surname>Borden</surname><given-names>LA</given-names></name><name><surname>Hartig</surname><given-names>PR</given-names></name><name><surname>Branchek</surname><given-names>T</given-names></name><name><surname>Weinshank</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors</article-title><source>Neuron</source><volume>8</volume><fpage>927</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(92)90207-t</pub-id><pub-id pub-id-type="pmid">1534013</pub-id></element-citation></ref><ref id="bib233"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sora</surname><given-names>I</given-names></name><name><surname>Richman</surname><given-names>J</given-names></name><name><surname>Santoro</surname><given-names>G</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Vanderah</surname><given-names>T</given-names></name><name><surname>Horvath</surname><given-names>R</given-names></name><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Waite</surname><given-names>S</given-names></name><name><surname>Roeske</surname><given-names>WR</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>The cloning and expression of a human creatine transporter</article-title><source>Biochemical and Biophysical Research Communications</source><volume>204</volume><fpage>419</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1994.2475</pub-id><pub-id pub-id-type="pmid">7945388</pub-id></element-citation></ref><ref id="bib234"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speer</surname><given-names>O</given-names></name><name><surname>Neukomm</surname><given-names>LJ</given-names></name><name><surname>Murphy</surname><given-names>RM</given-names></name><name><surname>Zanolla</surname><given-names>E</given-names></name><name><surname>Schlattner</surname><given-names>U</given-names></name><name><surname>Henry</surname><given-names>H</given-names></name><name><surname>Snow</surname><given-names>RJ</given-names></name><name><surname>Wallimann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Creatine transporters: a reappraisal</article-title><source>Molecular and Cellular Biochemistry</source><volume>256–257</volume><fpage>407</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1023/b:mcbi.0000009886.98508.e7</pub-id><pub-id pub-id-type="pmid">14977199</pub-id></element-citation></ref><ref id="bib235"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Squire</surname><given-names>L</given-names></name><name><surname>Berg</surname><given-names>D</given-names></name><name><surname>Bloom</surname><given-names>FE</given-names></name><name><surname>du</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Spitzer</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2012">2012</year><source>Fundamental Neuroscience</source><publisher-name>Elsevier</publisher-name></element-citation></ref><ref id="bib236"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockebrand</surname><given-names>M</given-names></name><name><surname>Sasani</surname><given-names>A</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Hornig</surname><given-names>S</given-names></name><name><surname>Hermans-Borgmeyer</surname><given-names>I</given-names></name><name><surname>Lake</surname><given-names>HA</given-names></name><name><surname>Isbrandt</surname><given-names>D</given-names></name><name><surname>Lygate</surname><given-names>CA</given-names></name><name><surname>Heerschap</surname><given-names>A</given-names></name><name><surname>Neu</surname><given-names>A</given-names></name><name><surname>Choe</surname><given-names>C-U</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A mouse model of creatine transporter deficiency reveals impaired motor function and muscle energy metabolism</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>773</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.00773</pub-id><pub-id pub-id-type="pmid">30013483</pub-id></element-citation></ref><ref id="bib237"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stöckler</surname><given-names>S</given-names></name><name><surname>Holzbach</surname><given-names>U</given-names></name><name><surname>Hanefeld</surname><given-names>F</given-names></name><name><surname>Marquardt</surname><given-names>I</given-names></name><name><surname>Helms</surname><given-names>G</given-names></name><name><surname>Requart</surname><given-names>M</given-names></name><name><surname>Hänicke</surname><given-names>W</given-names></name><name><surname>Frahm</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Creatine deficiency in the brain: a new, treatable inborn error of metabolism</article-title><source>Pediatric Research</source><volume>36</volume><fpage>409</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1203/00006450-199409000-00023</pub-id><pub-id pub-id-type="pmid">7808840</pub-id></element-citation></ref><ref id="bib238"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockler-Ipsiroglu</surname><given-names>S</given-names></name><name><surname>van Karnebeek</surname><given-names>C</given-names></name><name><surname>Longo</surname><given-names>N</given-names></name><name><surname>Korenke</surname><given-names>GC</given-names></name><name><surname>Mercimek-Mahmutoglu</surname><given-names>S</given-names></name><name><surname>Marquart</surname><given-names>I</given-names></name><name><surname>Barshop</surname><given-names>B</given-names></name><name><surname>Grolik</surname><given-names>C</given-names></name><name><surname>Schlune</surname><given-names>A</given-names></name><name><surname>Angle</surname><given-names>B</given-names></name><name><surname>Araújo</surname><given-names>HC</given-names></name><name><surname>Coskun</surname><given-names>T</given-names></name><name><surname>Diogo</surname><given-names>L</given-names></name><name><surname>Geraghty</surname><given-names>M</given-names></name><name><surname>Haliloglu</surname><given-names>G</given-names></name><name><surname>Konstantopoulou</surname><given-names>V</given-names></name><name><surname>Leuzzi</surname><given-names>V</given-names></name><name><surname>Levtova</surname><given-names>A</given-names></name><name><surname>Mackenzie</surname><given-names>J</given-names></name><name><surname>Maranda</surname><given-names>B</given-names></name><name><surname>Mhanni</surname><given-names>AA</given-names></name><name><surname>Mitchell</surname><given-names>G</given-names></name><name><surname>Morris</surname><given-names>A</given-names></name><name><surname>Newlove</surname><given-names>T</given-names></name><name><surname>Renaud</surname><given-names>D</given-names></name><name><surname>Scaglia</surname><given-names>F</given-names></name><name><surname>Valayannopoulos</surname><given-names>V</given-names></name><name><surname>van Spronsen</surname><given-names>FJ</given-names></name><name><surname>Verbruggen</surname><given-names>KT</given-names></name><name><surname>Yuskiv</surname><given-names>N</given-names></name><name><surname>Nyhan</surname><given-names>W</given-names></name><name><surname>Schulze</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring</article-title><source>Molecular Genetics and Metabolism</source><volume>111</volume><fpage>16</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2013.10.018</pub-id><pub-id pub-id-type="pmid">24268530</pub-id></element-citation></ref><ref id="bib239"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockler-Ipsiroglu</surname><given-names>S</given-names></name><name><surname>Apatean</surname><given-names>D</given-names></name><name><surname>Battini</surname><given-names>R</given-names></name><name><surname>DeBrosse</surname><given-names>S</given-names></name><name><surname>Dessoffy</surname><given-names>K</given-names></name><name><surname>Edvardson</surname><given-names>S</given-names></name><name><surname>Eichler</surname><given-names>F</given-names></name><name><surname>Johnston</surname><given-names>K</given-names></name><name><surname>Koeller</surname><given-names>DM</given-names></name><name><surname>Nouioua</surname><given-names>S</given-names></name><name><surname>Tazir</surname><given-names>M</given-names></name><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>Dowling</surname><given-names>MD</given-names></name><name><surname>Wierenga</surname><given-names>KJ</given-names></name><name><surname>Wierenga</surname><given-names>AM</given-names></name><name><surname>Zhang</surname><given-names>V</given-names></name><name><surname>Wong</surname><given-names>L-JC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Arginine:glycine amidinotransferase (AGAT) deficiency: Clinical features and long term outcomes in 16 patients diagnosed worldwide</article-title><source>Molecular Genetics and Metabolism</source><volume>116</volume><fpage>252</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2015.10.003</pub-id><pub-id pub-id-type="pmid">26490222</pub-id></element-citation></ref><ref id="bib240"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strecker</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1862">1862</year><article-title>Ueber einige neue Bestandtheile der Schweinegalle</article-title><source>Justus Liebigs Annalen Der Chemie</source><volume>123</volume><fpage>353</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1002/jlac.18621230310</pub-id></element-citation></ref><ref id="bib241"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stumpf</surname><given-names>A</given-names></name><name><surname>Parthier</surname><given-names>D</given-names></name><name><surname>Sammons</surname><given-names>RP</given-names></name><name><surname>Stempel</surname><given-names>AV</given-names></name><name><surname>Breustedt</surname><given-names>J</given-names></name><name><surname>Rost</surname><given-names>BR</given-names></name><name><surname>Schmitz</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons</article-title><source>Neuropharmacology</source><volume>139</volume><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2018.07.020</pub-id></element-citation></ref><ref id="bib242"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Lottspeich</surname><given-names>F</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name><name><surname>Mehl</surname><given-names>E</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>A synaptic vesicle protein with A novel cytoplasmic domain and four transmembrane regions</article-title><source>Science</source><volume>238</volume><fpage>1142</fpage><lpage>1144</lpage><pub-id pub-id-type="doi">10.1126/science.3120313</pub-id><pub-id pub-id-type="pmid">3120313</pub-id></element-citation></ref><ref id="bib243"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>YH</given-names></name><name><surname>Terashima</surname><given-names>A</given-names></name><name><surname>Petralia</surname><given-names>RS</given-names></name><name><surname>Wenthold</surname><given-names>RJ</given-names></name><name><surname>Isaac</surname><given-names>JTR</given-names></name><name><surname>Roche</surname><given-names>KW</given-names></name><name><surname>Roche</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A neuronal role for SNAP-23 in postsynaptic glutamate receptor trafficking</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>338</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1038/nn.2488</pub-id><pub-id pub-id-type="pmid">20118925</pub-id></element-citation></ref><ref id="bib244"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>GY</given-names></name><name><surname>Huang</surname><given-names>HM</given-names></name><name><surname>Kelleher</surname><given-names>JA</given-names></name><name><surname>Stubbs</surname><given-names>EB</given-names></name><name><surname>Sun</surname><given-names>AY</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Marker enzymes, phospholipids and acyl group composition of a somal plasma membrane fraction isolated from rat cerebral cortex: a comparison with microsomes and synaptic plasma membranes</article-title><source>Neurochemistry International</source><volume>12</volume><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/0197-0186(88)90150-7</pub-id></element-citation></ref><ref id="bib245"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamine</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1901">1901</year><article-title>Adrenalin, the active principle of the suprarenal glands and its mode of preparation</article-title><source>American Journal of Pharmacy</source><volume>73</volume><fpage>523</fpage><lpage>531</lpage></element-citation></ref><ref id="bib246"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamine</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1902">1902</year><article-title>The isolation of the active principle of the suprarenal gland</article-title><source>The Journal of Physiology</source><volume>27</volume><fpage>xxix</fpage><lpage>xxx</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1902.sp000893</pub-id></element-citation></ref><ref id="bib247"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamori</surname><given-names>S</given-names></name><name><surname>Rhee</surname><given-names>JS</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons</article-title><source>Nature</source><volume>407</volume><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1038/35025070</pub-id><pub-id pub-id-type="pmid">11001057</pub-id></element-citation></ref><ref id="bib248"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamori</surname><given-names>S</given-names></name><name><surname>Holt</surname><given-names>M</given-names></name><name><surname>Stenius</surname><given-names>K</given-names></name><name><surname>Lemke</surname><given-names>EA</given-names></name><name><surname>Grønborg</surname><given-names>M</given-names></name><name><surname>Riedel</surname><given-names>D</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Schenck</surname><given-names>S</given-names></name><name><surname>Brügger</surname><given-names>B</given-names></name><name><surname>Ringler</surname><given-names>P</given-names></name><name><surname>Müller</surname><given-names>SA</given-names></name><name><surname>Rammner</surname><given-names>B</given-names></name><name><surname>Gräter</surname><given-names>F</given-names></name><name><surname>Hub</surname><given-names>JS</given-names></name><name><surname>De Groot</surname><given-names>BL</given-names></name><name><surname>Mieskes</surname><given-names>G</given-names></name><name><surname>Moriyama</surname><given-names>Y</given-names></name><name><surname>Klingauf</surname><given-names>J</given-names></name><name><surname>Grubmüller</surname><given-names>H</given-names></name><name><surname>Heuser</surname><given-names>J</given-names></name><name><surname>Wieland</surname><given-names>F</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Molecular anatomy of a trafficking organelle</article-title><source>Cell</source><volume>127</volume><fpage>831</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.10.030</pub-id><pub-id pub-id-type="pmid">17110340</pub-id></element-citation></ref><ref id="bib249"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takuma</surname><given-names>K</given-names></name><name><surname>Matsuda</surname><given-names>T</given-names></name><name><surname>Kishida</surname><given-names>Y</given-names></name><name><surname>Asano</surname><given-names>S</given-names></name><name><surname>Azuma</surname><given-names>J</given-names></name><name><surname>Baba</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Ca2+ depletion facilitates taurine release in cultured rat astrocytes</article-title><source>Japanese Journal of Pharmacology</source><volume>72</volume><fpage>75</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1254/jjp.72.75</pub-id></element-citation></ref><ref id="bib250"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tie</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>DW</given-names></name><name><surname>Chen</surname><given-names>HX</given-names></name><name><surname>Song</surname><given-names>SL</given-names></name><name><surname>Zhang</surname><given-names>XX</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Study of the electrical connection mechanism of sheathless interface for capillary electrophoresis-electrospray ionization-mass spectrometry</article-title><source>Journal of Mass Spectrometry</source><volume>47</volume><fpage>1429</fpage><lpage>1434</lpage><pub-id pub-id-type="doi">10.1002/jms.3077</pub-id><pub-id pub-id-type="pmid">23147818</pub-id></element-citation></ref><ref id="bib251"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiedje</surname><given-names>KE</given-names></name><name><surname>Stevens</surname><given-names>K</given-names></name><name><surname>Barnes</surname><given-names>S</given-names></name><name><surname>Weaver</surname><given-names>DF</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Beta-alanine as a small molecule neurotransmitter</article-title><source>Neurochemistry International</source><volume>57</volume><fpage>177</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2010.06.001</pub-id><pub-id pub-id-type="pmid">20540981</pub-id></element-citation></ref><ref id="bib252"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Rudy</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>GABAergic interneurons in the neocortex: From cellular properties to circuits</article-title><source>Neuron</source><volume>91</volume><fpage>260</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.06.033</pub-id><pub-id pub-id-type="pmid">27477017</pub-id></element-citation></ref><ref id="bib253"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udenfriend</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1950">1950</year><article-title>Identification of gamma-aminobutyric acid in brain by the isotope derivative method</article-title><source>The Journal of Biological Chemistry</source><volume>187</volume><fpage>65</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">14794690</pub-id></element-citation></ref><ref id="bib254"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udobi</surname><given-names>KC</given-names></name><name><surname>Kokenge</surname><given-names>AN</given-names></name><name><surname>Hautman</surname><given-names>ER</given-names></name><name><surname>Ullio</surname><given-names>G</given-names></name><name><surname>Coene</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>MT</given-names></name><name><surname>Vorhees</surname><given-names>CV</given-names></name><name><surname>Mabondzo</surname><given-names>A</given-names></name><name><surname>Skelton</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cognitive deficits and increases in creatine precursors in a brain-specific knockout of the creatine transporter gene Slc6a8</article-title><source>Genes, Brain, and Behavior</source><volume>17</volume><elocation-id>e12461</elocation-id><pub-id pub-id-type="doi">10.1111/gbb.12461</pub-id><pub-id pub-id-type="pmid">29384270</pub-id></element-citation></ref><ref id="bib255"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Kamp</surname><given-names>JM</given-names></name><name><surname>Mancini</surname><given-names>GM</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>X-linked creatine transporter deficiency: clinical aspects and pathophysiology</article-title><source>Journal of Inherited Metabolic Disease</source><volume>37</volume><fpage>715</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1007/s10545-014-9713-8</pub-id><pub-id pub-id-type="pmid">24789340</pub-id></element-citation></ref><ref id="bib256"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Euler</surname><given-names>US</given-names></name></person-group><year iso-8601-date="1946">1946</year><article-title>A specific sympathomimetic ergone in adrenergic nerve fibres (Sympathin) and its relations to adrenaline and nor‐adrenaline</article-title><source>Acta Physiologica Scandinavica</source><volume>12</volume><fpage>73</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1111/j.1748-1716.1946.tb00368.x</pub-id></element-citation></ref><ref id="bib257"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Euler</surname><given-names>US</given-names></name></person-group><year iso-8601-date="1948">1948</year><article-title>Identification of the sympathominetic ergone in adrenergic nerves of cattle (Sympathin N) with Laevo‐Noradrenaline</article-title><source>Acta Physiologica Scandinavica</source><volume>16</volume><fpage>63</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1111/j.1748-1716.1948.tb00526.x</pub-id></element-citation></ref><ref id="bib258"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>von Euler</surname><given-names>US</given-names></name></person-group><year iso-8601-date="1956">1956</year><source>Noradrenaline. Chemistry, Physiology, Pharmacology and Clinical Aspects</source><publisher-name>Springfield</publisher-name></element-citation></ref><ref id="bib259"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallimann</surname><given-names>T</given-names></name><name><surname>Tokarska-Schlattner</surname><given-names>M</given-names></name><name><surname>Schlattner</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The creatine kinase system and pleiotropic effects of creatine</article-title><source>Amino Acids</source><volume>40</volume><fpage>1271</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1007/s00726-011-0877-3</pub-id><pub-id pub-id-type="pmid">21448658</pub-id></element-citation></ref><ref id="bib260"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallimann</surname><given-names>T</given-names></name><name><surname>Harris</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Creatine: a miserable life without it</article-title><source>Amino Acids</source><volume>48</volume><fpage>1739</fpage><lpage>1750</lpage><pub-id pub-id-type="doi">10.1007/s00726-016-2297-x</pub-id><pub-id pub-id-type="pmid">27422546</pub-id></element-citation></ref><ref id="bib261"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>A</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation</article-title><source>Neuroscience Research</source><volume>42</volume><fpage>279</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/s0168-0102(02)00007-x</pub-id><pub-id pub-id-type="pmid">11985880</pub-id></element-citation></ref><ref id="bib262"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whittaker</surname><given-names>VP</given-names></name><name><surname>Michaelson</surname><given-names>IA</given-names></name><name><surname>Kirkland</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="1964">1964</year><article-title>The separation of synaptic vesicles from nerve-ending particles (‘synaptosomes’)</article-title><source>Biochemical Journal</source><volume>90</volume><fpage>293</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1042/bj0900293</pub-id></element-citation></ref><ref id="bib263"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiedenmann</surname><given-names>B</given-names></name><name><surname>Franke</surname><given-names>WW</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles</article-title><source>Cell</source><volume>41</volume><fpage>1017</fpage><lpage>1028</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(85)80082-9</pub-id></element-citation></ref><ref id="bib264"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>DF</given-names></name><name><surname>Bryant</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>The discs-large tumor suppressor gene of <italic>Drosophila</italic> encodes a guanylate kinase homolog localized at septate junctions</article-title><source>Cell</source><volume>66</volume><fpage>451</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(81)90009-X</pub-id></element-citation></ref><ref id="bib265"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyss</surname><given-names>M</given-names></name><name><surname>Kaddurah-Daouk</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Creatine and creatinine metabolism</article-title><source>Physiological Reviews</source><volume>80</volume><fpage>1107</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1152/physrev.2000.80.3.1107</pub-id><pub-id pub-id-type="pmid">10893433</pub-id></element-citation></ref><ref id="bib266"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>D-J</given-names></name><name><surname>Uta</surname><given-names>D</given-names></name><name><surname>Feng</surname><given-names>P-Y</given-names></name><name><surname>Wakita</surname><given-names>M</given-names></name><name><surname>Shin</surname><given-names>M-C</given-names></name><name><surname>Furue</surname><given-names>H</given-names></name><name><surname>Yoshimura</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Identification of 5-HT receptor subtypes enhancing inhibitory transmission in the rat spinal dorsal horn <italic>in vitro</italic></article-title><source>Molecular Pain</source><volume>8</volume><fpage>1744</fpage><lpage>8069</lpage><pub-id pub-id-type="doi">10.1186/1744-8069-8-58</pub-id></element-citation></ref><ref id="bib267"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamawaki</surname><given-names>N</given-names></name><name><surname>Raineri Tapies</surname><given-names>MG</given-names></name><name><surname>Stults</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>GA</given-names></name><name><surname>Shepherd</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Circuit organization of the excitatory sensorimotor loop through hand/forelimb S1 and M1</article-title><source>eLife</source><volume>10</volume><elocation-id>e66836</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.66836</pub-id><pub-id pub-id-type="pmid">33851917</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89317.4.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Doe</surname><given-names>Chris Q</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Howard Hughes Medical Institute, University of Oregon</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>This study presents <bold>valuable</bold> observations on a potential role of creatine (Cr) as a novel neurotransmitter. The data provide <bold>solid</bold> evidence that Cr is present in synaptic vesicles. If, in the future, a receptor can be described, it will support the claim that Cr is synaptically released and binds to a post-synaptic receptor. This would be of wide interest to the field of neuroscience.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89317.4.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The overall tone of the rebuttal and lack of responses on several questions was surprising. Clearly, the authors did not appreciate the phrase 'no smoking gun' and provided a lengthy repetition of the fair argument about 'ticking boxes' on the classic list of criteria. They also make repeated historical references that descriptions of neurotransmitters include many papers, typically over decades, e.g. in the case of ACh and its discovery by Sir Henry Dale. While I empathize with the authors' apparent frustration (I quote: '...accept the reality that Rome was not built in a single day and that no transmitter was proven by a one single paper') I am a bit surprised at the complete brushing away of the argument, and in fact the discussion. In the original paper, the notion of a receptor was mentioned only in a single sentence and all three reviewers brought up this rather obvious question. The historical comparisons are difficult: Of course many papers contribute to the identification of a neurotransmitter, but there is a much higher burden of proof in 2023 compared to the work by Otto Loewi and Sir Henry Dale: most, if not all, currently accepted neurotransmitter have a clear biological function at the level of the brain and animal behavior or function - and were in fact first proposed to exist based on a functional biological experiment (e.g. Loewi's heart rate change). This, and the isolation of the chemical that does the job, were clear, unquestionable 'smoking guns' a hundred years ago. Fast forward 2023: Creatine has been carefully studied by the authors to tick many of the boxes for neurotransmitters, but there is no clear role for its function in an animal. The authors show convincing effects upon K+ stimulation and electrophysiological recordings that show altered neuronal activity using the slc6a8 and agat mutants as well as Cr application - but, as has been pointed out by other reviewers, these effects are not a clear-cut demonstration of a chemical transmitter function, however many boxes are ticked. The identification of a role of a neurotransmitter for brain function and animal behavior has reasonably more advanced possibilities in 2023 than a hundred years ago - and e.g. a discussion of approaches for possible receptor candidates should be possible.</p><p>Again, I reviewed this positively and agree that a lot of cumulative data are great to be put out there and allow the discovery to be more broadly discussed and tested. But I have to note, that the authors simply respond with the 'Rome was not built in a single day' statement to my suggestions on at least 'have some lead' how to approach the question of a receptor e.g. through agonists or antagonists (while clearly stating 'I do not think the publication of this manuscript should not be made dependent' on this). Similarly, in response to reviewer 2's concerns about a missing receptor, the authors' only (may I say snarky) response is ' We have deleted this sentence, though what could mediate postsynaptic responses other than receptors?' The bullet point by reviewer 3 ' • No candidate receptor for creatine has been identified postsynaptically.' is the one point by that reviewer that is simply ignored by the authors completely. Finally, I note that my reivew question on the K stimulation issues (e.g. 35 neurons that simply did not respond at all) was: ' Response: To avoid the disadvantage of K stimulation, we also performed optogenetic experiments recently and obtained encouraging preliminary results.' No details, not data - no response really.</p><p>In sum, I find this all a bit strange and the rebuttal surprising - all three reviewers were supportive and have carefully listed points of discussion that I found all valid and thoughtful. In response, the authors selectively responded scientifically to some experimental questions, but otherwise simply rather non-scientifically dismissed questions with 'Rome was not built in a day'-type answers, or less. I my view, the authors have disregarded the review process and the effort of three supportive reviewers, which should be part of the permanent record of this paper.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89317.4.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Bian et al studied creatine (Cr) in the context of central nervous system (CNS) function. They detected Cr in synaptic vesicles purified from mouse brains with anti-Synaptophysin using capillary electrophoresis-mass spectrometry. Cr levels in the synaptic vesicle fraction was reduced in mice lacking the Cr synthetase AGAT, or the Cr transporter SLC6A8. They provide evidence for Cr release within several minutes after treating brain slices with KCl. This KCl-induced Cr release was partially calcium dependent and was attenuated in slices obtained from AGAT and SLC6A8 mutant mice. Cr application also decreased the excitability of cortical pyramidal cells in one third of the cells tested. Finally, they provide evidence for SLC6A8-dependent Cr uptake into synaptosomes, and ATP-dependent Cr loading into synaptic vesicles. Based on these data, the authors propose that Cr may act as neurotransmitter in the CNS.</p><p>Strengths:</p><list list-type="order"><list-item><p>A major strength of the paper is the broad spectrum of tools used to investigate Cr.</p></list-item><list-item><p>The study provides evidence that Cr is present in/loaded into synaptic vesicles.</p></list-item></list><p>Weaknesses (resubmission):</p><list list-type="order"><list-item><p>There is no significant decrease in Cr content pulled down by anti-Syp in AGAT-/- mice when normalized to IgG controls. Hence, blocking AGAT activity/Cr synthesis does not affect Cr levels in the synaptic vesicle fraction, arguing against a Cr enrichment.</p></list-item><list-item><p>There is no difference in KCl-induced Cr release between SLC6A8-/Y and SLC6A8+/Y when normalizing the data to the respective controls. Thus, the data are not consistent with the idea that depolarization-induced Cr release requires SLC6A8.</p></list-item><list-item><p>The rationale of grouping the excitability data into responders and non-responders is not convincing because the threshold of 10% decrease in AP rate is arbitrary. The data do therefore not support the conclusion that Cr reduces neuronal excitability.</p></list-item></list></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89317.4.sa3</article-id><title-group><article-title>Reviewer #3 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>SUMMARY:</p><p>The manuscript by Bian et al. promotes the idea that creatine is a new neurotransmitter. The authors conduct an impressive combination of mass spectrometry (Fig. 1), genetics (Figs. 2, 3, 6), biochemistry (Figs. 2, 3, 8), immunostaining (Fig. 4), electrophysiology (Figs. 5, 6, 7), and EM (Fig. 8) in order to offer support for the hypothesis that creatine is a CNS neurotransmitter.</p><p>STRENGTHS:</p><p>There are many strengths to this study.</p><list list-type="bullet"><list-item><p>The combinatorial approach is a strength. There is no shortage of data in this study.</p></list-item><list-item><p>The careful consideration of specific criteria that creatine would need to meet in order to be considered a neurotransmitter is a strength.</p></list-item><list-item><p>The comparison studies that the authors have done in parallel with classical neurotransmitters are helpful.</p></list-item><list-item><p>Demonstration that creatine has inhibitory effects is another strength.</p></list-item><list-item><p>The new genetic mutations for Slc6a8 and AGAT are strengths and potentially incredibly helpful for downstream work.</p></list-item></list><p>WEAKNESSES:</p><list list-type="bullet"><list-item><p>Some data are indirect. Even though Slc6a8 and AGAT are helpful sentinels for the presence of creatine, they are not creatine themselves. Of note, these molecules themselves are not essential for making the case that creatine is a neurotransmitter.</p></list-item><list-item><p>Regarding Slc6a8, it seems to work only as a reuptake transporter - not as a transporter into SVs. Therefore, we do not know what the transporter into the TVs is.</p></list-item><list-item><p>Puzzlingly, Slc6a8 and AGAT are in different cells, setting up the complicated model that creatine is created in one cell type and then processed as a neurotransmitter in another. This matter will likely need to be resolved in future studies.</p></list-item><list-item><p>No candidate receptor for creatine has been identified postsynaptically. This will likely need to be resolved in future studies.</p></list-item><list-item><p>Because no candidate receptor has been identified, it is important to fully consider other possibilities for roles of creatine that would explain these observations other than it being a neurotransmitter? There is some attention to this in the Discussion.</p></list-item></list><p>There are several criteria that define a neurotransmitter. The authors nicely delineated many criteria in their discussion, but it is worth it for readers to do the same with their own understanding of the data.</p><p>By this reviewer's understanding (and combining some textbook definitions together) a neurotransmitter: 1) must be present within the presynaptic neuron and stored in vesicles; 2) must be released by depolarization of the presynaptic terminal; 3) must require Ca2+ influx upon depolarization prior to release; 4) must bind specific receptors present on the postsynaptic cell; 5) exogenous transmitter can mimic presynaptic release; 6) there exists a mechanism of removal of the neurotransmitter from the synaptic cleft.</p><p>For a paper to claim that the published work has identified a new neurotransmitter, several of these criteria would be met - and the paper would acknowledge in the discussion which ones have not been met. For this particular paper, this reviewer finds that condition 1 is clearly met.</p><p>Conditions 2 and 3 seem to be met by electrophysiology, but there are caveats here. High KCl stimulation is a blunt instrument that will depolarize absolutely everything in the prep all at once and could result in any number of non-specific biological reactions as a result of K+ rushing into all neurons in the prep. Moreover, the results in 0 Ca2+ are puzzling. For creatine (and for the other neurotransmitters), why is there such a massive uptick in release, even when the extracellular saline is devoid of calcium?</p><p>Condition 4 is not discussed in detail at all. In the discussion, the authors elide the criterion of receptors specified by Purves by inferring that the existence of postsynaptic responses implies the existence of receptors. True, but does it specifically imply the existence of creatinergic receptors? This reviewer does not think that is necessarily the case. The authors should be appropriately circumspect and consider other modes of inhibition that are induced by activation or potentiation of other receptors (e.g., GABAergic or glycinergic).</p><p>Condition 5 may be met, because authors applied exogenous creatine and observed inhibition. However, this is tough to know without understanding the effects of endogenous release of creatine. if they were to test if the absence of creatine caused excess excitation (at putative creatinergic synapses), then that would be supportive of the same. Nicely, Ghirardini et al., 2023 study cited by the reviewers does provide support for this exact notion in pyramidal neurons.</p><p>For condition 6, the authors made a great effort with Slc6a8. This is a very tough criterion to understand or prove for many synapses and neurotransmitters.</p><p>In terms of fundamental neuroscience, the story should be impactful. There are certainly more neurotransmitters out there than currently identified and by textbook criteria, creatine seems to be one of them taking all of the data in this study and others into account.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89317.4.sa4</article-id><title-group><article-title>Author Response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rao</surname><given-names>Yi</given-names></name><role specific-use="author">Author</role><aff><institution>Peking University</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Bian</surname><given-names>Xiling</given-names></name><role specific-use="author">Author</role><aff><institution>Peking University</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Jiemin</given-names></name><role specific-use="author">Author</role><aff><institution>Tsinghua University</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Jia</surname><given-names>Xiaobo</given-names></name><role specific-use="author">Author</role><aff><institution>Chinese Institute for Brain Research</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Liang</surname><given-names>Wenjun</given-names></name><role specific-use="author">Author</role><aff><institution>Chinese Institute for Brain Research</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Sihan</given-names></name><role specific-use="author">Author</role><aff><institution>Peking University</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Zhiqiang</given-names></name><role specific-use="author">Author</role><aff><institution>Peking University School of Life Sciences</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wenxia</given-names></name><role specific-use="author">Author</role><aff><institution>Peking University</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the previous reviews:</p><disp-quote content-type="editor-comment"><p>Point-to-Point Responses to Reviewers’ Comments</p></disp-quote><p>We are a bit surprised by the comments of Reviewer 1, but that our further responses can help communications with Reviewer 1. We have also responded to comments of Reviewers 2 and 3.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>The overall tone of the rebuttal and lack of responses on several questions was surprising. Clearly, the authors took umbrage at the phrase 'no smoking gun' and provided a lengthy repetition of the fair argument about 'ticking boxes' on the classic list of criteria. They also make repeated historical references that descriptions of neurotransmitters include many papers, typically over decades, e.g. in the case of ACh and its discovery by Sir Henry Dale. While I empathize with the authors' apparent frustration (I quote: '...accept the reality that Rome was not built in a single day and that no transmitter was proven by a one single paper') I am a bit surprised at the complete brushing away of the argument, and in fact the discussion. In the original paper, the notion of a receptor was mentioned only in a single sentence and all three reviewers brought up this rather obvious question. The historical comparisons are difficult: Of course many papers contribute to the identification of a neurotransmitter, but there is a much higher burden of proof in 2023 compared to the work by Otto Loewi and Sir Henry Dale: most, if not all, currently accepted neurotransmitter have a clear biological function at the level of the brain and animal behavior or function - and were in fact first proposed to exist based on a functional biological experiment (e.g. Loewi's heart rate change). This, and the isolation of the chemical that does the job, were clear, unquestionable 'smoking guns' a hundred years ago. Fast forward 2023: Creatine has been carefully studied by the authors to tick many of the boxes for neurotransmitters, but there is no clear role for its function in an animal. The authors show convincing effects upon K+ stimulation and electrophysiological recordings that show altered neuronal activity using the slc6a8 and agat mutants as well as Cr application - but, as has been pointed out by other reviewers, these effects are not a clear-cut demonstration of a chemical transmitter function, however many boxes are ticked. The identification of a role of a neurotransmitter for brain function and animal behavior has reasonably more advanced possibilities in 2023 than a hundred years ago - and e.g. a discussion of approaches for possible receptor candidates should be possible.</p><p>Again, I reviewed this positively and agree that a lot of cumulative data are great to be put out there and allow the discovery to be more broadly discussed and tested. But I have to note, that the authors simply respond with the 'Rome was not built in a single day' statement to my suggestions on at least 'have some lead' how to approach the question of a receptor e.g. through agonists or antagonists (while clearly stating 'I do not think the publication of this manuscript should not be made dependent' on this). Similarly, in response to reviewer 2's concerns about a missing receptor, the authors' only (may I say snarky) response is ' We have deleted this sentence, though what could mediate postsynaptic responses other than receptors?' The bullet point by reviewer 3 ' • No candidate receptor for creatine has been identified postsynaptically.' is the one point by that reviewer that is simply ignored by the authors completely. Finally, I note that my reivew question on the K stimulation issues (e.g. 35 neurons that simply did not respond at all) was: ' Response: To avoid the disadvantage of K stimulation, we also performed optogenetic experiments recently and obtained encouraging preliminary results.' No details, not data - no response really.</p><p>In sum, I find this all a bit strange and the rebuttal surprising - all three reviewers were supportive and have carefully listed points of discussion that I found all valid and thoughtful. In response, the authors selectively responded scientifically to some experimental questions, but otherwise simply rather non-scientifically dismissed questions with 'Rome was not built in a day'-type answers, or less. I my view, the authors have disregarded the review process and the effort of three supportive reviewers, which should be part of the permanent record of this paper.</p></disp-quote><p>Response:</p><p>We were very surprised by the tone of Reviewer 1 in the second round of reviewing. The corresponding author has spent some time including a long holiday to cool down and re-read our earlier responses. The following is entirely by the corresponding author.</p><p>I have finally checked the term “smoking gun”, and found out that I interpreted it wrongly while I had thought that Reviewer 1 was wrong. This came from a long story in that I was lectured by a native speaker for my English when submitting the first paper from my own paper. In that case, the Reviewer was wrong (in arguing that only adjectives but not nouns can be used to define nouns), I was quite offended and remembered it vividly. In the case of “smoking gun”, I wrongly believed that it meant a hint (while the definite evidence would be “the final nail in the coffin”). By interpreting is as a hint, I was then rebutting Reviewer 1 for negating all our experimental results as “not a single piece of suggestive evidence”.</p><p>For the above, I apologize.</p><p>I have another disagreement about “smoking gun”. For a transmitter, multiple criteria have to be met. For example, finding a receptor for a small molecule would not be definitive for a transmitter because if it is not present in the SVs, it is unlikely to be a typical transmitter. If a molecule has a receptor but they are not even in the nervous system, it is definitely no a transmitter.</p><p>The title of our paper is “Evidence suggesting creatine as a new central neurotransmitter”, not “Evidence proving creatine as a new central neurotransmitter”. In the Abstract, after “Our biochemical, chemical, genetic and electrophysiological results are consistent with the possibility of Cr as a neurotransmitter”, we are adding “though not yet reaching the level of proof for the now classic transmitters”. In the last sentence of the introduction, we have now added “though the discovery of a receptor for Cr would prove it”.</p><p>I do, however, believe that, however strong the wordings are, criticisms and rebuttals in science are normal and should be conducted even when emotions are involved.</p><p>One of my major point of differences with at least two of the reviewers is that the criteria for neurotransmitters should be those listed in major textbooks. While everyone can have one’s own opinions, the textbooks, especially those accepted by readers of the field for more than 40 years, should be the standards. Kandel has listed the 4 criteria not only 40 years ago but also just 2 years ago in their latest 6th edition. The reviewers have asked for more, while discounting Kandel et al. (2021). So, in essence, the Reviewer is not shy in scientific criticisms when stating “The identification of a role of a neurotransmitter for brain function and animal behavior has reasonably more advanced possibilities in 2023 than a hundred years ago”.</p><p>Reviewer 1 raised another new criterion: brain function and behavior, while this is not in any textbook lists. However, lack of Cr caused behavioral problems, as cited by us in the introduction: both humans and mice were defective in brain function with loss of function mutations in the gene for the specific Cr transporter SLC6A8. If the reviewer meant behavioral abnormalities caused by Cr injection, that was unclear. But that criterion may not be met by other transmitters which is the likely reason that it was not a criterion in any textbook.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>Bian et al studied creatine (Cr) in the context of central nervous system (CNS) function. They detected Cr in synaptic vesicles purified from mouse brains with anti-Synaptophysin using capillary electrophoresis-mass spectrometry. Cr levels in the synaptic vesicle fraction was reduced in mice lacking the Cr synthetase AGAT, or the Cr transporter SLC6A8. They provide evidence for Cr release within several minutes after treating brain slices with KCl. This KCl-induced Cr release was partially calcium dependent and was attenuated in slices obtained from AGAT and SLC6A8 mutant mice. Cr application also decreased the excitability of cortical pyramidal cells in one third of the cells tested. Finally, they provide evidence for SLC6A8-dependent Cr uptake into synaptosomes, and ATP-dependent Cr loading into synaptic vesicles. Based on these data, the authors propose that Cr may act as neurotransmitter in the CNS.</p><p>Strengths:</p><p>1. A major strength of the paper is the broad spectrum of tools used to investigate Cr.</p><p>2. The study provides evidence that Cr is present in/loaded into synaptic vesicles.</p><p>Weaknesses:</p><p>1. There is no significant decrease in Cr content pulled down by anti-Syp in AGAT-/- mice when normalized to IgG controls. Hence, blocking AGAT activity/Cr synthesis does not affect Cr levels in the synaptic vesicle fraction, arguing against a Cr enrichment.</p></disp-quote><p>Response: Evidence for Cr enrichment in the SVS was obtained robustly with wild type mice. When brain Cr is very low in AGAT-/- mutant mice, because there is little Cr, there is also little Cr in the SVs. One does not require that as a criterion: it does not argue against the normal levels of Cr could be transported into the SVs even if when the much reduced levels of AGAT-/- Cr in mutant mice could be enriched in SVs.</p><disp-quote content-type="editor-comment"><p>2. There is no difference in KCl-induced Cr release between SLC6A8-/Y and SLC6A8+/Y when normalizing the data to the respective controls. Thus, the data are not consistent with the idea that depolarization-induced Cr release requires SLC6A8.</p></disp-quote><p>Response: This comment of Reviewer 2 was based on Figure 5D. But if one carefully examines Figure 5G, it was clear that the Ca++ dependent component of KCl -induced Cr release was lower in SLC6A8-/Y than that in SLC6A8+/Y.</p><disp-quote content-type="editor-comment"><p>3. The rationale of grouping the excitability data into responders and non-responders is not convincing because the threshold of 10% decrease in AP rate is arbitrary. The data do therefore not support the conclusion that Cr reduces neuronal excitability.</p></disp-quote><p>Response: Comparison of the same neuron, before and after Cr did show effects on neuronal excitability though that would have no statistics if one does not group multiple cells into the same categories.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public Review):</bold></p><p>SUMMARY:</p><p>The manuscript by Bian et al. promotes the idea that creatine is a new neurotransmitter. The authors conduct an impressive combination of mass spectrometry (Fig. 1), genetics (Figs. 2, 3, 6), biochemistry (Figs. 2, 3, 8), immunostaining (Fig. 4), electrophysiology (Figs. 5, 6, 7), and EM (Fig. 8) in order to offer support for the hypothesis that creatine is a CNS neurotransmitter.</p><p>STRENGTHS:</p><p>There are many strengths to this study.</p><p>• The combinatorial approach is a strength. There is no shortage of data in this study.</p><p>• The careful consideration of specific criteria that creatine would need to meet in order to be considered a neurotransmitter is a strength.</p><p>• The comparison studies that the authors have done in parallel with classical neurotransmitters are helpful.</p><p>• Demonstration that creatine has inhibitory effects is another strength.</p><p>• The new genetic mutations for Slc6a8 and AGAT are strengths and potentially incredibly helpful for downstream work.</p><p>WEAKNESSES:</p><p>• Some data are indirect. Even though Slc6a8 and AGAT are helpful sentinels for the presence of creatine, they are not creatine themselves. Of note, these molecules themselves are not essential for making the case that creatine is a neurotransmitter.</p></disp-quote><p>Response: We agree, but those data are not inconsistent with the possibility.</p><disp-quote content-type="editor-comment"><p>• Regarding Slc6a8, it seems to work only as a reuptake transporter - not as a transporter into SVs. Therefore, we do not know what the transporter into the TVs is.</p></disp-quote><p>Response: SLC6A8 is not the transporter on the SVs, but is an excellent candidate for the transporter on the presynaptic cytoplasmic membrane for uptake of Cr into the presynaptic structure.</p><disp-quote content-type="editor-comment"><p>• Puzzlingly, Slc6a8 and AGAT are in different cells, setting up the complicated model that creatine is created in one cell type and then processed as a neurotransmitter in another. This matter will likely need to be resolved in future studies.</p></disp-quote><p>Response: We agree.</p><disp-quote content-type="editor-comment"><p>• No candidate receptor for creatine has been identified postsynaptically. This will likely need to be resolved in future studies.</p></disp-quote><p>Response: We agree.</p><disp-quote content-type="editor-comment"><p>• Because no candidate receptor has been identified, it is important to fully consider other possibilities for roles of creatine that would explain these observations other than it being a neurotransmitter? There is some attention to this in the Discussion.</p></disp-quote><p>Response: We agree.</p><disp-quote content-type="editor-comment"><p>There are several criteria that define a neurotransmitter. The authors nicely delineated many criteria in their discussion, but it is worth it for readers to do the same with their own understanding of the data.</p><p>By this reviewer's understanding (and combining some textbook definitions together) a neurotransmitter: 1) must be present within the presynaptic neuron and stored in vesicles; 2) must be released by depolarization of the presynaptic terminal; 3) must require Ca2+ influx upon depolarization prior to release; 4) must bind specific receptors present on the postsynaptic cell; 5) exogenous transmitter can mimic presynaptic release; 6) there exists a mechanism of removal of the neurotransmitter from the synaptic cleft.</p></disp-quote><p>Response: While any of us can come up with a list according to our own understanding, the paper copies lists from textbooks, especially from Kandel et al. (2021), which lists the same 4 criteria as Kandel et al. (1983), providing consistency and consensus.</p><disp-quote content-type="editor-comment"><p>For a paper to claim that the published work has identified a new neurotransmitter, several of these criteria would be met - and the paper would acknowledge in the discussion which ones have not been met. For this particular paper, this reviewer finds that condition 1 is clearly met.</p><p>Conditions 2 and 3 seem to be met by electrophysiology, but there are caveats here. High KCl stimulation is a blunt instrument that will depolarize absolutely everything in the prep all at once and could result in any number of non-specific biological reactions as a result of K+ rushing into all neurons in the prep. Moreover, the results in 0 Ca2+ are puzzling. For creatine (and for the other neurotransmitters), why is there such a massive uptick in release, even when the extracellular saline is devoid of calcium?</p></disp-quote><p>Response: Classic transmitters are released in a Ca++ dependent manner when stimulated by KCl, though they also had a Ca++ independent component as also shown in our Figure 5 E and F.</p><disp-quote content-type="editor-comment"><p>Condition 4 is not discussed in detail at all. In the discussion, the authors elide the criterion of receptors specified by Purves by inferring that the existence of postsynaptic responses implies the existence of receptors. True, but does it specifically imply the existence of creatinergic receptors? This reviewer does not think that is necessarily the case. The authors should be appropriately circumspect and consider other modes of inhibition that are induced by activation or potentiation of other receptors (e.g., GABAergic or glycinergic).</p></disp-quote><p>Response: Kandel et al. did not list this.</p><disp-quote content-type="editor-comment"><p>Condition 5 may be met, because authors applied exogenous creatine and observed inhibition. However, this is tough to know without understanding the effects of endogenous release of creatine. if they were to test if the absence of creatine caused excess excitation (at putative creatinergic synapses), then that would be supportive of the same. Nicely, Ghirardini et al., 2023 study cited by the reviewers does provide support for this exact notion in pyramidal neurons.</p></disp-quote><p>Response: For most commonly accepted transmitters, this criterion has never been met. For example, the simplest case would be ACh at the neuromuscular junction. Howver, we have now found that choline is clearly present in SVs. So, how does anyone be sure that only ACh is released only, or how does anyone rule out effects of choline on postsynaptic cells when cholinergic neurons are stimulated?</p><p>Many synapses are now known to release more than one transmitter, making it difficult to define the effect of one transmitter released endogenously.</p><p>These are perhaps reasons why some textbooks do not emphasize similarities of endogenously released vs exogenously applied molecules.</p><disp-quote content-type="editor-comment"><p>For condition 6, the authors made a great effort with Slc6a8. This is a very tough criterion to understand or prove for many synapses and neurotransmitters.</p></disp-quote><p>Response: SLC6A8 is a transporter on the cytoplasmic membrane, thus a good candidate for removal of Cr from the synaptic cleft.</p><disp-quote content-type="editor-comment"><p>In terms of fundamental neuroscience, the story should be impactful. There are certainly more neurotransmitters out there than currently identified and by textbook criteria, creatine seems to be one of them taking all of the data in this study and others into account.</p></disp-quote><p>Response: We hope that more will join our lonely efforts in trying to discover more transmitters.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>Since the authors largely disregarded questions in the review process, I do not see a point in listing recommendation for the authors again.</p></disp-quote><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>1. The different sections of the manuscript are not separated by headers.</p></disp-quote><p>Response: We do have separate subheadings.</p><disp-quote content-type="editor-comment"><p>2. The beginning of the results section either does not reference the underlying literature or refers to unpublished data.</p></disp-quote><p>Response: We have a very long introduction which was criticized for being too long and with too much historical citations. We therefore refrained from citation again in the beginning part of the Results section.</p><disp-quote content-type="editor-comment"><p>3. The text contains many opinions and historical information that are not required (e.g., &quot;It has never been easy to discover a new neurotransmitter, especially one in the central nervous system (CNS). We have been searching for new neurotransmitters for 12 years.&quot;; l. 17).</p></disp-quote><p>Response: We would like to keep these because most readers are young and do not know the history and difficulties of discovering transmitters.</p><disp-quote content-type="editor-comment"><p>4. Almeida et al. (2008; doi: 10.1002/syn.20280) provided evidence for electrical activity-, and Ca2+-dependent Cr release from rat brain slices. This paper should be introduced in the introduction.</p></disp-quote><p>Response: Done.</p><disp-quote content-type="editor-comment"><p>5. Fig. 7: A Y-scale for the stimulation protocol is missing.</p></disp-quote><p>Response: Done.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations For The Authors):</bold></p><p>The main suggestion by this reviewer (beyond the details in the public review) was to consider the full spectrum of biology that is consistent with these results. By my reading, creatine could be a neurotransmitter, but other possibilities also exist. The authors have highlighted some of those for their Discussion.</p></disp-quote></body></sub-article></article>